{"doc_id": 0, "doc": {"person_id": 115969842, "visit_occurrence_id": 46071774, "visit_start_datetime": "2011-11-21 10:44:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 123.0, "current_label": 0, "next_value": 102.0, "next_label": 0, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2009-01-08 00:00:00, ended at 2009-01-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-22 12:55:31, ended at 2009-11-22 17:40:53\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-29 09:44:00, ended at 2009-11-29 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 119 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.4 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 09:30:00, ended at 2009-12-30 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study\n\n### Condition\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-03 00:00:00, ended at 2010-01-03 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-01-04 00:00:00, ended at 2010-01-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-26 11:20:22, ended at 2010-01-26 15:28:03\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-01-26 13:39:00, ended at 2010-01-26 20:14:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Disorder of cardiovascular system\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-28 00:00:00, ended at 2010-01-28 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cyanosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-28 08:19:58, ended at 2010-01-28 09:43:49\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-28 09:51:00, ended at 2010-01-28 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 14:17:57, ended at 2010-02-11 14:42:27\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-23 08:56:07, ended at 2010-11-23 11:57:55\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Visual disturbance\n- Hyperlipidemia\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., through Subcutaneous route, started on 2010-11-23, presumably until 2010-11-24, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.5 mL by SUBCUTANEOUS route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-23 10:21:00, ended at 2010-11-23 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-28 13:16:40, ended at 2010-12-28 13:55:25\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-02 09:54:08, ended at 2011-01-02 10:38:28\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-28 10:53:15, ended at 2011-02-28 13:13:17\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-28 00:00:00, ended at 2011-07-28 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-04 22:20:00, ended at 2011-08-05 03:26:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- MCH [Entitic mass] by Automated count: 36.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Hyperlipidemia\n- Dizziness and giddiness\n- Nuclear senile cataract\n- Essential hypertension\n- Gastroesophageal reflux disease\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-05 10:45:10, ended at 2011-09-05 11:33:54\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Right lower quadrant pain\n- Diarrhea\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-09-05, presumably until 2011-10-30, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Deficiency anemias\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 08:40:00, ended at 2011-09-20 12:30:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.04 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 455 (picogram per milliliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopic biopsy of large intestine\n\n### Condition\n- Right lower quadrant pain\n- Deficiency anemias\n- Diarrhea\n- Disorder of intestine\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n- midazolam 1 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-10-21 21:47:00, ended at 2011-10-22 00:08:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Essential hypertension\n- Nausea and vomiting\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n- Chest pain\n- Dizziness and giddiness\n- Disorder of function of stomach\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-10-21, presumably until 2011-10-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-30 11:03:49, ended at 2011-10-30 11:52:44\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Irritable bowel syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-11-07 00:00:00, ended at 2011-11-07 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-21 08:54:05, ended at 2011-11-21 10:26:50\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2012-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2013-02-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-21 10:44:00, ended at 2011-11-21 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 343 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Disorder of hematopoietic structure\n- Benign paroxysmal positional vertigo\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 27, "cumulated_approximate_token_count": 7080}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-01-08 00:00:00, ended at 2009-01-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-22 12:55:31, ended at 2009-11-22 17:40:53\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-29 09:44:00, ended at 2009-11-29 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 119 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.4 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 09:30:00, ended at 2009-12-30 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study\n\n### Condition\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-03 00:00:00, ended at 2010-01-03 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-01-04 00:00:00, ended at 2010-01-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-26 11:20:22, ended at 2010-01-26 15:28:03\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-01-26 13:39:00, ended at 2010-01-26 20:14:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Disorder of cardiovascular system\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-28 00:00:00, ended at 2010-01-28 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cyanosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-28 08:19:58, ended at 2010-01-28 09:43:49\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-28 09:51:00, ended at 2010-01-28 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 14:17:57, ended at 2010-02-11 14:42:27\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-23 08:56:07, ended at 2010-11-23 11:57:55\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Visual disturbance\n- Hyperlipidemia\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., through Subcutaneous route, started on 2010-11-23, presumably until 2010-11-24, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.5 mL by SUBCUTANEOUS route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-23 10:21:00, ended at 2010-11-23 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-28 13:16:40, ended at 2010-12-28 13:55:25\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-02 09:54:08, ended at 2011-01-02 10:38:28\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-28 10:53:15, ended at 2011-02-28 13:13:17\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-28 00:00:00, ended at 2011-07-28 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-04 22:20:00, ended at 2011-08-05 03:26:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- MCH [Entitic mass] by Automated count: 36.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Hyperlipidemia\n- Dizziness and giddiness\n- Nuclear senile cataract\n- Essential hypertension\n- Gastroesophageal reflux disease\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-05 10:45:10, ended at 2011-09-05 11:33:54\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Right lower quadrant pain\n- Diarrhea\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-09-05, presumably until 2011-10-30, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Deficiency anemias\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 08:40:00, ended at 2011-09-20 12:30:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.04 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 455 (picogram per milliliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopic biopsy of large intestine\n\n### Condition\n- Right lower quadrant pain\n- Deficiency anemias\n- Diarrhea\n- Disorder of intestine\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n- midazolam 1 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-10-21 21:47:00, ended at 2011-10-22 00:08:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Essential hypertension\n- Nausea and vomiting\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n- Chest pain\n- Dizziness and giddiness\n- Disorder of function of stomach\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-10-21, presumably until 2011-10-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-30 11:03:49, ended at 2011-10-30 11:52:44\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Irritable bowel syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-11-07 00:00:00, ended at 2011-11-07 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-21 08:54:05, ended at 2011-11-21 10:26:50\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2012-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2013-02-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-21 10:44:00, ended at 2011-11-21 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 343 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Disorder of hematopoietic structure\n- Benign paroxysmal positional vertigo\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 123.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "68f634b4d4cb5f9872dd1cae14f31d05df07798aacce8e5bc5cc831f370d5b0b", "prompt_hash": "565a5968ae937a7c71ba20f925fd4277d3970cb120e4658ca9d2be044ea335e2", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115971386, "visit_occurrence_id": 105074724, "visit_start_datetime": "2017-07-08 00:00:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 105.0, "current_label": 0, "next_value": 114.0, "next_label": 0, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-27 00:00:00, ended at 2014-05-27 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 188 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.62 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 118 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.9 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-06 00:00:00, ended at 2014-06-06 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2014-06-06, presumably until 2015-08-29, with intended 4 refill(s). Instructions: Take 1 tablet by mouth  daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-06 09:46:05, ended at 2014-06-06 12:22:48\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- General examination of patient\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Chronic kidney disease\n- Hyperlipidemia\n- Essential hypertension\n- Nodular prostate without urinary obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-20 09:24:09, ended at 2014-08-20 12:15:16\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Injury of free lower limb\n- Primary diagnosis: Soft tissue injury\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-06 00:00:00, ended at 2014-12-06 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 111 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.43 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 41 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.3 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- MCV [Entitic volume] by Automated count: 88 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 1.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.1 (ratio unit)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-11 00:00:00, ended at 2014-12-11 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2014-12-11, presumably until 2014-12-12, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-05-21 00:00:00, ended at 2015-05-21 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cystatin C [Mass/volume] in Serum or Plasma: 1.06 (milligram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.45 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 128 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-20 00:00:00, ended at 2015-06-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary erectile dysfunction\n\n### Drug\n- sildenafil 25 MG Oral Tablet, through Oral route, started on 2015-06-20, presumably until 2016-06-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-29 00:00:00, ended at 2015-08-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2015-08-29, presumably until 2016-11-29, with intended 4 refill(s). Instructions: Take 1 tablet by mouth   daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-26 00:00:00, ended at 2015-09-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone acetate 25 MG Rectal Suppository, started on 2015-09-28, presumably until 2017-10-07, with intended 0 refill(s). Instructions: INSERT 1 SUPPOSITORY (25MG) BY RECTAL ROUTE 2TIMES EVERY DAY FOR 2 WEEKS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-14 00:00:00, ended at 2015-11-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.42 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Triglyceride [Moles/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-27 00:00:00, ended at 2016-05-27 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio unit)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.53 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 110 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-29 00:00:00, ended at 2016-11-29 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2016-11-29, presumably until 2018-02-02, with intended 4 refill(s). Instructions: Take 1 tablet by mouth   daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-17 00:00:00, ended at 2016-12-17 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.4 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.46 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26 (percent)\n- Albumin/Creatinine [Mass Ratio] in Urine: 8.2 (milligram per gram of creatinine)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 108 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 12.6 (microgram per milliliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 100 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 152.9 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-14 00:00:00, ended at 2017-06-14 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-21 00:00:00, ended at 2017-06-21 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- melatonin 3 MG Oral Tablet, through Oral route, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take by mouth\n- triamcinolone acetonide 0.25 MG/ML Topical Cream, presumably until 2021-08-18, with intended 0 refill(s). Instructions: Apply topically 2 (two) times a day.\n- calcium citrate 950 MG / cholecalciferol 250 UNT Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day Pt takes 2 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-08 00:00:00, ended at 2017-07-08 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 13 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 105 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.56 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 154 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.47 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 17, "cumulated_approximate_token_count": 7442}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-27 00:00:00, ended at 2014-05-27 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 188 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.62 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 118 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.9 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-06 00:00:00, ended at 2014-06-06 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2014-06-06, presumably until 2015-08-29, with intended 4 refill(s). Instructions: Take 1 tablet by mouth  daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-06 09:46:05, ended at 2014-06-06 12:22:48\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- General examination of patient\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Chronic kidney disease\n- Hyperlipidemia\n- Essential hypertension\n- Nodular prostate without urinary obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-20 09:24:09, ended at 2014-08-20 12:15:16\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Injury of free lower limb\n- Primary diagnosis: Soft tissue injury\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-06 00:00:00, ended at 2014-12-06 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 111 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.43 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 41 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.3 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- MCV [Entitic volume] by Automated count: 88 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 1.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.1 (ratio unit)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-11 00:00:00, ended at 2014-12-11 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2014-12-11, presumably until 2014-12-12, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-05-21 00:00:00, ended at 2015-05-21 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cystatin C [Mass/volume] in Serum or Plasma: 1.06 (milligram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.45 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 128 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-20 00:00:00, ended at 2015-06-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary erectile dysfunction\n\n### Drug\n- sildenafil 25 MG Oral Tablet, through Oral route, started on 2015-06-20, presumably until 2016-06-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-29 00:00:00, ended at 2015-08-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2015-08-29, presumably until 2016-11-29, with intended 4 refill(s). Instructions: Take 1 tablet by mouth   daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-26 00:00:00, ended at 2015-09-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone acetate 25 MG Rectal Suppository, started on 2015-09-28, presumably until 2017-10-07, with intended 0 refill(s). Instructions: INSERT 1 SUPPOSITORY (25MG) BY RECTAL ROUTE 2TIMES EVERY DAY FOR 2 WEEKS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-14 00:00:00, ended at 2015-11-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.42 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Triglyceride [Moles/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-27 00:00:00, ended at 2016-05-27 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio unit)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.53 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 110 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-29 00:00:00, ended at 2016-11-29 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2016-11-29, presumably until 2018-02-02, with intended 4 refill(s). Instructions: Take 1 tablet by mouth   daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-17 00:00:00, ended at 2016-12-17 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.4 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.46 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26 (percent)\n- Albumin/Creatinine [Mass Ratio] in Urine: 8.2 (milligram per gram of creatinine)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 108 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 12.6 (microgram per milliliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 100 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 152.9 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-14 00:00:00, ended at 2017-06-14 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-21 00:00:00, ended at 2017-06-21 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- melatonin 3 MG Oral Tablet, through Oral route, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take by mouth\n- triamcinolone acetonide 0.25 MG/ML Topical Cream, presumably until 2021-08-18, with intended 0 refill(s). Instructions: Apply topically 2 (two) times a day.\n- calcium citrate 950 MG / cholecalciferol 250 UNT Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day Pt takes 2 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-08 00:00:00, ended at 2017-07-08 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 13 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 105 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.56 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 154 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.47 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 105.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "a27befac2867d85ada5da5c8ef254eede144a817209c0c4e14a438b44404e666", "prompt_hash": "2569c690882ae229b846e63cce0918438a58db7f625a41daad38a68cdccc161a", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115972706, "visit_occurrence_id": 38676527, "visit_start_datetime": "2010-03-23 10:54:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 68.0, "current_label": 0, "next_value": 69.0, "next_label": 0, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Hospital, started at 2008-01-24 10:08:00, ended at 2008-02-01 13:40:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.6 (second)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 15.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-02-27 07:10:00, ended at 2008-02-27 23:59:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cellulitis and abscess of finger\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-22 00:00:00, ended at 2008-03-22 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 19.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.2 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.76 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- MCV [Entitic volume] by Automated count: 81.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Prothrombin time (PT): 30.6 (second)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 10.1 (micromole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-24 00:00:00, ended at 2008-05-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Prothrombin time (PT): 30.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-05-30 08:07:00, ended at 2008-05-30 16:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-traumatic tendon rupture\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take 30 mg by mouth. TID\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2008-05-30, presumably until 2008-05-30\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2009-05-22. Instructions: take by mouth as needed \n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2008-05-30, presumably until 2008-06-17, with quantity of 12.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-06-17. Instructions: take by mouth. TID\n- warfarin sodium 1 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth. \n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take by mouth daily. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-05-30, presumably until 2008-05-30, with quantity of 55.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-06-19 13:04:00, ended at 2008-06-19 19:47:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cataract\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take 30 mg by mouth 2 times a day. \n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take 2 Caps by mouth 2 times a day. \n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take by mouth daily. \n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-09-01. Instructions: take 25 mg by mouth 2 times a day. \n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- gabapentin 300 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 300 mg by mouth 2 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth daily. \n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-26 00:00:00, ended at 2008-06-26 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 26.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Prothrombin time (PT): 33.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 348 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.45 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-25 00:00:00, ended at 2008-07-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.65 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 346 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Prothrombin time (PT): 32.6 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.3 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-08 00:00:00, ended at 2008-08-08 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 26.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-20 00:00:00, ended at 2008-08-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.5 (percent)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 324 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 64 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Prothrombin time (PT): 31.7 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-04 00:00:00, ended at 2008-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-09 00:00:00, ended at 2008-09-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 77.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Prothrombin time (PT): 29.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-09-11 10:38:00, ended at 2008-09-11 18:15:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2010-09-01. Instructions: take by mouth daily. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth 2 times a day. 09/10/2008\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-23 00:00:00, ended at 2008-09-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- MCV [Entitic volume] by Automated count: 77.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.3 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-09 00:00:00, ended at 2008-10-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 341 (microgram per deciliter)\n- Prothrombin time (PT): 25.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 9 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-24 00:00:00, ended at 2008-10-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 73.8 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 349 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-05 00:00:00, ended at 2008-11-05 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Prothrombin time (PT): 31.6 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 47 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.7 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 59 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.39 (thousand per microliter)\n- Prothrombin time (PT): 31.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.49 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-03 00:00:00, ended at 2008-12-03 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 22.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-09 00:00:00, ended at 2008-12-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- MCV [Entitic volume] by Automated count: 86.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.07 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-09 15:14:00, ended at 2008-12-11 17:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Prothrombin time (PT): 28.2 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.54 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 3.6\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 46.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2009-02-20, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2009-02-27. Instructions: take 325 mg by mouth 2 times a day. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- isosorbide dinitrate 10 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-09\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, presumably until 2008-12-11. Instructions: take 500 mg by mouth 2 times a day. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-11\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-07-03. Instructions: 0.4 mg by Sublingual route as needed \n- ascorbic acid 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 500 mg by mouth 2 times a day. \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-12-10, presumably until 2008-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-24 00:00:00, ended at 2008-12-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 18.7 (second)\n- Tacrolimus [Mass/volume] in Blood: 20.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte sedimentation rate: 0 (millimeter per hour)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-27 00:00:00, ended at 2008-12-27 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-06 00:00:00, ended at 2009-01-06 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Prothrombin time (PT): 27.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-23 00:00:00, ended at 2009-01-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 24.1 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.59 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- MCV [Entitic volume] by Automated count: 89.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-20 00:00:00, ended at 2009-02-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 60 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 68 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.86 (thousand per microliter)\n- Prothrombin time (PT): 29.4 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-02-21 15:20:00, ended at 2009-02-22 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peritonsillar abscess\n\n### Drug\n- clindamycin 150 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-02-21\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-03-01, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution, through Oral route, started on 2009-02-21, presumably until 2009-03-07, with intended 0 refill(s). Instructions: take 25 mL by mouth every 6 hours as needed for Pain. max 4 grams tylenol per day \n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2009-02-21, presumably until 2009-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-02-27 09:12:00, ended at 2009-02-27 17:05:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 36.5 (second)\n- Prothrombin time (PT): 25.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2009-02-27, presumably until 2009-02-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-04 00:00:00, ended at 2009-03-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-03-04 14:48:00, ended at 2009-03-04 17:51:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 51.1 (second)\n- Prothrombin time (PT): 30.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-03-04, presumably until 2009-08-28, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-24 00:00:00, ended at 2009-03-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Prothrombin time (PT): 29.9 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.65 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.38 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-04-07 00:00:00, ended at 2009-04-07 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-04-15 11:24:00, ended at 2009-04-15 13:52:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, presumably until 2009-06-03. Instructions: take by mouth. \n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-04-15, presumably until 2009-04-15\n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-04-15, presumably until 2009-04-15\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- midazolam 1 MG/ML Injectable Solution, started on 2009-04-15, presumably until 2009-04-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-18 00:00:00, ended at 2009-04-18 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of function of stomach\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2009-04-18, presumably until 2012-05-31, with quantity of 90.0, with intended 4 refill(s). Instructions: take 300 mg by mouth daily with dinner. Take T PO every day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-22 00:00:00, ended at 2009-04-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.45 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Prothrombin time (PT): 18.2 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-01 00:00:00, ended at 2009-05-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-22 00:00:00, ended at 2009-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.93 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Prothrombin time (PT): 22.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-28 00:00:00, ended at 2009-05-28 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-05-28, presumably until 2009-10-24, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-29 00:00:00, ended at 2009-05-29 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-05-29, presumably until 2009-09-23, with quantity of 4.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-24 00:00:00, ended at 2009-06-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.8 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.04 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 25.6 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-26 00:00:00, ended at 2009-06-26 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-06-26, presumably until 2009-08-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-07-03 00:00:00, ended at 2009-07-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-24 00:00:00, ended at 2009-07-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Prothrombin time (PT): 28.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-25 00:00:00, ended at 2009-08-25 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 283 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Prothrombin time (PT): 28.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-01 00:00:00, ended at 2009-09-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-03 00:00:00, ended at 2009-09-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-16 00:00:00, ended at 2009-09-16 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2009-09-16, presumably until 2010-09-23, with quantity of 180.0, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-23 00:00:00, ended at 2009-09-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2010-02-23, with quantity of 4.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 12:14:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Prothrombin time (PT): 33.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- MCV [Entitic volume] by Automated count: 83.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.4 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Disorder of phosphorus metabolism\n- Blood chemistry abnormal\n- Hyperlipidemia\n- Closed fracture of distal end of radius\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-30 13:55:43, ended at 2009-09-30 15:19:38\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-01 13:48:16, ended at 2009-10-01 15:06:06\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Disorder of eye due to diabetes mellitus\n- Vitreous hemorrhage\n- Vitreous opacities\n- Epiretinal membrane\n- Vitreous degeneration\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-09 14:34:29, ended at 2009-10-09 15:16:10\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-14 00:00:00, ended at 2009-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-15 13:20:00, ended at 2009-10-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)\n\n### Condition\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 10:24:00, ended at 2009-10-23 11:45:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-23 10:25:09, ended at 2009-10-23 13:40:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intermittent claudication\n- Primary diagnosis: Atherosclerosis of arteries of the extremities\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2009-10-24. Instructions: take by mouth as needed pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 11:46:00, ended at 2009-10-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte sedimentation rate: 3 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.6 (picogram)\n- Prothrombin time (PT): 26.4 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hypersensitivity angiitis\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-12-16, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-03-03, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-30 10:27:40, ended at 2009-10-30 14:31:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-30 10:32:00, ended at 2009-10-30 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-03 00:00:00, ended at 2009-11-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-18 09:47:20, ended at 2009-11-18 10:26:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Routine gynecologic examination\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 10:45:00, ended at 2009-11-21 12:33:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.3 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCV [Entitic volume] by Automated count: 80.0 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Blood chemistry abnormal\n- Disorder of phosphorus metabolism\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 12:34:00, ended at 2009-11-21 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Ultrasound, transvaginal\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-27 00:00:00, ended at 2009-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-27 00:00:00, ended at 2009-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-27 10:40:56, ended at 2009-11-27 12:08:18\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 15:26:00, ended at 2009-12-03 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-15 12:41:04, ended at 2009-12-15 22:21:16\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-15, presumably until 2010-03-31, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-15 13:49:00, ended at 2009-12-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.69 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-15 13:49:00, ended at 2009-12-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-16 12:24:00, ended at 2009-12-16 15:30:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Disorder of upper gastrointestinal tract\n- Dysphagia\n- Epigastric pain\n- Gastritis\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-12-16, presumably until 2009-12-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-12-16, presumably until 2009-12-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-12-23 00:00:00, ended at 2009-12-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-04-28, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. 09/10/2008 \n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-12-31, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 11:21:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3.91 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.76 (million per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 75 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.1 (femtoliter)\n- Prothrombin time (PT): 36.3 (second)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 67 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 310 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypersensitivity angiitis\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-29 10:13:32, ended at 2009-12-29 11:07:58\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-29 14:08:15, ended at 2009-12-29 17:53:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose veins of lower extremity with inflammation\n\n### Drug\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, started on 2009-12-29, presumably until 2010-12-29, with intended 3 refill(s). Instructions: by Topical route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-01 08:32:00, ended at 2010-01-01 12:05:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Esophageal motility (manometric study of the esophagus and/or gastroesophageal junction) study with interpretation and report\n- Other nonoperative measurements and examinations\n- Esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation\n\n### Condition\n- Abdominal pain\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-01-01, presumably until 2010-01-01\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2010-01-01, presumably until 2010-01-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-07 00:00:00, ended at 2010-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-08 13:03:00, ended at 2010-01-08 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Female genital organ symptoms\n- Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-14 00:00:00, ended at 2010-01-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-22 09:37:00, ended at 2010-01-22 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.1 (second)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.80 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 318 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-03 10:49:40, ended at 2010-02-03 11:50:41\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphagia\n- Acute pharyngitis\n- Nausea and vomiting\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-02-04 00:00:00, ended at 2010-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-02-12, presumably until 2010-06-19, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-02-09 16:04:00, ended at 2010-02-09 17:35:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Superficial foreign body\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2010-02-09, presumably until 2010-02-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 10:46:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n\n### Condition\n- Acute pharyngitis\n- Gastroesophageal reflux disease\n- Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-23 00:00:00, ended at 2010-02-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-23 10:41:40, ended at 2010-02-23 11:57:43\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Neurogenic bladder\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-23 12:03:00, ended at 2010-02-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Prothrombin time (PT): 22.7 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Coronary arteriosclerosis\n- Hyperlipidemia\n- Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-24 00:00:00, ended at 2010-02-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-06-30, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-03 00:00:00, ended at 2010-03-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-07-22, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-12 09:54:00, ended at 2010-03-12 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gastric emptying imaging study (eg, solid, liquid, or both)\n- Gastroesophageal reflux study\n\n### Condition\n- Peripheral vascular disease\n- Flatulence, eructation and gas pain\n- Hyperlipidemia\n- Nonproliferative retinopathy due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Nausea and vomiting\n- Coronary arteriosclerosis\n- Disorder of eye due to diabetes mellitus\n- Systemic lupus erythematosus\n- Chronic kidney disease stage 5 due to hypertension\n- End-stage renal disease\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-23 10:54:00, ended at 2010-03-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 68 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Prothrombin time (PT): 21.0 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 73.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 97, "cumulated_approximate_token_count": 37086}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Hospital, started at 2008-01-24 10:08:00, ended at 2008-02-01 13:40:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.6 (second)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 15.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-02-27 07:10:00, ended at 2008-02-27 23:59:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cellulitis and abscess of finger\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-22 00:00:00, ended at 2008-03-22 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 19.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.2 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.76 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- MCV [Entitic volume] by Automated count: 81.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Prothrombin time (PT): 30.6 (second)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 10.1 (micromole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-24 00:00:00, ended at 2008-05-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Prothrombin time (PT): 30.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-05-30 08:07:00, ended at 2008-05-30 16:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-traumatic tendon rupture\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take 30 mg by mouth. TID\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2008-05-30, presumably until 2008-05-30\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2009-05-22. Instructions: take by mouth as needed \n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2008-05-30, presumably until 2008-06-17, with quantity of 12.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-06-17. Instructions: take by mouth. TID\n- warfarin sodium 1 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth. \n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take by mouth daily. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-05-30, presumably until 2008-05-30, with quantity of 55.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-06-19 13:04:00, ended at 2008-06-19 19:47:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cataract\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take 30 mg by mouth 2 times a day. \n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take 2 Caps by mouth 2 times a day. \n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take by mouth daily. \n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-09-01. Instructions: take 25 mg by mouth 2 times a day. \n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- gabapentin 300 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 300 mg by mouth 2 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth daily. \n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-26 00:00:00, ended at 2008-06-26 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 26.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Prothrombin time (PT): 33.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 348 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.45 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-25 00:00:00, ended at 2008-07-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.65 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 346 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Prothrombin time (PT): 32.6 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.3 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-08 00:00:00, ended at 2008-08-08 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 26.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-20 00:00:00, ended at 2008-08-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.5 (percent)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 324 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 64 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Prothrombin time (PT): 31.7 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-04 00:00:00, ended at 2008-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-09 00:00:00, ended at 2008-09-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 77.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Prothrombin time (PT): 29.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-09-11 10:38:00, ended at 2008-09-11 18:15:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2010-09-01. Instructions: take by mouth daily. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth 2 times a day. 09/10/2008\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-23 00:00:00, ended at 2008-09-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- MCV [Entitic volume] by Automated count: 77.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.3 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-09 00:00:00, ended at 2008-10-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 341 (microgram per deciliter)\n- Prothrombin time (PT): 25.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 9 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-24 00:00:00, ended at 2008-10-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 73.8 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 349 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-05 00:00:00, ended at 2008-11-05 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Prothrombin time (PT): 31.6 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 47 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.7 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 59 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.39 (thousand per microliter)\n- Prothrombin time (PT): 31.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.49 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-03 00:00:00, ended at 2008-12-03 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 22.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-09 00:00:00, ended at 2008-12-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- MCV [Entitic volume] by Automated count: 86.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.07 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-09 15:14:00, ended at 2008-12-11 17:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Prothrombin time (PT): 28.2 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.54 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 3.6\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 46.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2009-02-20, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2009-02-27. Instructions: take 325 mg by mouth 2 times a day. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- isosorbide dinitrate 10 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-09\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, presumably until 2008-12-11. Instructions: take 500 mg by mouth 2 times a day. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-11\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-07-03. Instructions: 0.4 mg by Sublingual route as needed \n- ascorbic acid 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 500 mg by mouth 2 times a day. \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-12-10, presumably until 2008-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-24 00:00:00, ended at 2008-12-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 18.7 (second)\n- Tacrolimus [Mass/volume] in Blood: 20.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte sedimentation rate: 0 (millimeter per hour)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-27 00:00:00, ended at 2008-12-27 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-06 00:00:00, ended at 2009-01-06 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Prothrombin time (PT): 27.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-23 00:00:00, ended at 2009-01-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 24.1 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.59 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- MCV [Entitic volume] by Automated count: 89.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-20 00:00:00, ended at 2009-02-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 60 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 68 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.86 (thousand per microliter)\n- Prothrombin time (PT): 29.4 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-02-21 15:20:00, ended at 2009-02-22 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peritonsillar abscess\n\n### Drug\n- clindamycin 150 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-02-21\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-03-01, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution, through Oral route, started on 2009-02-21, presumably until 2009-03-07, with intended 0 refill(s). Instructions: take 25 mL by mouth every 6 hours as needed for Pain. max 4 grams tylenol per day \n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2009-02-21, presumably until 2009-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-02-27 09:12:00, ended at 2009-02-27 17:05:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 36.5 (second)\n- Prothrombin time (PT): 25.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2009-02-27, presumably until 2009-02-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-04 00:00:00, ended at 2009-03-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-03-04 14:48:00, ended at 2009-03-04 17:51:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 51.1 (second)\n- Prothrombin time (PT): 30.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-03-04, presumably until 2009-08-28, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-24 00:00:00, ended at 2009-03-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Prothrombin time (PT): 29.9 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.65 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.38 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-04-07 00:00:00, ended at 2009-04-07 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-04-15 11:24:00, ended at 2009-04-15 13:52:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, presumably until 2009-06-03. Instructions: take by mouth. \n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-04-15, presumably until 2009-04-15\n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-04-15, presumably until 2009-04-15\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- midazolam 1 MG/ML Injectable Solution, started on 2009-04-15, presumably until 2009-04-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-18 00:00:00, ended at 2009-04-18 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of function of stomach\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2009-04-18, presumably until 2012-05-31, with quantity of 90.0, with intended 4 refill(s). Instructions: take 300 mg by mouth daily with dinner. Take T PO every day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-22 00:00:00, ended at 2009-04-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.45 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Prothrombin time (PT): 18.2 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-01 00:00:00, ended at 2009-05-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-22 00:00:00, ended at 2009-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.93 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Prothrombin time (PT): 22.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-28 00:00:00, ended at 2009-05-28 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-05-28, presumably until 2009-10-24, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-29 00:00:00, ended at 2009-05-29 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-05-29, presumably until 2009-09-23, with quantity of 4.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-24 00:00:00, ended at 2009-06-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.8 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.04 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 25.6 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-26 00:00:00, ended at 2009-06-26 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-06-26, presumably until 2009-08-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-07-03 00:00:00, ended at 2009-07-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-24 00:00:00, ended at 2009-07-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Prothrombin time (PT): 28.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-25 00:00:00, ended at 2009-08-25 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 283 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Prothrombin time (PT): 28.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-01 00:00:00, ended at 2009-09-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-03 00:00:00, ended at 2009-09-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-16 00:00:00, ended at 2009-09-16 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2009-09-16, presumably until 2010-09-23, with quantity of 180.0, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-23 00:00:00, ended at 2009-09-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2010-02-23, with quantity of 4.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 12:14:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Prothrombin time (PT): 33.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- MCV [Entitic volume] by Automated count: 83.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.4 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Disorder of phosphorus metabolism\n- Blood chemistry abnormal\n- Hyperlipidemia\n- Closed fracture of distal end of radius\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-30 13:55:43, ended at 2009-09-30 15:19:38\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-01 13:48:16, ended at 2009-10-01 15:06:06\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Disorder of eye due to diabetes mellitus\n- Vitreous hemorrhage\n- Vitreous opacities\n- Epiretinal membrane\n- Vitreous degeneration\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-09 14:34:29, ended at 2009-10-09 15:16:10\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-14 00:00:00, ended at 2009-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-15 13:20:00, ended at 2009-10-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)\n\n### Condition\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 10:24:00, ended at 2009-10-23 11:45:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-23 10:25:09, ended at 2009-10-23 13:40:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intermittent claudication\n- Primary diagnosis: Atherosclerosis of arteries of the extremities\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2009-10-24. Instructions: take by mouth as needed pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 11:46:00, ended at 2009-10-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte sedimentation rate: 3 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.6 (picogram)\n- Prothrombin time (PT): 26.4 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hypersensitivity angiitis\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-12-16, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-03-03, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-30 10:27:40, ended at 2009-10-30 14:31:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-30 10:32:00, ended at 2009-10-30 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-03 00:00:00, ended at 2009-11-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-18 09:47:20, ended at 2009-11-18 10:26:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Routine gynecologic examination\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 10:45:00, ended at 2009-11-21 12:33:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.3 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCV [Entitic volume] by Automated count: 80.0 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Blood chemistry abnormal\n- Disorder of phosphorus metabolism\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 12:34:00, ended at 2009-11-21 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Ultrasound, transvaginal\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-27 00:00:00, ended at 2009-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-27 00:00:00, ended at 2009-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-27 10:40:56, ended at 2009-11-27 12:08:18\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 15:26:00, ended at 2009-12-03 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-15 12:41:04, ended at 2009-12-15 22:21:16\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-15, presumably until 2010-03-31, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-15 13:49:00, ended at 2009-12-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.69 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-15 13:49:00, ended at 2009-12-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-16 12:24:00, ended at 2009-12-16 15:30:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Disorder of upper gastrointestinal tract\n- Dysphagia\n- Epigastric pain\n- Gastritis\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-12-16, presumably until 2009-12-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-12-16, presumably until 2009-12-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-12-23 00:00:00, ended at 2009-12-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-04-28, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. 09/10/2008 \n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-12-31, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 11:21:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3.91 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.76 (million per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 75 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.1 (femtoliter)\n- Prothrombin time (PT): 36.3 (second)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 67 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 310 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypersensitivity angiitis\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-29 10:13:32, ended at 2009-12-29 11:07:58\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-29 14:08:15, ended at 2009-12-29 17:53:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose veins of lower extremity with inflammation\n\n### Drug\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, started on 2009-12-29, presumably until 2010-12-29, with intended 3 refill(s). Instructions: by Topical route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-01 08:32:00, ended at 2010-01-01 12:05:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Esophageal motility (manometric study of the esophagus and/or gastroesophageal junction) study with interpretation and report\n- Other nonoperative measurements and examinations\n- Esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation\n\n### Condition\n- Abdominal pain\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-01-01, presumably until 2010-01-01\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2010-01-01, presumably until 2010-01-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-07 00:00:00, ended at 2010-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-08 13:03:00, ended at 2010-01-08 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Female genital organ symptoms\n- Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-14 00:00:00, ended at 2010-01-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-22 09:37:00, ended at 2010-01-22 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.1 (second)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.80 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 318 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-03 10:49:40, ended at 2010-02-03 11:50:41\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphagia\n- Acute pharyngitis\n- Nausea and vomiting\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-02-04 00:00:00, ended at 2010-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-02-12, presumably until 2010-06-19, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-02-09 16:04:00, ended at 2010-02-09 17:35:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Superficial foreign body\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2010-02-09, presumably until 2010-02-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 10:46:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n\n### Condition\n- Acute pharyngitis\n- Gastroesophageal reflux disease\n- Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-23 00:00:00, ended at 2010-02-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-23 10:41:40, ended at 2010-02-23 11:57:43\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Neurogenic bladder\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-23 12:03:00, ended at 2010-02-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Prothrombin time (PT): 22.7 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Coronary arteriosclerosis\n- Hyperlipidemia\n- Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-24 00:00:00, ended at 2010-02-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-06-30, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-03 00:00:00, ended at 2010-03-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-07-22, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-12 09:54:00, ended at 2010-03-12 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gastric emptying imaging study (eg, solid, liquid, or both)\n- Gastroesophageal reflux study\n\n### Condition\n- Peripheral vascular disease\n- Flatulence, eructation and gas pain\n- Hyperlipidemia\n- Nonproliferative retinopathy due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Nausea and vomiting\n- Coronary arteriosclerosis\n- Disorder of eye due to diabetes mellitus\n- Systemic lupus erythematosus\n- Chronic kidney disease stage 5 due to hypertension\n- End-stage renal disease\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-23 10:54:00, ended at 2010-03-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 68 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Prothrombin time (PT): 21.0 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 73.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 68.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "4c293235c7e190177f16e008f8b6c7b2bb9aca7133ab5a6d146c79671ee7422a", "prompt_hash": "207d452b897d1c0de14299495567e23819dc68cc22e070f002bb3c1be9f23653", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115973298, "visit_occurrence_id": 178411357, "visit_start_datetime": "2021-05-08 00:00:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 102.0, "current_label": 0, "next_value": 86.0, "next_label": 0, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-05 00:00:00, ended at 2019-11-05 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.8 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-12 14:34:26, ended at 2019-11-12 15:40:52\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gastroesophageal reflux disease without esophagitis\n- Obesity\n- Diaphragmatic hernia\n- Impaired glucose tolerance\n- Pure hypercholesterolemia\n\n### Drug\n- candesartan cilexetil 16 MG Oral Tablet, through Oral route, started on 2019-07-28, presumably until 2019-12-24, with intended 0 refill(s). Instructions: take 32 mg by mouth every bedtime\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2019-03-02, presumably until 2020-01-21, with intended 0 refill(s). Instructions: take 60 mg by mouth every bedtime\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2019-04-30, presumably until 2020-01-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n- ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-12-16, presumably until 2019-11-12, with intended 0 refill(s). Instructions: 1 Spray by Nasal route\n- betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Cream, through Topical route, started on 2014-02-08, presumably until 2019-11-27, with intended 0 refill(s). Instructions: by Topical route\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-06-20, presumably until 2020-03-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-19 00:00:00, ended at 2019-11-19 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 106 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired glucose tolerance\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-27 15:09:41, ended at 2019-11-27 15:39:01\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Impaired fasting glycemia\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-03 07:17:00, ended at 2019-12-03 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 16 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-02-15, with intended 3 refill(s). Instructions: take 32 mg by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-21 00:00:00, ended at 2020-01-21 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2021-01-16, with intended 3 refill(s). Instructions: take 1.5 Tabs (60 mg total) by mouth every bedtime\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2021-01-26, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-15 00:00:00, ended at 2020-02-15 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 32 MG Oral Tablet, through Oral route, started on 2020-02-15, presumably until 2021-02-14, with intended 4 refill(s). Instructions: take 32 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-22 00:00:00, ended at 2020-02-22 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 21 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-03-01 14:44:24, ended at 2020-03-01 15:37:16\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Pure hypercholesterolemia\n- Primary diagnosis: Impaired fasting glycemia\n- Essential hypertension\n\n### Drug\n- 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection, through Intramuscular route, started on 2020-03-01, presumably until 2020-03-01, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- amoxicillin 500 MG Oral Tablet, started on 2020-02-29, presumably until 2020-07-14, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-11 00:00:00, ended at 2020-04-11 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 2\n- Primary diagnosis: Chronic kidney disease due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-01 13:40:00, ended at 2020-06-01 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Chronic kidney disease stage 2\n- Chronic kidney disease due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-13 00:00:00, ended at 2020-07-13 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 89 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: 0-10 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.2 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-14 13:51:07, ended at 2020-07-14 14:40:06\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Pure hypercholesterolemia\n- Hyperkalemia\n- Primary diagnosis: Chronic kidney disease stage 2\n- Obesity\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2020-07-14, presumably until 2020-12-26, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Folate [Mass/volume] in Serum or Plasma: 6.6 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 537 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Chronic kidney disease due to hypertension\n- Chronic kidney disease stage 2\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 10:17:37, ended at 2020-07-29 11:00:09\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Obesity\n- Primary diagnosis: Chronic kidney disease stage 2\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-07-29, presumably until 2021-05-23, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-12 09:59:41, ended at 2020-08-12 10:20:55\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Chronic kidney disease stage 2\n- Hyperglycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to hypertension\n- Benign prostatic hyperplasia\n- Finding of frequency of urination\n- Chronic kidney disease stage 2\n- Primary diagnosis: Pure hypercholesterolemia\n- Impaired fasting glycemia\n- Malaise\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-08 00:00:00, ended at 2020-11-08 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.20 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to hypertension\n- Hyperglycemia\n- Chronic kidney disease stage 2\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 13:14:23, ended at 2020-11-14 13:49:50\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.4 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Body height: 6' 1\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 88 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Primary diagnosis: Chronic kidney disease stage 2\n- Disorder of hematopoietic structure\n- Obesity\n- Hyperglycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-26 00:00:00, ended at 2020-12-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, started on 2020-12-26, presumably until 2021-12-18, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-16 00:00:00, ended at 2021-01-16 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2021-01-16, presumably until 2021-02-20, with intended 3 refill(s). Instructions: TAKE 1 AND 1/2 TABLETS     (=60MG) AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2021-01-26, presumably until 2022-01-27, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-10 00:00:00, ended at 2021-02-10 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-14 13:08:00, ended at 2021-02-14 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-14 13:08:28, ended at 2021-02-14 15:01:06\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-20 11:16:43, ended at 2021-02-20 11:58:18\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain of left knee region\n- Obesity\n- Primary diagnosis: Chronic kidney disease stage 2\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Disorder of hematopoietic structure\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n- Chronic pain\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2021-02-20, presumably until 2021-02-25, with intended 2 refill(s). Instructions: Apply to left knee painful area 4 times daily prn for pain\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-02-20, presumably until 2021-05-23, with intended 1 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-25 00:00:00, ended at 2021-02-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2021-02-25, presumably until 2021-12-05, with intended 2 refill(s). Instructions: Apply to left knee painful area 4 times daily prn for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-27 00:00:00, ended at 2021-02-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 32 MG Oral Tablet, started on 2021-02-28, presumably until 2022-02-27, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-08 00:00:00, ended at 2021-05-08 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 102 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.26 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 30, "cumulated_approximate_token_count": 8326}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-05 00:00:00, ended at 2019-11-05 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.8 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-12 14:34:26, ended at 2019-11-12 15:40:52\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gastroesophageal reflux disease without esophagitis\n- Obesity\n- Diaphragmatic hernia\n- Impaired glucose tolerance\n- Pure hypercholesterolemia\n\n### Drug\n- candesartan cilexetil 16 MG Oral Tablet, through Oral route, started on 2019-07-28, presumably until 2019-12-24, with intended 0 refill(s). Instructions: take 32 mg by mouth every bedtime\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2019-03-02, presumably until 2020-01-21, with intended 0 refill(s). Instructions: take 60 mg by mouth every bedtime\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2019-04-30, presumably until 2020-01-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n- ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-12-16, presumably until 2019-11-12, with intended 0 refill(s). Instructions: 1 Spray by Nasal route\n- betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Cream, through Topical route, started on 2014-02-08, presumably until 2019-11-27, with intended 0 refill(s). Instructions: by Topical route\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-06-20, presumably until 2020-03-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-19 00:00:00, ended at 2019-11-19 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 106 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired glucose tolerance\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-27 15:09:41, ended at 2019-11-27 15:39:01\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Impaired fasting glycemia\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-03 07:17:00, ended at 2019-12-03 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 16 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-02-15, with intended 3 refill(s). Instructions: take 32 mg by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-21 00:00:00, ended at 2020-01-21 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2021-01-16, with intended 3 refill(s). Instructions: take 1.5 Tabs (60 mg total) by mouth every bedtime\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2021-01-26, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-15 00:00:00, ended at 2020-02-15 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 32 MG Oral Tablet, through Oral route, started on 2020-02-15, presumably until 2021-02-14, with intended 4 refill(s). Instructions: take 32 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-22 00:00:00, ended at 2020-02-22 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 21 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-03-01 14:44:24, ended at 2020-03-01 15:37:16\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Pure hypercholesterolemia\n- Primary diagnosis: Impaired fasting glycemia\n- Essential hypertension\n\n### Drug\n- 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection, through Intramuscular route, started on 2020-03-01, presumably until 2020-03-01, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- amoxicillin 500 MG Oral Tablet, started on 2020-02-29, presumably until 2020-07-14, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-11 00:00:00, ended at 2020-04-11 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 2\n- Primary diagnosis: Chronic kidney disease due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-01 13:40:00, ended at 2020-06-01 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Chronic kidney disease stage 2\n- Chronic kidney disease due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-13 00:00:00, ended at 2020-07-13 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 89 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: 0-10 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.2 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-14 13:51:07, ended at 2020-07-14 14:40:06\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Pure hypercholesterolemia\n- Hyperkalemia\n- Primary diagnosis: Chronic kidney disease stage 2\n- Obesity\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2020-07-14, presumably until 2020-12-26, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Folate [Mass/volume] in Serum or Plasma: 6.6 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 537 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Chronic kidney disease due to hypertension\n- Chronic kidney disease stage 2\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 10:17:37, ended at 2020-07-29 11:00:09\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Obesity\n- Primary diagnosis: Chronic kidney disease stage 2\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-07-29, presumably until 2021-05-23, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-12 09:59:41, ended at 2020-08-12 10:20:55\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Chronic kidney disease stage 2\n- Hyperglycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to hypertension\n- Benign prostatic hyperplasia\n- Finding of frequency of urination\n- Chronic kidney disease stage 2\n- Primary diagnosis: Pure hypercholesterolemia\n- Impaired fasting glycemia\n- Malaise\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-08 00:00:00, ended at 2020-11-08 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.20 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to hypertension\n- Hyperglycemia\n- Chronic kidney disease stage 2\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 13:14:23, ended at 2020-11-14 13:49:50\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.4 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Body height: 6' 1\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 88 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Primary diagnosis: Chronic kidney disease stage 2\n- Disorder of hematopoietic structure\n- Obesity\n- Hyperglycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-26 00:00:00, ended at 2020-12-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, started on 2020-12-26, presumably until 2021-12-18, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-16 00:00:00, ended at 2021-01-16 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2021-01-16, presumably until 2021-02-20, with intended 3 refill(s). Instructions: TAKE 1 AND 1/2 TABLETS     (=60MG) AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2021-01-26, presumably until 2022-01-27, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-10 00:00:00, ended at 2021-02-10 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-14 13:08:00, ended at 2021-02-14 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-14 13:08:28, ended at 2021-02-14 15:01:06\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-20 11:16:43, ended at 2021-02-20 11:58:18\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain of left knee region\n- Obesity\n- Primary diagnosis: Chronic kidney disease stage 2\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Disorder of hematopoietic structure\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n- Chronic pain\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2021-02-20, presumably until 2021-02-25, with intended 2 refill(s). Instructions: Apply to left knee painful area 4 times daily prn for pain\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-02-20, presumably until 2021-05-23, with intended 1 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-25 00:00:00, ended at 2021-02-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2021-02-25, presumably until 2021-12-05, with intended 2 refill(s). Instructions: Apply to left knee painful area 4 times daily prn for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-27 00:00:00, ended at 2021-02-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 32 MG Oral Tablet, started on 2021-02-28, presumably until 2022-02-27, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-08 00:00:00, ended at 2021-05-08 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 102 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.26 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 102.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "e8c7a29c6e4f2cf53b1a1cd9bfe45760220295fdcade8ab6c78e37623287b35b", "prompt_hash": "cdf64a83c84945891f667dcc57bf32a2315b470d256dcf8a4131a2bd5416eb92", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115968228, "visit_occurrence_id": 108054793, "visit_start_datetime": "2017-08-24 00:00:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 74.0, "current_label": 0, "next_value": 83.0, "next_label": 0, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-11 00:00:00, ended at 2013-01-11 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-01-27 20:42:00, ended at 2013-02-05 17:30:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 178 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 109.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 89 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Prothrombin time (PT): 18.0 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 7 (nanogram per milliliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.48 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 37.8 (picogram)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.95 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 69 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46.9 (percent)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 11.7 (microgram per milliliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 200 (cells)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.09 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 410 (nanogram per milliliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 294 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 825 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.91 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 39 (percent)\n\n### Procedure\n- Phlebography of the portal venous system using contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract formation/dilatation, stent placement and all associated imag\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Intra-abdominal venous shunt\n- Computed tomography, abdomen; with contrast material(s)\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Acquired absence of organ\n- Hypovolemia\n- Chronic lymphoid leukemia, disease\n- Esophageal varices associated with another disorder\n- Leukocytosis\n- Thrombocytopenic disorder\n- Viral hepatitis B without hepatic coma\n- Hypervolemia\n- Hypo-osmolality and or hyponatremia\n- Interstitial emphysema of lung\n- Coag./bleeding tests abnormal\n- Pleural effusion\n- Primary diagnosis: Cirrhosis - non-alcoholic\n- Non-infectious disorder of lymphatics\n- Swelling of limb\n- Deficiency anemias\n- Lung field abnormal\n- Pneumothorax\n- Splenomegaly\n- Viral hepatitis C\n- Ascites\n- Portal hypertension\n- Sequela of chronic liver disease\n\n### Drug\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2013-01-30, presumably until 2013-02-03\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2013-01-29, presumably until 2013-01-31\n- spironolactone 100 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-01\n- nadolol 40 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-07-08. Instructions: take 40 mg by mouth daily.  \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2014-02-04, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-02-02, presumably until 2013-02-02\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-01-31, presumably until 2013-02-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-04\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2013-02-02, presumably until 2013-02-05\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2013-02-04, presumably until 2013-06-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-02-01, presumably until 2013-02-05\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-07-12. Instructions: take 40 mg by mouth daily.  \n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-05\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-01-30, presumably until 2013-01-31\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-02-01, presumably until 2013-02-01\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-02-02, presumably until 2014-02-04, with intended 3 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2013-02-02, presumably until 2014-02-04, with intended 3 refill(s). Instructions: take 3 Tabs by mouth daily.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-01-27, presumably until 2013-06-20. Instructions: take 0.4 mg by mouth Every Day.  \n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-01-31, presumably until 2013-02-04\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-02-04, presumably until 2013-08-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2013-01-29, presumably until 2013-01-30\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-01-27, presumably until 2013-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-02-03 00:00:00, ended at 2013-02-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); intrahepatic or portal circulation (eg, transvenous intrahepatic portosystemic shunt[s] [TIPS])\n\n### Condition\n- Cirrhosis - non-alcoholic\n- Pneumothorax\n- Pleural effusion\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-02-03, presumably until 2013-02-03\n- 500 ML sodium chloride 30 MG/ML Injection, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-02-03, presumably until 2013-02-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-31 00:00:00, ended at 2013-03-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-03-31, presumably until 2013-07-08, with intended 11 refill(s). Instructions: take 15 mL by mouth 2 times a day. Titrate to achieve BM 3-4x/daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-01 10:17:00, ended at 2013-04-01 10:22:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-01 10:23:00, ended at 2013-04-01 23:59:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 186 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 19 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 185 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 115 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.22 (million per microliter)\n- MCH [Entitic mass] by Automated count: 38.0 (picogram)\n- Neutrophils [#/volume] in Blood by Manual count: 5.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 76 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 212 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 43 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 269 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 789 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Prothrombin time (PT): 17.5 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 110.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-06-20 17:47:00, ended at 2013-07-08 15:35:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 774 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 69 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 6.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 152 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 278 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Osmolality of Serum or Plasma: 261 (milliosmole per kilogram)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 15.5 (microgram per milliliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 134 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 397 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 242 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.66 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 64.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 6.3 (millimole per liter)\n- Prothrombin time (PT): N/A (second)\n- Thrombin time: 18.9 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.0 (second)\n- Body height: 5' 10\" (inch (US))\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 154 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 116 (percent)\n- Lactate [Moles/volume] in Blood: 1.2 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 82 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 9.74 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 113.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.76 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 175.3 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.87 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Left ventricular Ejection fraction: 62 (percent)\n- MCH [Entitic mass] by Automated count: 39.2 (picogram)\n- Osmolality of Urine: 319 (milliosmole per kilogram)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n- Angioplasty of other non-coronary vessel(s)\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Thoracentesis\n- Revision of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract recannulization/dilatation, stent placement and all associated\n- Thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Procedure on single vessel\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n\n### Condition\n- Allergic reaction caused by insect bite and/or insect sting\n- Esophageal varices\n- Anemia\n- Gastroesophageal reflux disease\n- Viral hepatitis C\n- Acquired absence of organ\n- Candidiasis of urogenital site\n- Cirrhosis - non-alcoholic\n- Depressive disorder\n- Hyperkalemia\n- Thrombocytopenic disorder\n- Acute renal failure syndrome\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Primary bacterial peritonitis\n- Altered mental status\n- Hepatic coma due to viral hepatitis C\n- Lung field abnormal\n- Sequela of chronic liver disease\n- Ascites\n- Atelectasis\n- Cramp in limb\n- Pleural effusion\n- Portal hypertension\n- Cardiomegaly\n- Chronic lymphoid leukemia in remission\n- Chronic lymphoid leukemia, disease\n- Edema\n- Hyperosmolality and or hypernatremia\n- Incontinence of feces\n- Splenomegaly\n- Premature beats\n\n### Drug\n- nadolol 20 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-06-23\n- vitamin K1 5 MG Oral Tablet, through Oral route, started on 2013-06-20, presumably until 2013-07-07\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2013-06-29, presumably until 2013-07-08\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2013-06-20, presumably until 2013-06-23\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-08\n- spironolactone 100 MG Oral Tablet, through Oral route, started on 2013-07-08, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- nadolol 40 MG Oral Tablet, through Oral route, started on 2013-06-24, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-08\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-06-23, presumably until 2013-07-03\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2013-06-28, presumably until 2013-06-30\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-06-20, presumably until 2013-06-20\n- amphotericin B 50 MG Injection, started on 2013-07-04, presumably until 2013-07-08\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2013-06-27, presumably until 2013-07-08\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2013-07-03, presumably until 2013-07-03\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2013-09-01. Instructions: take 2,000 mg by mouth daily.\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-06-21, presumably until 2013-06-30\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-29, presumably until 2013-07-08\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2013-06-21, presumably until 2013-06-23\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2013-06-29, presumably until 2013-07-01\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2013-07-01, presumably until 2013-07-01\n- cholecalciferol 0.05 MG Oral Capsule, through Oral route, presumably until 2013-09-01. Instructions: take 1 Cap by mouth Every Day.\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2013-06-26, presumably until 2013-06-26\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-06-26, presumably until 2013-06-27\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2013-06-20, presumably until 2013-06-20\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-06-21, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 30 mL by mouth every 6 hours.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2013-06-26, presumably until 2013-06-27\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2013-06-28, presumably until 2013-06-30\n- phenazopyridine hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-07-06, presumably until 2013-07-08\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2013-07-01, presumably until 2013-09-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML Injection, through Intravenous route, started on 2013-07-03, presumably until 2013-07-04\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-06-23, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-02\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2013-07-02, presumably until 2013-07-08\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2013-06-28, presumably until 2013-06-30\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-06-21, presumably until 2013-06-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-22 00:00:00, ended at 2013-06-22 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic lymphoid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-12 09:28:00, ended at 2013-07-12 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.323\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic lymphoid leukemia, disease\n- Primary diagnosis: Lymphocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-15 09:38:28, ended at 2013-07-15 09:46:40\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral hepatitis C\n- Chronic lymphoid leukemia, disease\n- Cirrhosis - non-alcoholic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-08-07 10:15:00, ended at 2013-09-01 15:40:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 68 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 41.5 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 54.6 (second)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: <5.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.44 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 529 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.5 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 23 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Body height: 5' 7.323\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 216 (microgram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.21 (milli-international unit per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 9.0 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 23 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 296 (unit per liter)\n- MCH [Entitic mass] by Automated count: 37.7 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Prothrombin time (PT): 29.8 (second)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 57.1 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 89 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 52 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 24 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: >10.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.0 (millimole per liter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 83 (millimeter mercury column)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Selective catheter placement, venous system; first order branch (eg, renal vein, jugular vein)\n- Packed blood cell transfusion\n- Transjugular biopsy of liver\n- Central venous catheter placement with guidance\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Thoracentesis\n- Controlled ventilation procedure and therapy, initiation and management\n- Transcatheter biopsy\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Transfusion of coagulation factors\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Occupational therapy re-evaluation\n- Splitting of blood or blood products, each unit\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Delayed allogeneic transplantation, cadaver donor\n- Collection of blood specimen from a completely implantable venous access device\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Continuous invasive mechanical ventilation for less than 96 consecutive hours\n- Platelet transfusion\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Physical therapy evaluation\n- Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\n- Other transplant of liver\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transfusion of other serum\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Physical therapy re-evaluation\n- Insertion of pleural tube drain\n- Cholecystectomy\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Transcatheter biopsy, radiological supervision and interpretation\n- Other incision of other bile duct\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Infusion of immunosuppressive antibody therapy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n- Pooling of platelets or other blood products\n\n### Condition\n- Acute tubular necrosis\n- Cardiac arrhythmia\n- Electrocardiogram abnormal\n- Postprocedural state finding\n- Candidiasis\n- Delirium\n- Depressive disorder\n- Low blood pressure\n- Malaise\n- Primary diagnosis: Transplanted liver present\n- Acute pharyngitis\n- Hypercalcemia\n- Metabolic encephalopathy\n- Portal hypertension\n- Pulmonary congestion and hypostasis\n- Splenomegaly\n- Anemia in chronic kidney disease\n- Fever\n- Lung field abnormal\n- Supraventricular premature beats\n- Thrombocytopenic disorder\n- Acute renal failure syndrome\n- Cirrhosis - non-alcoholic\n- Coag./bleeding tests abnormal\n- Disorder of tongue\n- Esophageal varices\n- Hepatorenal syndrome\n- Viral hepatitis C\n- Acute respiratory failure\n- Cardiomegaly\n- Chronic hepatitis C\n- Hypervolemia\n- Primary bacterial peritonitis\n- Sequela of chronic liver disease\n- Urinary tract infectious disease\n- Allergic reaction caused by insect bite and/or insect sting\n- Anemia\n- Chronic kidney disease\n- Chronic viral hepatitis C with hepatic coma\n- Jaundice\n- Pneumothorax\n- Acquired absence of organ\n- Ascites\n- Dizziness and giddiness\n- Hypo-osmolality and or hyponatremia\n- Hypovolemia\n- Chronic lymphoid leukemia, disease\n- Hyperkalemia\n- Pleural effusion\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2013-08-13, presumably until 2013-08-16\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2013-08-21, presumably until 2013-09-05, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-08-19\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2013-08-23, presumably until 2014-03-24, with intended 11 refill(s). Instructions: take 4 Caps by mouth 2 times a day.\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2013-08-11, presumably until 2013-08-11\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2013-08-07, presumably until 2013-08-12\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-16\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2013-08-16, presumably until 2013-08-20\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2013-08-18, presumably until 2014-08-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2013-08-13, presumably until 2013-08-17\n- haloperidol 5 MG/ML Injectable Solution, started on 2013-08-20, presumably until 2013-08-31\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-08-08, presumably until 2013-09-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-08-09, presumably until 2013-08-11\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-11-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2013-08-10, presumably until 2013-08-10\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-08-08, presumably until 2013-08-12\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-08-11, presumably until 2013-08-17\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2013-08-18, presumably until 2013-08-22, with intended 11 refill(s). Instructions: Take up to 4 caps PO BID\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-08-16\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2013-08-13, presumably until 2013-08-14\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2013-08-10, presumably until 2013-08-11\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2013-08-15, presumably until 2013-08-15\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-08-17, presumably until 2013-12-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2013-08-19, presumably until 2013-08-30, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-08-31, presumably until 2013-09-05, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2013-08-25, presumably until 2013-08-31\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2013-08-26, presumably until 2013-12-19, with intended 2 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day.\n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2013-08-25, presumably until 2013-08-25\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-08-09, presumably until 2013-08-10\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-08-10, presumably until 2013-08-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-27\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-08-16\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2013-08-21, presumably until 2013-12-19, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-08-13, presumably until 2013-08-28\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-08-17, presumably until 2013-09-01\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-16\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2013-08-20, presumably until 2013-08-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-08-08, presumably until 2013-08-08\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-16\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-08-08, presumably until 2013-08-08\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2013-08-09, presumably until 2013-08-11\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-30\n- risperidone 0.5 MG Oral Tablet, through Oral route, started on 2013-08-30, presumably until 2013-09-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2013-08-08, presumably until 2013-08-11\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2013-08-18, presumably until 2013-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2014-08-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-08-19, presumably until 2015-12-10, with intended 11 refill(s). Instructions: take 20 mg by mouth daily.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2013-08-14, presumably until 2013-08-17\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-08-08, presumably until 2013-08-12\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2013-08-29, presumably until 2013-09-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-08-17, presumably until 2013-08-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2013-08-13, presumably until 2013-08-28\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2013-08-23, presumably until 2013-09-01\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-12-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-08-19, presumably until 2013-08-29\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2013-08-16, presumably until 2013-08-19\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2013-09-01, presumably until 2013-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; liver transplant (recipient)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n\n### Condition\n- Acute hepatitis C\n- Cirrhosis - non-alcoholic\n- Hepatic encephalopathy\n- Portal hypertension\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-12\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-08-13, presumably until 2013-08-13\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-12\n- midazolam 1 MG/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-13\n- methylprednisolone 125 MG Injection, started on 2013-08-12, presumably until 2013-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2013-08-12, presumably until 2013-08-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-04 09:21:00, ended at 2013-09-04 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.97 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 471 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 183 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.48 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute renal failure syndrome\n- Anemia\n- Disorder of hematopoietic structure\n- Transplanted liver present\n- Chronic lymphoid leukemia, disease\n- Viral hepatitis C\n- Lymphocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-08 09:08:29, ended at 2013-09-08 15:00:09\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Acute renal failure syndrome\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of magnesium metabolism\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2013-09-12, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-19 00:00:00, ended at 2013-09-19 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, started on 2013-09-19, presumably until 2013-09-19, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-29 09:50:37, ended at 2013-09-29 11:13:13\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Chronic lymphoid leukemia, disease\n- Primary diagnosis: Viral hepatitis C\n- Transplanted liver present\n- Cerebral hemorrhage\n\n### Drug\n- levetiracetam 750 MG Oral Tablet, through Oral route, presumably until 2016-08-25. Instructions: take  by mouth 2 times a day.\n- losartan potassium 50 MG Oral Tablet, through Oral route, presumably until 2014-03-24. Instructions: take 50 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-29 11:19:00, ended at 2013-09-29 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.99 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cerebral hemorrhage\n- Essential hypertension\n- Viral hepatitis C\n- Chronic lymphoid leukemia, disease\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-31 15:44:15, ended at 2013-10-31 16:42:44\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.717\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-01 13:21:16, ended at 2013-11-01 14:45:21\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral hemorrhage\n\n### Drug\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2013-12-19. Instructions: take 1,000 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2013-11-09, presumably until 2013-12-19, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-19 12:58:00, ended at 2013-12-19 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Headache\n- Essential hypertension\n- Altered sensation of skin\n- Transplanted liver present\n- Cerebral hemorrhage\n- Seizure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-19 14:14:37, ended at 2013-12-19 15:31:21\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Viral hepatitis C\n- Primary diagnosis: Cirrhosis - non-alcoholic\n- Transplanted liver present\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2016-09-26. Instructions: take 0.1 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-17 00:00:00, ended at 2014-02-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Friction blister without infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-23 00:00:00, ended at 2014-03-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of magnesium metabolism\n- Viral hepatitis C\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-24 09:53:00, ended at 2014-03-24 11:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 6.77 (log copies per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL: [000000] (international unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.16 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 183 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of magnesium metabolism\n- Transplanted liver present\n- Disorder of oral soft tissues\n- Viral hepatitis C\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-24 12:00:00, ended at 2014-03-24 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of oral soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-04 00:00:00, ended at 2014-06-04 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, started on 2014-06-04, presumably until 2014-06-04, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-08 00:00:00, ended at 2014-06-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2014-06-08, presumably until 2015-03-20, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-11 00:00:00, ended at 2014-08-11 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2014-08-11, presumably until 2014-08-11, with intended 11 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-03 00:00:00, ended at 2014-09-03 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sertraline 100 MG Oral Tablet, started on 2014-09-03, presumably until 2014-09-03, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of magnesium metabolism\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-09-27, presumably until 2015-12-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2014-09-27, presumably until 2014-09-27, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-27 00:00:00, ended at 2014-12-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of oral soft tissues\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2014-12-27, presumably until 2015-12-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-20 00:00:00, ended at 2015-03-20 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n- Transplanted liver present\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-03-20, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-26 00:00:00, ended at 2015-03-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet, through Oral route, started on 2015-03-26, presumably until 2015-09-16, with intended 5 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-04 00:00:00, ended at 2015-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-04, presumably until 2015-09-13, with intended 11 refill(s). Instructions: 2 caps twice daily take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-13 00:00:00, ended at 2015-09-13 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-13, presumably until 2015-09-25, with intended 11 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-09-13, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-09-13, presumably until 2016-08-25, with intended 11 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-16 00:00:00, ended at 2015-09-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2015-10-17, presumably until 2015-10-17, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-25 00:00:00, ended at 2015-09-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Primary diagnosis: Transplanted liver present\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-25, presumably until 2015-10-16, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-09-25, presumably until 2015-10-16, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-16 00:00:00, ended at 2015-10-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Primary diagnosis: Transplanted liver present\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-10-16, presumably until 2015-12-10, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-10-16, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-10 00:00:00, ended at 2015-12-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Hyperkalemia\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-12-10, presumably until 2017-04-27, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2016-12-25, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-19 00:00:00, ended at 2015-12-19 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-11 00:00:00, ended at 2016-06-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 63 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.39 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 58 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 26 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 142 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-09 00:00:00, ended at 2016-07-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 86 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.54 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59 (percent)\n- cycloSPORINE [Mass/volume] in Blood: 80 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-04 00:00:00, ended at 2016-08-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-20 00:00:00, ended at 2016-08-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 87 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- MCV [Entitic volume] by Automated count: 93 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-25 16:47:09, ended at 2016-08-25 17:35:51\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n- Disorder of immune function\n- Transplanted liver present\n- Chronic hepatitis C\n\n### Drug\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2016-08-08, presumably until 2016-08-25, with intended 1 refill(s). Instructions: take 100 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-12 00:00:00, ended at 2016-09-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 110 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.30 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood: 53 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-22 09:50:32, ended at 2016-09-22 10:43:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Transplanted liver present\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-26 08:29:04, ended at 2016-09-26 09:40:12\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Benign neoplasm of transverse colon\n- Polyp of colon\n- Primary diagnosis: Cirrhosis of liver\n- Nocturia\n- Plantar fascial fibromatosis\n- B-cell chronic lymphocytic leukemia\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2016-09-26, presumably until 2016-09-26, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-08 11:24:23, ended at 2016-10-08 12:27:24\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.992\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Basal cell carcinoma of face\n- Disorder of immune function\n- Disorder of skin and/or subcutaneous tissue\n- Senile hyperkeratosis\n- Neoplasm of uncertain behavior of skin\n- Trichilemmal cyst\n- B-cell chronic lymphocytic leukemia\n- Primary diagnosis: Neoplastic disease of uncertain behavior\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2016-11-04, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congenital anomaly of skin\n- Primary diagnosis: Basal cell carcinoma of skin\n\n### Drug\n- fluorouracil 50 MG/ML Topical Cream, through Topical route, started on 2016-10-13, presumably until 2016-11-12, with intended 1 refill(s). Instructions: by Topical route 2 times a day To right anterior thigh lesion, cover with bandaid, x 3-4 wks. Expect redness, crusting, poss. Itching\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-14 00:00:00, ended at 2016-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.27 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 51 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-20 00:00:00, ended at 2016-10-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: B-cell chronic lymphocytic leukemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-22 08:59:00, ended at 2016-10-22 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.9 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.6 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Polyp of colon\n- Cirrhosis of liver\n- Benign neoplasm of transverse colon\n- Nocturia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-22 09:05:36, ended at 2016-10-22 09:47:10\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: B-cell chronic lymphocytic leukemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-24 07:18:14, ended at 2016-10-24 10:51:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or less\n- Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (\n\n### Condition\n- Primary diagnosis: Basal cell carcinoma of face\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2016-10-24, presumably until 2016-10-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 5 days\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2016-10-24, presumably until 2017-01-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-05 00:00:00, ended at 2016-11-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congenital anomaly of skin\n\n### Drug\n- hydrocortisone 25 MG/ML Topical Cream, started on 2016-11-05, presumably until 2016-11-12, with intended 0 refill(s). Instructions: Apply to affected area twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.31 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.3 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-25 00:00:00, ended at 2016-12-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Transplanted liver present\n- Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2016-12-25, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-05 16:48:59, ended at 2017-01-05 17:28:58\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open wound of lower leg\n- Hyperkalemia\n- Hypomagnesemia\n- Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2017-01-05, presumably until 2017-05-23, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-14, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-06-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth as needed\n- hydrocortisone 0.025 MG/MG Topical Ointment, started on 2017-01-05, presumably until 2017-01-19, with intended 0 refill(s). Instructions: Apply to open area on R leg as directed daily. Wash daily with soap/water\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-01-05, presumably until 2017-06-05, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-06-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-05-23, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-14, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 09:48:47, ended at 2017-01-19 10:29:14\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-21 00:00:00, ended at 2017-01-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 106 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 144 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 47 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-02-04 00:00:00, ended at 2017-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 20 ML bupivacaine liposome 13.3 MG/ML Injection, through Infiltration route, started on 2017-02-04, presumably until 2017-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-04 00:00:00, ended at 2017-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Transplanted liver present\n- Hernia of anterior abdominal wall\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- cefazolin 1000 MG Injection, started on 2017-02-04, presumably until 2017-02-04\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- midazolam 1 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-04 05:22:00, ended at 2017-02-05 16:37:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Body height: 5' 7.992\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n\n### Procedure\n- Supplement Abdominal Wall with Synthetic Substitute, Open Approach\n- Repair initial incisional or ventral hernia; reducible\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Collection of venous blood by venipuncture\n- Implantation of mesh or other prosthesis for open incisional or ventral hernia repair or mesh for closure of debridement for necrotizing soft tissue infection (List separately in addition to code for the incisional or ventral hernia repair)\n\n### Condition\n- Primary diagnosis: Incisional hernia\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Major depression, single episode\n- Obesity\n- Viral hepatitis C\n- Cirrhosis of liver\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2017-02-04, presumably until 2017-02-04\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-04\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-02-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed (constipation)\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-02-04, presumably until 2017-02-05\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-02-04, presumably until 2017-02-05\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-06-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-12 11:22:17, ended at 2017-02-12 11:48:57\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Hernia of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-23 00:00:00, ended at 2017-02-23 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-25 00:00:00, ended at 2017-03-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.36 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.1 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 49 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 76 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-21 00:00:00, ended at 2017-04-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.33 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 82 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-27 00:00:00, ended at 2017-04-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n- Transplanted liver present\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-04-27, presumably until 2017-06-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.1 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 42 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 141 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.66 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 8 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-23 11:53:35, ended at 2017-05-23 13:22:24\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-05-23 14:22:00, ended at 2017-06-05 11:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: 4 (per microliter)\n- Glucose [Mass/volume] in Blood: 96 (milligram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 438 (per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Protein [Mass/volume] in Cerebral spinal fluid: 107 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cystatin C [Mass/volume] in Serum or Plasma: 1.35 (milligram per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence: <1:64 (titer)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence: <1:10 (titer)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Histoplasma capsulatum Ag [Mass/volume] in Urine: 0.05 (nanogram per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 13.4 (microgram per milliliter)\n- Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence: <1:10 (titer)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.57 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Body height: 5' 8\" (inch (US))\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.59 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Prothrombin time (PT): 15.4 (second)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Erythrocyte sedimentation rate: 7 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n\n### Procedure\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hospital discharge day management; more than 30 minutes\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n\n### Condition\n- Acquired absence of organ\n- Disorder of digestive system\n- Disorder of intestine\n- Electrocardiogram abnormal\n- Lymphocytosis\n- Complication of transplanted liver\n- Disorder of immune function\n- Esophageal varices without bleeding, associated with another disorder\n- Headache\n- Loss of appetite\n- Transplanted liver present\n- Basal cell carcinoma of face\n- Primary diagnosis: Cirrhosis of liver\n- Dizziness and giddiness\n- B-cell chronic lymphocytic leukemia\n- Bradycardia\n- Chronic kidney disease\n- Encephalitis due to Herpesviridae\n- Fever\n- Spontaneous cerebral hemorrhage\n- Anterograde amnesia\n- Chronic hepatitis C\n- General finding of observation of patient\n- Hypo-osmolality and or hyponatremia\n- Pain in right lower limb\n- Abdominal pain\n- Depressive disorder\n- Hypomagnesemia\n- Chronic kidney disease due to hypertension\n- Obesity\n- Pain in left lower limb\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Acute renal failure syndrome\n- Parastomal hernia\n- Splenomegaly\n- Visual disturbance\n- Kidney stone\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2017-06-02, presumably until 2017-07-01, with intended 1 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2017-06-05, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-05-26, presumably until 2017-06-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-06-05\n- 10 ML acyclovir 50 MG/ML Injection, through Intravenous route, started on 2017-05-30, presumably until 2017-06-17, with intended 0 refill(s). Instructions: 13.7 mL by Intravenous route every 8 hours\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-05-23, presumably until 2017-06-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2019-06-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth daily as needed\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-07-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-05-23, presumably until 2017-05-27\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2017-05-24, presumably until 2017-05-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-06-01, presumably until 2017-06-01\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2017-06-01, presumably until 2017-06-04\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-06-01, presumably until 2017-06-04\n- gadobenate, through Intravenous route, started on 2017-05-28, presumably until 2017-06-02\n- cholecalciferol 0.01 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-05-23, presumably until 2017-06-02\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2017-05-28, presumably until 2017-05-29\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-05-23, presumably until 2017-06-01\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-05-30, presumably until 2017-09-22, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-05-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-05-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-06-04\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-05-29, presumably until 2017-05-29\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-05-25\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2017-05-31, presumably until 2017-06-12, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 3 times a day for 14 days\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-05-29, presumably until 2017-05-31\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2018-03-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-05-27, presumably until 2017-05-29\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-06-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-05-26, presumably until 2017-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-27 00:00:00, ended at 2017-05-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 62.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-28 09:23:00, ended at 2017-05-28 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Basal cell carcinoma of face\n- Fever\n- Abnormal findings on diagnostic imaging of lung\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-12 16:03:02, ended at 2017-06-12 16:50:56\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- 10 ML acyclovir 50 MG/ML Injection, through Intravenous route, started on 2017-06-17, presumably until 2017-06-19, with intended 0 refill(s). Instructions: 13.7 mL by Intravenous route every 8 hours\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-06-20, presumably until 2017-06-24, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-19 09:33:55, ended at 2017-06-19 10:12:44\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-19 10:13:00, ended at 2017-06-19 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.64 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.49 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.8 (percent)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.45 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 08:11:40, ended at 2017-06-24 10:57:32\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 250 mg by mouth\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 100 mg by mouth\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2018-01-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 20 mg by mouth\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 5 mg by mouth every 4 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 12:41:35, ended at 2017-06-24 13:39:49\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 14:47:02, ended at 2017-06-24 15:29:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-06-24, presumably until 2017-07-29, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-28 00:00:00, ended at 2017-06-28 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-07-27, presumably until 2017-07-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2017-07-01, presumably until 2017-09-22, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-07-07, presumably until 2018-07-11, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-07 08:01:00, ended at 2017-07-07 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electroencephalogram (EEG); including recording awake and asleep\n\n### Condition\n- Spontaneous cerebral hemorrhage\n- Encephalitis due to Herpesviridae\n- Headache\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-29 14:23:37, ended at 2017-07-29 15:05:45\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Visual disturbance\n- Transplanted liver present\n- Spontaneous cerebral hemorrhage\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-29, presumably until 2018-07-14, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-19 00:00:00, ended at 2017-08-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-20 00:00:00, ended at 2017-08-20 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-20 15:31:23, ended at 2017-08-20 16:43:44\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Basal cell carcinoma of face\n- Primary diagnosis: Cirrhosis of liver\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-20 15:53:00, ended at 2017-08-20 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.19 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Cirrhosis of liver\n- Basal cell carcinoma of face\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-21 00:00:00, ended at 2017-08-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-24 00:00:00, ended at 2017-08-24 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.6 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: None Detected (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.6 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 97, "cumulated_approximate_token_count": 42345}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-11 00:00:00, ended at 2013-01-11 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-01-27 20:42:00, ended at 2013-02-05 17:30:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 178 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 109.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 89 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Prothrombin time (PT): 18.0 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 7 (nanogram per milliliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.48 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 37.8 (picogram)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.95 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 69 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46.9 (percent)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 11.7 (microgram per milliliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 200 (cells)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.09 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 410 (nanogram per milliliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 294 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 825 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.91 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 39 (percent)\n\n### Procedure\n- Phlebography of the portal venous system using contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract formation/dilatation, stent placement and all associated imag\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Intra-abdominal venous shunt\n- Computed tomography, abdomen; with contrast material(s)\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Acquired absence of organ\n- Hypovolemia\n- Chronic lymphoid leukemia, disease\n- Esophageal varices associated with another disorder\n- Leukocytosis\n- Thrombocytopenic disorder\n- Viral hepatitis B without hepatic coma\n- Hypervolemia\n- Hypo-osmolality and or hyponatremia\n- Interstitial emphysema of lung\n- Coag./bleeding tests abnormal\n- Pleural effusion\n- Primary diagnosis: Cirrhosis - non-alcoholic\n- Non-infectious disorder of lymphatics\n- Swelling of limb\n- Deficiency anemias\n- Lung field abnormal\n- Pneumothorax\n- Splenomegaly\n- Viral hepatitis C\n- Ascites\n- Portal hypertension\n- Sequela of chronic liver disease\n\n### Drug\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2013-01-30, presumably until 2013-02-03\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2013-01-29, presumably until 2013-01-31\n- spironolactone 100 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-01\n- nadolol 40 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-07-08. Instructions: take 40 mg by mouth daily.  \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2014-02-04, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-02-02, presumably until 2013-02-02\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-01-31, presumably until 2013-02-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-04\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2013-02-02, presumably until 2013-02-05\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2013-02-04, presumably until 2013-06-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-02-01, presumably until 2013-02-05\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-07-12. Instructions: take 40 mg by mouth daily.  \n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-05\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-01-30, presumably until 2013-01-31\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-02-01, presumably until 2013-02-01\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-02-02, presumably until 2014-02-04, with intended 3 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2013-02-02, presumably until 2014-02-04, with intended 3 refill(s). Instructions: take 3 Tabs by mouth daily.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-01-27, presumably until 2013-06-20. Instructions: take 0.4 mg by mouth Every Day.  \n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-01-31, presumably until 2013-02-04\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-02-04, presumably until 2013-08-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2013-01-29, presumably until 2013-01-30\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-01-27, presumably until 2013-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-02-03 00:00:00, ended at 2013-02-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); intrahepatic or portal circulation (eg, transvenous intrahepatic portosystemic shunt[s] [TIPS])\n\n### Condition\n- Cirrhosis - non-alcoholic\n- Pneumothorax\n- Pleural effusion\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-02-03, presumably until 2013-02-03\n- 500 ML sodium chloride 30 MG/ML Injection, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-02-03, presumably until 2013-02-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-31 00:00:00, ended at 2013-03-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-03-31, presumably until 2013-07-08, with intended 11 refill(s). Instructions: take 15 mL by mouth 2 times a day. Titrate to achieve BM 3-4x/daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-01 10:17:00, ended at 2013-04-01 10:22:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-01 10:23:00, ended at 2013-04-01 23:59:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 186 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 19 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 185 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 115 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.22 (million per microliter)\n- MCH [Entitic mass] by Automated count: 38.0 (picogram)\n- Neutrophils [#/volume] in Blood by Manual count: 5.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 76 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 212 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 43 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 269 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 789 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Prothrombin time (PT): 17.5 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 110.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-06-20 17:47:00, ended at 2013-07-08 15:35:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 774 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 69 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 6.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 152 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 278 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Osmolality of Serum or Plasma: 261 (milliosmole per kilogram)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 15.5 (microgram per milliliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 134 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 397 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 242 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.66 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 64.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 6.3 (millimole per liter)\n- Prothrombin time (PT): N/A (second)\n- Thrombin time: 18.9 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.0 (second)\n- Body height: 5' 10\" (inch (US))\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 154 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 116 (percent)\n- Lactate [Moles/volume] in Blood: 1.2 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 82 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 9.74 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 113.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.76 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 175.3 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.87 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Left ventricular Ejection fraction: 62 (percent)\n- MCH [Entitic mass] by Automated count: 39.2 (picogram)\n- Osmolality of Urine: 319 (milliosmole per kilogram)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n- Angioplasty of other non-coronary vessel(s)\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Thoracentesis\n- Revision of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract recannulization/dilatation, stent placement and all associated\n- Thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Procedure on single vessel\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n\n### Condition\n- Allergic reaction caused by insect bite and/or insect sting\n- Esophageal varices\n- Anemia\n- Gastroesophageal reflux disease\n- Viral hepatitis C\n- Acquired absence of organ\n- Candidiasis of urogenital site\n- Cirrhosis - non-alcoholic\n- Depressive disorder\n- Hyperkalemia\n- Thrombocytopenic disorder\n- Acute renal failure syndrome\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Primary bacterial peritonitis\n- Altered mental status\n- Hepatic coma due to viral hepatitis C\n- Lung field abnormal\n- Sequela of chronic liver disease\n- Ascites\n- Atelectasis\n- Cramp in limb\n- Pleural effusion\n- Portal hypertension\n- Cardiomegaly\n- Chronic lymphoid leukemia in remission\n- Chronic lymphoid leukemia, disease\n- Edema\n- Hyperosmolality and or hypernatremia\n- Incontinence of feces\n- Splenomegaly\n- Premature beats\n\n### Drug\n- nadolol 20 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-06-23\n- vitamin K1 5 MG Oral Tablet, through Oral route, started on 2013-06-20, presumably until 2013-07-07\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2013-06-29, presumably until 2013-07-08\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2013-06-20, presumably until 2013-06-23\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-08\n- spironolactone 100 MG Oral Tablet, through Oral route, started on 2013-07-08, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- nadolol 40 MG Oral Tablet, through Oral route, started on 2013-06-24, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-08\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-06-23, presumably until 2013-07-03\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2013-06-28, presumably until 2013-06-30\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-06-20, presumably until 2013-06-20\n- amphotericin B 50 MG Injection, started on 2013-07-04, presumably until 2013-07-08\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2013-06-27, presumably until 2013-07-08\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2013-07-03, presumably until 2013-07-03\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2013-09-01. Instructions: take 2,000 mg by mouth daily.\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-06-21, presumably until 2013-06-30\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-29, presumably until 2013-07-08\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2013-06-21, presumably until 2013-06-23\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2013-06-29, presumably until 2013-07-01\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2013-07-01, presumably until 2013-07-01\n- cholecalciferol 0.05 MG Oral Capsule, through Oral route, presumably until 2013-09-01. Instructions: take 1 Cap by mouth Every Day.\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2013-06-26, presumably until 2013-06-26\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-06-26, presumably until 2013-06-27\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2013-06-20, presumably until 2013-06-20\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-06-21, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 30 mL by mouth every 6 hours.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2013-06-26, presumably until 2013-06-27\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2013-06-28, presumably until 2013-06-30\n- phenazopyridine hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-07-06, presumably until 2013-07-08\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2013-07-01, presumably until 2013-09-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML Injection, through Intravenous route, started on 2013-07-03, presumably until 2013-07-04\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-06-23, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-02\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2013-07-02, presumably until 2013-07-08\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2013-06-28, presumably until 2013-06-30\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-06-21, presumably until 2013-06-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-22 00:00:00, ended at 2013-06-22 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic lymphoid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-12 09:28:00, ended at 2013-07-12 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.323\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic lymphoid leukemia, disease\n- Primary diagnosis: Lymphocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-15 09:38:28, ended at 2013-07-15 09:46:40\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral hepatitis C\n- Chronic lymphoid leukemia, disease\n- Cirrhosis - non-alcoholic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-08-07 10:15:00, ended at 2013-09-01 15:40:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 68 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 41.5 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 54.6 (second)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: <5.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.44 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 529 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.5 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 23 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Body height: 5' 7.323\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 216 (microgram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.21 (milli-international unit per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 9.0 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 23 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 296 (unit per liter)\n- MCH [Entitic mass] by Automated count: 37.7 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Prothrombin time (PT): 29.8 (second)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 57.1 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 89 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 52 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 24 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: >10.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.0 (millimole per liter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 83 (millimeter mercury column)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Selective catheter placement, venous system; first order branch (eg, renal vein, jugular vein)\n- Packed blood cell transfusion\n- Transjugular biopsy of liver\n- Central venous catheter placement with guidance\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Thoracentesis\n- Controlled ventilation procedure and therapy, initiation and management\n- Transcatheter biopsy\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Transfusion of coagulation factors\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Occupational therapy re-evaluation\n- Splitting of blood or blood products, each unit\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Delayed allogeneic transplantation, cadaver donor\n- Collection of blood specimen from a completely implantable venous access device\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Continuous invasive mechanical ventilation for less than 96 consecutive hours\n- Platelet transfusion\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Physical therapy evaluation\n- Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\n- Other transplant of liver\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transfusion of other serum\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Physical therapy re-evaluation\n- Insertion of pleural tube drain\n- Cholecystectomy\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Transcatheter biopsy, radiological supervision and interpretation\n- Other incision of other bile duct\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Infusion of immunosuppressive antibody therapy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n- Pooling of platelets or other blood products\n\n### Condition\n- Acute tubular necrosis\n- Cardiac arrhythmia\n- Electrocardiogram abnormal\n- Postprocedural state finding\n- Candidiasis\n- Delirium\n- Depressive disorder\n- Low blood pressure\n- Malaise\n- Primary diagnosis: Transplanted liver present\n- Acute pharyngitis\n- Hypercalcemia\n- Metabolic encephalopathy\n- Portal hypertension\n- Pulmonary congestion and hypostasis\n- Splenomegaly\n- Anemia in chronic kidney disease\n- Fever\n- Lung field abnormal\n- Supraventricular premature beats\n- Thrombocytopenic disorder\n- Acute renal failure syndrome\n- Cirrhosis - non-alcoholic\n- Coag./bleeding tests abnormal\n- Disorder of tongue\n- Esophageal varices\n- Hepatorenal syndrome\n- Viral hepatitis C\n- Acute respiratory failure\n- Cardiomegaly\n- Chronic hepatitis C\n- Hypervolemia\n- Primary bacterial peritonitis\n- Sequela of chronic liver disease\n- Urinary tract infectious disease\n- Allergic reaction caused by insect bite and/or insect sting\n- Anemia\n- Chronic kidney disease\n- Chronic viral hepatitis C with hepatic coma\n- Jaundice\n- Pneumothorax\n- Acquired absence of organ\n- Ascites\n- Dizziness and giddiness\n- Hypo-osmolality and or hyponatremia\n- Hypovolemia\n- Chronic lymphoid leukemia, disease\n- Hyperkalemia\n- Pleural effusion\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2013-08-13, presumably until 2013-08-16\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2013-08-21, presumably until 2013-09-05, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-08-19\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2013-08-23, presumably until 2014-03-24, with intended 11 refill(s). Instructions: take 4 Caps by mouth 2 times a day.\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2013-08-11, presumably until 2013-08-11\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2013-08-07, presumably until 2013-08-12\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-16\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2013-08-16, presumably until 2013-08-20\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2013-08-18, presumably until 2014-08-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2013-08-13, presumably until 2013-08-17\n- haloperidol 5 MG/ML Injectable Solution, started on 2013-08-20, presumably until 2013-08-31\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-08-08, presumably until 2013-09-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-08-09, presumably until 2013-08-11\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-11-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2013-08-10, presumably until 2013-08-10\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-08-08, presumably until 2013-08-12\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-08-11, presumably until 2013-08-17\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2013-08-18, presumably until 2013-08-22, with intended 11 refill(s). Instructions: Take up to 4 caps PO BID\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-08-16\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2013-08-13, presumably until 2013-08-14\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2013-08-10, presumably until 2013-08-11\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2013-08-15, presumably until 2013-08-15\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-08-17, presumably until 2013-12-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2013-08-19, presumably until 2013-08-30, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-08-31, presumably until 2013-09-05, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2013-08-25, presumably until 2013-08-31\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2013-08-26, presumably until 2013-12-19, with intended 2 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day.\n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2013-08-25, presumably until 2013-08-25\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-08-09, presumably until 2013-08-10\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-08-10, presumably until 2013-08-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-27\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-08-16\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2013-08-21, presumably until 2013-12-19, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-08-13, presumably until 2013-08-28\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-08-17, presumably until 2013-09-01\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-16\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2013-08-20, presumably until 2013-08-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-08-08, presumably until 2013-08-08\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-16\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-08-08, presumably until 2013-08-08\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2013-08-09, presumably until 2013-08-11\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-30\n- risperidone 0.5 MG Oral Tablet, through Oral route, started on 2013-08-30, presumably until 2013-09-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2013-08-08, presumably until 2013-08-11\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2013-08-18, presumably until 2013-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2014-08-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-08-19, presumably until 2015-12-10, with intended 11 refill(s). Instructions: take 20 mg by mouth daily.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2013-08-14, presumably until 2013-08-17\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-08-08, presumably until 2013-08-12\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2013-08-29, presumably until 2013-09-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-08-17, presumably until 2013-08-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2013-08-13, presumably until 2013-08-28\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2013-08-23, presumably until 2013-09-01\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-12-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-08-19, presumably until 2013-08-29\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2013-08-16, presumably until 2013-08-19\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2013-09-01, presumably until 2013-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; liver transplant (recipient)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n\n### Condition\n- Acute hepatitis C\n- Cirrhosis - non-alcoholic\n- Hepatic encephalopathy\n- Portal hypertension\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-12\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-08-13, presumably until 2013-08-13\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-12\n- midazolam 1 MG/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-13\n- methylprednisolone 125 MG Injection, started on 2013-08-12, presumably until 2013-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2013-08-12, presumably until 2013-08-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-04 09:21:00, ended at 2013-09-04 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.97 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 471 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 183 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.48 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute renal failure syndrome\n- Anemia\n- Disorder of hematopoietic structure\n- Transplanted liver present\n- Chronic lymphoid leukemia, disease\n- Viral hepatitis C\n- Lymphocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-08 09:08:29, ended at 2013-09-08 15:00:09\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Acute renal failure syndrome\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of magnesium metabolism\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2013-09-12, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-19 00:00:00, ended at 2013-09-19 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, started on 2013-09-19, presumably until 2013-09-19, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-29 09:50:37, ended at 2013-09-29 11:13:13\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Chronic lymphoid leukemia, disease\n- Primary diagnosis: Viral hepatitis C\n- Transplanted liver present\n- Cerebral hemorrhage\n\n### Drug\n- levetiracetam 750 MG Oral Tablet, through Oral route, presumably until 2016-08-25. Instructions: take  by mouth 2 times a day.\n- losartan potassium 50 MG Oral Tablet, through Oral route, presumably until 2014-03-24. Instructions: take 50 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-29 11:19:00, ended at 2013-09-29 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.99 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cerebral hemorrhage\n- Essential hypertension\n- Viral hepatitis C\n- Chronic lymphoid leukemia, disease\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-31 15:44:15, ended at 2013-10-31 16:42:44\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.717\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-01 13:21:16, ended at 2013-11-01 14:45:21\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral hemorrhage\n\n### Drug\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2013-12-19. Instructions: take 1,000 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2013-11-09, presumably until 2013-12-19, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-19 12:58:00, ended at 2013-12-19 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Headache\n- Essential hypertension\n- Altered sensation of skin\n- Transplanted liver present\n- Cerebral hemorrhage\n- Seizure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-19 14:14:37, ended at 2013-12-19 15:31:21\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Viral hepatitis C\n- Primary diagnosis: Cirrhosis - non-alcoholic\n- Transplanted liver present\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2016-09-26. Instructions: take 0.1 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-17 00:00:00, ended at 2014-02-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Friction blister without infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-23 00:00:00, ended at 2014-03-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of magnesium metabolism\n- Viral hepatitis C\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-24 09:53:00, ended at 2014-03-24 11:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 6.77 (log copies per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL: [000000] (international unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.16 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 183 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of magnesium metabolism\n- Transplanted liver present\n- Disorder of oral soft tissues\n- Viral hepatitis C\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-24 12:00:00, ended at 2014-03-24 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of oral soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-04 00:00:00, ended at 2014-06-04 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, started on 2014-06-04, presumably until 2014-06-04, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-08 00:00:00, ended at 2014-06-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2014-06-08, presumably until 2015-03-20, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-11 00:00:00, ended at 2014-08-11 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2014-08-11, presumably until 2014-08-11, with intended 11 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-03 00:00:00, ended at 2014-09-03 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sertraline 100 MG Oral Tablet, started on 2014-09-03, presumably until 2014-09-03, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of magnesium metabolism\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-09-27, presumably until 2015-12-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2014-09-27, presumably until 2014-09-27, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-27 00:00:00, ended at 2014-12-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of oral soft tissues\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2014-12-27, presumably until 2015-12-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-20 00:00:00, ended at 2015-03-20 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n- Transplanted liver present\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-03-20, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-26 00:00:00, ended at 2015-03-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet, through Oral route, started on 2015-03-26, presumably until 2015-09-16, with intended 5 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-04 00:00:00, ended at 2015-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-04, presumably until 2015-09-13, with intended 11 refill(s). Instructions: 2 caps twice daily take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-13 00:00:00, ended at 2015-09-13 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-13, presumably until 2015-09-25, with intended 11 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-09-13, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-09-13, presumably until 2016-08-25, with intended 11 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-16 00:00:00, ended at 2015-09-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2015-10-17, presumably until 2015-10-17, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-25 00:00:00, ended at 2015-09-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Primary diagnosis: Transplanted liver present\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-25, presumably until 2015-10-16, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-09-25, presumably until 2015-10-16, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-16 00:00:00, ended at 2015-10-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Primary diagnosis: Transplanted liver present\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-10-16, presumably until 2015-12-10, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-10-16, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-10 00:00:00, ended at 2015-12-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Hyperkalemia\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-12-10, presumably until 2017-04-27, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2016-12-25, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-19 00:00:00, ended at 2015-12-19 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-11 00:00:00, ended at 2016-06-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 63 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.39 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 58 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 26 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 142 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-09 00:00:00, ended at 2016-07-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 86 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.54 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59 (percent)\n- cycloSPORINE [Mass/volume] in Blood: 80 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-04 00:00:00, ended at 2016-08-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-20 00:00:00, ended at 2016-08-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 87 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- MCV [Entitic volume] by Automated count: 93 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-25 16:47:09, ended at 2016-08-25 17:35:51\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n- Disorder of immune function\n- Transplanted liver present\n- Chronic hepatitis C\n\n### Drug\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2016-08-08, presumably until 2016-08-25, with intended 1 refill(s). Instructions: take 100 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-12 00:00:00, ended at 2016-09-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 110 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.30 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood: 53 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-22 09:50:32, ended at 2016-09-22 10:43:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Transplanted liver present\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-26 08:29:04, ended at 2016-09-26 09:40:12\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Benign neoplasm of transverse colon\n- Polyp of colon\n- Primary diagnosis: Cirrhosis of liver\n- Nocturia\n- Plantar fascial fibromatosis\n- B-cell chronic lymphocytic leukemia\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2016-09-26, presumably until 2016-09-26, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-08 11:24:23, ended at 2016-10-08 12:27:24\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.992\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Basal cell carcinoma of face\n- Disorder of immune function\n- Disorder of skin and/or subcutaneous tissue\n- Senile hyperkeratosis\n- Neoplasm of uncertain behavior of skin\n- Trichilemmal cyst\n- B-cell chronic lymphocytic leukemia\n- Primary diagnosis: Neoplastic disease of uncertain behavior\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2016-11-04, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congenital anomaly of skin\n- Primary diagnosis: Basal cell carcinoma of skin\n\n### Drug\n- fluorouracil 50 MG/ML Topical Cream, through Topical route, started on 2016-10-13, presumably until 2016-11-12, with intended 1 refill(s). Instructions: by Topical route 2 times a day To right anterior thigh lesion, cover with bandaid, x 3-4 wks. Expect redness, crusting, poss. Itching\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-14 00:00:00, ended at 2016-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.27 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 51 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-20 00:00:00, ended at 2016-10-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: B-cell chronic lymphocytic leukemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-22 08:59:00, ended at 2016-10-22 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.9 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.6 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Polyp of colon\n- Cirrhosis of liver\n- Benign neoplasm of transverse colon\n- Nocturia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-22 09:05:36, ended at 2016-10-22 09:47:10\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: B-cell chronic lymphocytic leukemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-24 07:18:14, ended at 2016-10-24 10:51:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or less\n- Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (\n\n### Condition\n- Primary diagnosis: Basal cell carcinoma of face\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2016-10-24, presumably until 2016-10-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 5 days\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2016-10-24, presumably until 2017-01-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-05 00:00:00, ended at 2016-11-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congenital anomaly of skin\n\n### Drug\n- hydrocortisone 25 MG/ML Topical Cream, started on 2016-11-05, presumably until 2016-11-12, with intended 0 refill(s). Instructions: Apply to affected area twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.31 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.3 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-25 00:00:00, ended at 2016-12-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Transplanted liver present\n- Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2016-12-25, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-05 16:48:59, ended at 2017-01-05 17:28:58\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open wound of lower leg\n- Hyperkalemia\n- Hypomagnesemia\n- Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2017-01-05, presumably until 2017-05-23, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-14, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-06-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth as needed\n- hydrocortisone 0.025 MG/MG Topical Ointment, started on 2017-01-05, presumably until 2017-01-19, with intended 0 refill(s). Instructions: Apply to open area on R leg as directed daily. Wash daily with soap/water\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-01-05, presumably until 2017-06-05, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-06-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-05-23, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-14, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 09:48:47, ended at 2017-01-19 10:29:14\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-21 00:00:00, ended at 2017-01-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 106 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 144 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 47 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-02-04 00:00:00, ended at 2017-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 20 ML bupivacaine liposome 13.3 MG/ML Injection, through Infiltration route, started on 2017-02-04, presumably until 2017-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-04 00:00:00, ended at 2017-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Transplanted liver present\n- Hernia of anterior abdominal wall\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- cefazolin 1000 MG Injection, started on 2017-02-04, presumably until 2017-02-04\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- midazolam 1 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-04 05:22:00, ended at 2017-02-05 16:37:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Body height: 5' 7.992\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n\n### Procedure\n- Supplement Abdominal Wall with Synthetic Substitute, Open Approach\n- Repair initial incisional or ventral hernia; reducible\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Collection of venous blood by venipuncture\n- Implantation of mesh or other prosthesis for open incisional or ventral hernia repair or mesh for closure of debridement for necrotizing soft tissue infection (List separately in addition to code for the incisional or ventral hernia repair)\n\n### Condition\n- Primary diagnosis: Incisional hernia\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Major depression, single episode\n- Obesity\n- Viral hepatitis C\n- Cirrhosis of liver\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2017-02-04, presumably until 2017-02-04\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-04\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-02-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed (constipation)\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-02-04, presumably until 2017-02-05\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-02-04, presumably until 2017-02-05\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-06-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-12 11:22:17, ended at 2017-02-12 11:48:57\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Hernia of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-23 00:00:00, ended at 2017-02-23 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-25 00:00:00, ended at 2017-03-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.36 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.1 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 49 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 76 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-21 00:00:00, ended at 2017-04-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.33 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 82 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-27 00:00:00, ended at 2017-04-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n- Transplanted liver present\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-04-27, presumably until 2017-06-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.1 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 42 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 141 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.66 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 8 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-23 11:53:35, ended at 2017-05-23 13:22:24\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-05-23 14:22:00, ended at 2017-06-05 11:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: 4 (per microliter)\n- Glucose [Mass/volume] in Blood: 96 (milligram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 438 (per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Protein [Mass/volume] in Cerebral spinal fluid: 107 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cystatin C [Mass/volume] in Serum or Plasma: 1.35 (milligram per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence: <1:64 (titer)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence: <1:10 (titer)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Histoplasma capsulatum Ag [Mass/volume] in Urine: 0.05 (nanogram per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 13.4 (microgram per milliliter)\n- Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence: <1:10 (titer)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.57 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Body height: 5' 8\" (inch (US))\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.59 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Prothrombin time (PT): 15.4 (second)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Erythrocyte sedimentation rate: 7 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n\n### Procedure\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hospital discharge day management; more than 30 minutes\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n\n### Condition\n- Acquired absence of organ\n- Disorder of digestive system\n- Disorder of intestine\n- Electrocardiogram abnormal\n- Lymphocytosis\n- Complication of transplanted liver\n- Disorder of immune function\n- Esophageal varices without bleeding, associated with another disorder\n- Headache\n- Loss of appetite\n- Transplanted liver present\n- Basal cell carcinoma of face\n- Primary diagnosis: Cirrhosis of liver\n- Dizziness and giddiness\n- B-cell chronic lymphocytic leukemia\n- Bradycardia\n- Chronic kidney disease\n- Encephalitis due to Herpesviridae\n- Fever\n- Spontaneous cerebral hemorrhage\n- Anterograde amnesia\n- Chronic hepatitis C\n- General finding of observation of patient\n- Hypo-osmolality and or hyponatremia\n- Pain in right lower limb\n- Abdominal pain\n- Depressive disorder\n- Hypomagnesemia\n- Chronic kidney disease due to hypertension\n- Obesity\n- Pain in left lower limb\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Acute renal failure syndrome\n- Parastomal hernia\n- Splenomegaly\n- Visual disturbance\n- Kidney stone\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2017-06-02, presumably until 2017-07-01, with intended 1 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2017-06-05, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-05-26, presumably until 2017-06-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-06-05\n- 10 ML acyclovir 50 MG/ML Injection, through Intravenous route, started on 2017-05-30, presumably until 2017-06-17, with intended 0 refill(s). Instructions: 13.7 mL by Intravenous route every 8 hours\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-05-23, presumably until 2017-06-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2019-06-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth daily as needed\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-07-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-05-23, presumably until 2017-05-27\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2017-05-24, presumably until 2017-05-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-06-01, presumably until 2017-06-01\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2017-06-01, presumably until 2017-06-04\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-06-01, presumably until 2017-06-04\n- gadobenate, through Intravenous route, started on 2017-05-28, presumably until 2017-06-02\n- cholecalciferol 0.01 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-05-23, presumably until 2017-06-02\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2017-05-28, presumably until 2017-05-29\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-05-23, presumably until 2017-06-01\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-05-30, presumably until 2017-09-22, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-05-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-05-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-06-04\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-05-29, presumably until 2017-05-29\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-05-25\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2017-05-31, presumably until 2017-06-12, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 3 times a day for 14 days\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-05-29, presumably until 2017-05-31\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2018-03-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-05-27, presumably until 2017-05-29\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-06-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-05-26, presumably until 2017-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-27 00:00:00, ended at 2017-05-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 62.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-28 09:23:00, ended at 2017-05-28 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Basal cell carcinoma of face\n- Fever\n- Abnormal findings on diagnostic imaging of lung\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-12 16:03:02, ended at 2017-06-12 16:50:56\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- 10 ML acyclovir 50 MG/ML Injection, through Intravenous route, started on 2017-06-17, presumably until 2017-06-19, with intended 0 refill(s). Instructions: 13.7 mL by Intravenous route every 8 hours\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-06-20, presumably until 2017-06-24, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-19 09:33:55, ended at 2017-06-19 10:12:44\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-19 10:13:00, ended at 2017-06-19 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.64 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.49 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.8 (percent)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.45 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 08:11:40, ended at 2017-06-24 10:57:32\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 250 mg by mouth\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 100 mg by mouth\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2018-01-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 20 mg by mouth\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 5 mg by mouth every 4 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 12:41:35, ended at 2017-06-24 13:39:49\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 14:47:02, ended at 2017-06-24 15:29:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-06-24, presumably until 2017-07-29, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-28 00:00:00, ended at 2017-06-28 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-07-27, presumably until 2017-07-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2017-07-01, presumably until 2017-09-22, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-07-07, presumably until 2018-07-11, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-07 08:01:00, ended at 2017-07-07 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electroencephalogram (EEG); including recording awake and asleep\n\n### Condition\n- Spontaneous cerebral hemorrhage\n- Encephalitis due to Herpesviridae\n- Headache\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-29 14:23:37, ended at 2017-07-29 15:05:45\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Visual disturbance\n- Transplanted liver present\n- Spontaneous cerebral hemorrhage\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-29, presumably until 2018-07-14, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-19 00:00:00, ended at 2017-08-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-20 00:00:00, ended at 2017-08-20 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-20 15:31:23, ended at 2017-08-20 16:43:44\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Basal cell carcinoma of face\n- Primary diagnosis: Cirrhosis of liver\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-20 15:53:00, ended at 2017-08-20 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.19 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Cirrhosis of liver\n- Basal cell carcinoma of face\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-21 00:00:00, ended at 2017-08-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-24 00:00:00, ended at 2017-08-24 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.6 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: None Detected (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.6 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 74.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "92a0f4f427a0ed9b4c650d10872a6c270a1c5efbf8ce89c39604dbef5379743d", "prompt_hash": "b2107120281ecd4203096109d94891dddc536ea113cfeddb2bd5f13235b7edf5", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 5, "doc": {"person_id": 115968738, "visit_occurrence_id": 103242230, "visit_start_datetime": "2017-06-10 00:00:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 122.0, "current_label": 0, "next_value": 87.0, "next_label": 0, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-20 00:00:00, ended at 2012-11-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory disorder of digestive tract\n\n### Drug\n- ranitidine 150 MG Oral Tablet, started on 2012-11-20, presumably until 2013-06-21, with intended 6 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-25 10:35:50, ended at 2012-11-25 12:02:19\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Urine: 81.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 86.5 (microgram per milliliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 106.3 (milligram per gram of creatinine)\n- Body height: 5' 4\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 105 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Disorder of muscle\n- Inflammatory disorder of digestive tract\n- Bipolar disorder\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-11-25, presumably until 2012-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-12-09 00:00:00, ended at 2012-12-09 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-09, presumably until 2012-12-26, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-19 00:00:00, ended at 2012-12-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neck pain\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-12-19, presumably until 2013-02-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-21 00:00:00, ended at 2012-12-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of muscle\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-12-21, presumably until 2013-06-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-26 00:00:00, ended at 2012-12-26 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-26, presumably until 2013-01-09, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-09 00:00:00, ended at 2013-01-09 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Cough\n- Disorder of muscle\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-01-09, presumably until 2013-02-07, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-01-09, presumably until 2013-03-31, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-01-09, presumably until 2013-01-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-12 00:00:00, ended at 2013-01-12 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n- Agoraphobia without history of panic disorder without limited symptom attacks\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-01-12, presumably until 2013-07-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2013-01-12, presumably until 2013-01-12. Instructions: take 1 Tab by mouth 2 times a day as needed.  \n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2013-01-13, presumably until 2013-02-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed for Anxiety.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-20 00:00:00, ended at 2013-01-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of muscle\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2013-02-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-02-07 00:00:00, ended at 2013-02-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-02-07, presumably until 2013-02-24, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-02-07, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-20 00:00:00, ended at 2013-02-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Disorder of muscle\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-02-20, presumably until 2013-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 10:28:21, ended at 2013-02-24 11:53:30\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lumbar spine\n- Primary diagnosis: Recurrent major depression\n- Cervical spondylosis without myelopathy\n- Bipolar disorder\n- Hyperlipidemia\n- Insomnia\n- Mucopurulent chronic bronchitis\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-02-24, presumably until 2013-03-20, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- quetiapine 50 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-04-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2013-02-24, presumably until 2013-09-13, with intended 3 refill(s). Instructions: take 1 Felman by mouth every bedtime as needed for Insomnia.\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-06-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-20 00:00:00, ended at 2013-03-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-03-20, presumably until 2013-04-04, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-03-31 00:00:00, ended at 2013-03-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Hyperlipidemia\n- Recurrent major depression\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-06-07, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-04-25, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-04 00:00:00, ended at 2013-04-04 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-04, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-04-05 00:00:00, ended at 2013-04-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-21, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-04-07 00:00:00, ended at 2013-04-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n- Bipolar disorder\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- 24 HR venlafaxine 150 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2014-03-16, with intended 3 refill(s). Instructions: take 2 Tabs by mouth Every Day.\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2013-04-28, with intended 6 refill(s). Instructions: take 3 Tabs by mouth 2 times a day.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2013-04-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-21 00:00:00, ended at 2013-04-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-21, presumably until 2013-05-05, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-06-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-25 00:00:00, ended at 2013-04-25 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-04-25, presumably until 2013-06-21, with intended 5 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-04-25, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-28 11:09:55, ended at 2013-04-28 12:48:57\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Disorder of lumbar spine\n- Disorder of muscle\n- Mucopurulent chronic bronchitis\n- Primary diagnosis: Recurrent major depression\n- Allergic rhinitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2013-04-28, presumably until 2013-06-21, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route Every Day.\n- 12 HR oxycodone hydrochloride 40 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-28, presumably until 2013-05-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. For chronic pain\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2013-04-28, presumably until 2013-06-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2013-04-28, presumably until 2014-07-02, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-03 00:00:00, ended at 2013-05-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-05, presumably until 2013-05-17, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-05-08, presumably until 2013-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-05 00:00:00, ended at 2013-05-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of lumbar spine\n- Disorder of muscle\n\n### Drug\n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2013-05-05, presumably until 2013-06-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-14 00:00:00, ended at 2013-05-14 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-15, presumably until 2013-05-15, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-17 00:00:00, ended at 2013-05-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-17, presumably until 2013-05-31, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-18 00:00:00, ended at 2013-05-18 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-31 00:00:00, ended at 2013-05-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Disorder of muscle\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-31, presumably until 2013-06-12, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2013-06-02, presumably until 2013-08-16, with intended 3 refill(s). Instructions: Use as directed as needed for allergic reaction\n- 12 HR oxycodone hydrochloride 30 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-02, presumably until 2013-06-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-31 00:00:00, ended at 2013-05-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-31, presumably until 2013-05-31, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-07 00:00:00, ended at 2013-06-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Recurrent major depression\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-06-07, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-06-07, presumably until 2013-10-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-12 00:00:00, ended at 2013-06-12 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-06-12, presumably until 2013-06-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-20 00:00:00, ended at 2013-06-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Essential hypertension\n- Hyperlipidemia\n- Inflammatory disorder of digestive tract\n- Mucopurulent chronic bronchitis\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Recurrent major depression\n- Allergic rhinitis\n\n### Drug\n- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2013-06-21, presumably until 2015-05-17, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route Every Day.\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-06-23, presumably until 2013-06-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-10-09, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-04-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-12-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- ranitidine 150 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-07-18, with intended 3 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-07-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-20 00:00:00, ended at 2013-06-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Agoraphobia without history of panic disorder without limited symptom attacks\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-06-20, presumably until 2013-06-28, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-23 00:00:00, ended at 2013-06-23 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-06-23, presumably until 2013-07-05, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-26 00:00:00, ended at 2013-06-26 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-28 00:00:00, ended at 2013-06-28 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-06-28, presumably until 2013-08-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-05 00:00:00, ended at 2013-07-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-07-05, presumably until 2013-07-19, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-07-06 00:00:00, ended at 2013-07-06 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n- Recurrent major depression\n- Primary diagnosis: Bipolar disorder\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-07-07, presumably until 2013-07-24. Instructions: take 1 Tab by mouth 2 times a day.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-07-07, presumably until 2013-08-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-16 00:00:00, ended at 2013-07-16 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2013-07-16, presumably until 2013-07-16, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-17 11:30:09, ended at 2013-07-17 12:59:33\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of lumbar spine\n- Osteoarthritis of knee\n- Mucopurulent chronic bronchitis\n- Chronic pain syndrome\n- Disorder of muscle\n- Recurrent major depression\n- Essential hypertension\n\n### Drug\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2013-07-17, presumably until 2013-12-12, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day. For muscle spasm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-19 00:00:00, ended at 2013-07-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-07-19, presumably until 2013-08-18, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-21 00:00:00, ended at 2013-07-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bipolar disorder\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-07-21, presumably until 2013-10-25, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-15 00:00:00, ended at 2013-08-15 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-08-15, presumably until 2014-05-06, with intended 4 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-16 12:58:26, ended at 2013-08-16 14:26:39\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.400 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Obstructive sleep apnea syndrome\n- Hyperlipidemia\n- Primary diagnosis: Recurrent major depression\n- Cervical spondylosis without myelopathy\n- Backache\n- Bipolar disorder\n- Disorder of muscle\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Chronic sinusitis\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2013-08-16, presumably until 2013-08-18, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n- azithromycin 250 MG Oral Tablet, started on 2013-08-16, presumably until 2013-09-20, with intended 0 refill(s). Instructions: Take 2 tabs today, then 1 tab daily for next 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-08-17 00:00:00, ended at 2013-08-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-08-18, presumably until 2013-10-11, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-30 08:49:35, ended at 2013-08-30 10:39:58\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Borderline personality disorder\n- Primary diagnosis: Disorder of muscle\n- Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2013-09-13, presumably until 2014-03-27, with intended 4 refill(s). Instructions: take 1 Pohl by mouth every bedtime as needed for Insomnia.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-09-13, presumably until 2013-09-13, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-09-13, presumably until 2013-10-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-14 00:00:00, ended at 2013-09-14 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of muscle\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2013-09-14, presumably until 2014-10-03, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-20 12:43:54, ended at 2013-09-20 13:48:20\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Chronic pain syndrome\n- Essential hypertension\n- Disorder of lumbar spine\n- Disorder of muscle\n- Morbid obesity\n- Borderline personality disorder\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, started on 2013-09-20, presumably until 2013-10-30, with intended 0 refill(s). Instructions: Take 60 mg a day per Dr. Pritts\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-09 00:00:00, ended at 2013-10-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n- Primary diagnosis: Recurrent major depression\n- Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-10-09, presumably until 2014-02-21, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2014-10-10, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2013-10-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2014-04-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-10-11, presumably until 2013-11-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n- alprazolam 2 MG Oral Tablet, started on 2013-10-09, presumably until 2013-10-09, with intended 4 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-23 00:00:00, ended at 2013-10-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, started on 2013-10-23, presumably until 2013-12-15, with intended 0 refill(s). Instructions: TAKE 3 TABLETS BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-30 00:00:00, ended at 2013-10-30 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2013-11-08, presumably until 2014-04-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2013-12-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-01 00:00:00, ended at 2013-11-01 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2013-11-01, presumably until 2013-11-01, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-20 09:06:04, ended at 2013-11-20 11:05:24\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Morbid obesity\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Disorder of muscle\n- Backache\n- Chronic pain syndrome\n- Disorder of lumbar spine\n- Chronic pain\n\n### Drug\n- influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension, through Intramuscular route, started on 2013-11-20, presumably until 2013-11-21, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-11 00:00:00, ended at 2013-12-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2013-12-11, presumably until 2014-03-28, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-11 00:00:00, ended at 2013-12-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-12-11, presumably until 2014-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-12 00:00:00, ended at 2013-12-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Backache\n\n### Drug\n- baclofen 10 MG Oral Tablet, started on 2013-12-12, presumably until 2014-04-22, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 3 TIMES A DAY. FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-15 00:00:00, ended at 2013-12-15 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-12-15, presumably until 2015-04-10, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-08 00:00:00, ended at 2014-01-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-01-08, presumably until 2014-02-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-08 00:00:00, ended at 2014-01-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2014-01-08, presumably until 2015-03-26, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-01-08, presumably until 2014-04-09, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-09 08:49:38, ended at 2014-02-09 10:07:01\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoarthritis of knee\n- Primary diagnosis: Carpal tunnel syndrome\n- Chronic pain syndrome\n- Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Disorder of lumbar spine\n- Disorder of muscle\n- Major depression, single episode\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-02-09, presumably until 2014-03-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-02-21 00:00:00, ended at 2014-02-21 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-02-21, presumably until 2014-05-05, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-03-09 00:00:00, ended at 2014-03-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-03-09, presumably until 2014-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-16 00:00:00, ended at 2014-03-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR venlafaxine 150 MG Extended Release Oral Capsule, started on 2014-03-16, presumably until 2014-06-08, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-27 00:00:00, ended at 2014-03-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n- Major depression, single episode\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2014-03-28, presumably until 2014-06-27, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- temazepam 30 MG Oral Capsule, started on 2014-03-27, presumably until 2014-08-20, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AT BEDTIME FOR INSOMNIA\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-04-05 00:00:00, ended at 2014-04-05 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-09 10:28:35, ended at 2014-04-09 11:39:27\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 10.5 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.50 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 36 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.24 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 4.480 (micro-international unit per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Backache\n- Carpal tunnel syndrome\n- Primary diagnosis: Major depression, single episode\n- Essential hypertension\n- Chronic pain syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-04-09, presumably until 2014-05-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-13 10:20:47, ended at 2014-04-13 11:53:05\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Disorder of muscle\n- Borderline personality disorder\n- Primary diagnosis: Major depression, single episode\n- Obstructive sleep apnea syndrome\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2014-04-13, presumably until 2014-05-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. For 2 weeks then 120 mg daily\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2014-04-13, presumably until 2014-05-25, with intended 4 refill(s). Instructions: take 2 Caps by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-22 00:00:00, ended at 2014-04-22 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- baclofen 10 MG Oral Tablet, started on 2014-04-22, presumably until 2014-10-10, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 3 TIMES A DAY. FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-23 00:00:00, ended at 2014-04-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-04-23, presumably until 2014-06-21, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-30 11:21:58, ended at 2014-04-30 12:36:15\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n- Pre-surgery evaluation\n\n### Condition\n- Essential hypertension\n- Obstructive sleep apnea syndrome\n- Major depression, single episode\n- Carpal tunnel syndrome\n- Chronic pain syndrome\n- Disorder of muscle\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-04 00:00:00, ended at 2014-05-04 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n- Disorder of muscle\n- Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-05-04, presumably until 2014-07-11, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-05-04, presumably until 2014-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-06 00:00:00, ended at 2014-05-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-05-06, presumably until 2014-05-06, with intended 0 refill(s). Instructions: TAKE 1 TEASPOONFUL BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-06 00:00:00, ended at 2014-05-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2014-05-06, presumably until 2014-08-29, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY FOUR TIMES DAILY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-05-08, presumably until 2014-06-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-23 00:00:00, ended at 2014-05-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-05-23, presumably until 2014-08-10, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2014-05-25, presumably until 2014-06-08, with intended 4 refill(s). Instructions: take 2 Caps by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-30 00:00:00, ended at 2014-05-30 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-05-30, presumably until 2014-05-30, with intended 4 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-05 00:00:00, ended at 2014-06-05 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of muscle\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-06-05, presumably until 2014-07-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-08 09:18:19, ended at 2014-06-08 10:10:19\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 33 (percent)\n- Body height: 5' 4\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 52 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Chronic pain syndrome\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Carpal tunnel syndrome\n- Disorder of muscle\n- Hyperlipidemia\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2014-06-08, presumably until 2014-06-14, with intended 4 refill(s). Instructions: take 2 Caps by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-14 00:00:00, ended at 2014-06-14 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2014-06-14, presumably until 2020-08-05, with intended 4 refill(s). Instructions: take 2 Caps by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-21 00:00:00, ended at 2014-06-21 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-06-21, presumably until 2014-08-10, with intended 3 refill(s). Instructions: take one tablet orally every 3-4 hours as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-27 00:00:00, ended at 2014-06-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- quetiapine 100 MG Oral Tablet, started on 2014-06-27, presumably until 2015-03-08, with intended 2 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-07-02 00:00:00, ended at 2014-07-02 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-07-02, presumably until 2014-07-02, with intended 0 refill(s). Instructions: take one tablet orally every 3-4 hours as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-02 00:00:00, ended at 2014-07-02 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2014-07-02, presumably until 2014-10-10, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 HOURS AS NEEDED.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-03 00:00:00, ended at 2014-07-03 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2014-07-03, presumably until 2015-07-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-09 00:00:00, ended at 2014-07-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of muscle\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-07-09, presumably until 2014-08-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-11 00:00:00, ended at 2014-07-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-07-11, presumably until 2014-08-10, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-18 00:00:00, ended at 2014-07-18 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ranitidine 150 MG Oral Tablet, started on 2014-07-18, presumably until 2015-10-19, with intended 3 refill(s). Instructions: TAKE 150 MG BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-10 09:08:21, ended at 2014-08-10 10:42:43\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Cough\n- Primary diagnosis: Chronic pain syndrome\n- Type 2 diabetes mellitus without complication\n- Disorder of lumbar spine\n- Major depression, single episode\n- Chronic sinusitis\n- Disorder of muscle\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-08-10, presumably until 2014-08-17, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-08-10, presumably until 2014-09-26, with intended 0 refill(s). Instructions: take one tablet orally every 3-4 hours as needed for breakthrough pain\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-08-10, presumably until 2014-09-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- dextromethorphan hydrobromide 3 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2014-08-10, presumably until 2014-10-10, with intended 3 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-08-16 00:00:00, ended at 2014-08-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tobacco dependence syndrome\n\n### Drug\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2014-08-17, presumably until 2014-08-21, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-19 00:00:00, ended at 2014-08-19 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, started on 2014-08-19, presumably until 2014-08-20, with intended 3 refill(s). Instructions: TAKE 2 TABS BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-20 00:00:00, ended at 2014-08-20 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2014-08-20, presumably until 2014-10-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- temazepam 30 MG Oral Capsule, started on 2014-08-20, presumably until 2015-03-22, with intended 4 refill(s). Instructions: Take on capsule by mouth at bedtime for insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-08-21 00:00:00, ended at 2014-08-21 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2014-08-21, presumably until 2015-03-02, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2014-08-29, presumably until 2014-09-26, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-05 00:00:00, ended at 2014-09-05 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Disorder of muscle\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-09-05, presumably until 2014-10-05, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-14 00:00:00, ended at 2014-09-14 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2014-09-14, presumably until 2014-10-10, with intended 0 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-09-26, presumably until 2014-10-24, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n- alprazolam 2 MG Oral Tablet, started on 2014-09-26, presumably until 2014-12-26, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-03 00:00:00, ended at 2014-10-03 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of muscle\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-10-03, presumably until 2015-10-04, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-03 00:00:00, ended at 2014-10-03 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bronchitis\n- Disorder of muscle\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2014-10-05, presumably until 2014-10-10, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-10-05, presumably until 2015-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-10 00:00:00, ended at 2014-10-10 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2014-10-10, presumably until 2014-10-10, with intended 0 refill(s). Instructions: 3 mL by Nebulization route One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-10 09:18:45, ended at 2014-10-10 10:32:38\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n\n### Condition\n- Major depression, single episode\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Chronic bronchitis\n- Primary diagnosis: Acute bronchitis\n- Tobacco dependence syndrome\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2014-10-10, presumably until 2014-11-09, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2014-10-10, presumably until 2015-11-15, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-11 00:00:00, ended at 2014-10-11 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spasm\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, through Oral route, started on 2014-10-15, presumably until 2015-10-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Muscle spasms.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-23 00:00:00, ended at 2014-10-23 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-10-23, presumably until 2014-11-26, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-24 00:00:00, ended at 2014-10-24 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2014-10-24, presumably until 2014-10-24, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-24 00:00:00, ended at 2014-10-24 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2014-10-24, presumably until 2015-01-21, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Disorder of muscle\n- Acute bronchitis\n- Chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2014-11-09, presumably until 2014-12-07, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-11-05, presumably until 2014-11-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-26 00:00:00, ended at 2014-11-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-11-26, presumably until 2014-12-24, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-28 00:00:00, ended at 2014-11-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Disorder of muscle\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-11-28, presumably until 2014-12-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-07 00:00:00, ended at 2014-12-07 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-12-07, presumably until 2014-12-25, with intended 0 refill(s). Instructions: TAKE 5ML ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-24 00:00:00, ended at 2014-12-24 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-12-24, presumably until 2015-01-09, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-12-24, presumably until 2015-01-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-25 00:00:00, ended at 2014-12-25 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2014-12-25, presumably until 2015-02-07, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-25 00:00:00, ended at 2014-12-25 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-12-25, presumably until 2015-01-21, with intended 0 refill(s). Instructions: TAKE 5ML ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-09 09:57:21, ended at 2015-01-09 11:06:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 120 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 5.2 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 4.7 (milligram per gram of creatinine)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 199 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 167 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 110.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 33 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Major depression, single episode\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Primary diagnosis: Burn erythema of abdominal wall\n- Cough\n- Essential hypertension\n- Obstructive sleep apnea syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-01-09, presumably until 2015-02-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-01-09, presumably until 2015-02-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-18 10:07:05, ended at 2015-01-18 12:22:10\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Obstructive sleep apnea syndrome\n- Borderline personality disorder\n- Primary diagnosis: Major depression, single episode\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-18 10:22:16, ended at 2015-01-18 12:21:06\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-21 00:00:00, ended at 2015-01-21 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-01-21, presumably until 2015-03-15, with intended 1 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-01-21, presumably until 2015-02-07, with intended 0 refill(s). Instructions: TAKE 5 MLS ( ONE TEASPOONFUL ) EVERY SIX HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-22 00:00:00, ended at 2015-01-22 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-01-22, presumably until 2015-01-22, with intended 1 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-01-22, presumably until 2015-01-22, with intended 0 refill(s). Instructions: TAKE 5 MLS ( ONE TEASPOONFUL ) EVERY SIX HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-02-07 00:00:00, ended at 2015-02-07 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-02-07, presumably until 2015-03-07, with intended 0 refill(s). Instructions: TAKE 5 MLS ( ONE TEASPOONFUL ) EVERY SIX HOURS AS NEEDED FOR COUGH\n- alprazolam 2 MG Oral Tablet, started on 2015-02-07, presumably until 2015-04-23, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-02-19 00:00:00, ended at 2015-02-19 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-02-19, presumably until 2015-03-15, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-02-19, presumably until 2015-03-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-02 00:00:00, ended at 2015-03-02 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2015-03-02, presumably until 2015-05-17, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-07 00:00:00, ended at 2015-03-07 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-03-07, presumably until 2015-04-01, with intended 0 refill(s). Instructions: TAKE 5 ML ( 1 TEASPOON ) BY MOUTH EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-08 00:00:00, ended at 2015-03-08 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-03-08, presumably until 2015-03-08, with intended 0 refill(s). Instructions: TAKE 5 ML ( 1 TEASPOON ) BY MOUTH EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-08 09:50:28, ended at 2015-03-08 10:39:50\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence syndrome\n- Type 2 diabetes mellitus without complication\n- Headache\n- Primary diagnosis: Major depression, single episode\n- Chronic pain syndrome\n- Cough\n- Essential hypertension\n\n### Drug\n- quetiapine 100 MG Oral Tablet, started on 2015-03-08, presumably until 2015-05-17, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-03-15, presumably until 2015-04-12, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-04-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-03-15, presumably until 2015-05-17, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-15 10:34:21, ended at 2015-03-15 11:16:55\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Disorder of muscle\n- Obstructive sleep apnea syndrome\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-06-14, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-22 00:00:00, ended at 2015-03-22 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- temazepam 30 MG Oral Capsule, started on 2015-03-22, presumably until 2015-05-17, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH AT BEDTIME FOR INSOMNIA\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-26 00:00:00, ended at 2015-03-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2015-03-26, presumably until 2015-04-12, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2015-03-26, presumably until 2015-08-09, with intended 3 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 HOURS AS NEEDED.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-26 00:00:00, ended at 2015-03-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2015-03-26, presumably until 2016-04-26, with intended 5 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERYDAY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-01 00:00:00, ended at 2015-04-01 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-04-01, presumably until 2015-04-23, with intended 0 refill(s). Instructions: TAKE 5 ML ( 1 TEASPOON ) BY MOUTH EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-10 00:00:00, ended at 2015-04-10 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, started on 2015-04-11, presumably until 2015-11-15, with intended 3 refill(s). Instructions: TAKE 2 TABLETS ORALLY 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-12 00:00:00, ended at 2015-04-12 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2015-04-12, presumably until 2015-06-14, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-12 00:00:00, ended at 2015-04-12 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-04-15, presumably until 2015-05-17, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-04-15, presumably until 2015-05-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-23 00:00:00, ended at 2015-04-23 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-04-24, presumably until 2015-05-17, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6HOURS AS NEEDED FOR COUGH\n- alprazolam 2 MG Oral Tablet, started on 2015-04-24, presumably until 2015-06-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET FOUR TIMES DAILY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-06 00:00:00, ended at 2015-05-06 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-05-06, presumably until 2015-05-06, with intended 0 refill(s)\n- alprazolam 2 MG Oral Tablet, started on 2015-05-06, presumably until 2015-05-06, with intended 3 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-14 00:00:00, ended at 2015-05-14 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-05-14, presumably until 2015-05-14, with intended 0 refill(s). Instructions: TAKE 5ML ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-17 09:21:42, ended at 2015-05-17 09:59:51\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Obstructive sleep apnea syndrome\n- Borderline personality disorder\n\n### Drug\n- quetiapine 100 MG Oral Tablet, started on 2015-05-17, presumably until 2015-11-15, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-17 10:04:40, ended at 2015-05-17 13:04:42\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lumbar spine\n- Morbid obesity\n- Essential hypertension\n- Chronic pain syndrome\n- Cough\n- Osteoarthritis of knee\n- Tobacco dependence syndrome\n- Insomnia\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-05-17, presumably until 2015-06-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-05-17, presumably until 2015-06-07, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6HOURS AS NEEDED FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-05-17, presumably until 2015-06-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- temazepam 30 MG Oral Capsule, started on 2015-05-17, presumably until 2015-11-15, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH AT BEDTIME FOR INSOMNIA\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-05-17, presumably until 2015-06-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2015-05-17, presumably until 2015-08-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-07 00:00:00, ended at 2015-06-07 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-06-07, presumably until 2015-06-28, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-14 00:00:00, ended at 2015-06-14 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Major depression, single episode\n- Disorder of lumbar spine\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-06-14, presumably until 2015-06-28, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-06-14, presumably until 2015-07-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- metformin hydrochloride 500 MG Oral Tablet, started on 2015-06-14, presumably until 2016-06-26, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, started on 2015-06-14, presumably until 2015-07-19, with intended 3 refill(s). Instructions: TAKE ONE TABLET FOUR TIMES DAILY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-14 09:51:02, ended at 2015-06-14 11:06:20\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Borderline personality disorder\n- Obstructive sleep apnea syndrome\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-28 00:00:00, ended at 2015-06-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-06-28, presumably until 2015-07-19, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-06-28 00:00:00, ended at 2015-06-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of lumbar spine\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-06-28, presumably until 2015-08-29, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, started on 2015-07-17, presumably until 2016-07-27, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-19 00:00:00, ended at 2015-07-19 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-07-19, presumably until 2015-07-19, with intended 0 refill(s). Instructions: TAKE ONE TEASPOONFUL ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-19 09:23:13, ended at 2015-07-19 11:08:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lumbar spine\n- Essential hypertension\n- Joint pain of pelvic region\n- Carpal tunnel syndrome\n- Type 2 diabetes mellitus without complication\n- Chronic pain syndrome\n- Major depression, single episode\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-07-19, presumably until 2015-08-09, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-07-19, presumably until 2015-08-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-07-19, presumably until 2015-08-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, started on 2015-07-19, presumably until 2015-10-17, with intended 0 refill(s). Instructions: TAKE ONE TABLET FOUR TIMES DAILY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-19 10:17:43, ended at 2015-07-19 12:37:20\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Borderline personality disorder\n- Primary diagnosis: Major depression, single episode\n- Obstructive sleep apnea syndrome\n\n### Drug\n- aripiprazole 10 MG Oral Tablet, through Oral route, started on 2015-07-19, presumably until 2015-11-15, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-08-09, presumably until 2015-08-29, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-08-09, presumably until 2016-12-18, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB or wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-16 00:00:00, ended at 2015-08-16 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tobacco dependence syndrome\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2015-08-16, presumably until 2015-10-23, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-21 00:00:00, ended at 2015-08-21 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-08-21, presumably until 2015-09-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-08-21, presumably until 2015-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-29 00:00:00, ended at 2015-08-29 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-08-30, presumably until 2015-09-12, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-29 00:00:00, ended at 2015-08-29 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of lumbar spine\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-08-30, presumably until 2015-12-30, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-03 00:00:00, ended at 2015-09-03 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, started on 2015-09-09, presumably until 2016-09-24, with intended 4 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-11 00:00:00, ended at 2015-09-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-09-11, presumably until 2015-10-10, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-09-11, presumably until 2015-10-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-12 00:00:00, ended at 2015-09-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-09-13, presumably until 2015-10-10, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-04 00:00:00, ended at 2015-10-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2015-10-07, presumably until 2016-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-10 00:00:00, ended at 2015-10-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-10-11, presumably until 2015-11-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-10 00:00:00, ended at 2015-10-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-10-11, presumably until 2015-10-16, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-12 00:00:00, ended at 2015-10-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-10-12, presumably until 2015-10-12, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-14 14:26:53, ended at 2015-10-14 15:57:48\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Chronic pain syndrome\n- Post-laminectomy syndrome\n- Carpal tunnel syndrome\n- Essential hypertension\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Polyneuropathy\n- Polyneuropathy due to diabetes mellitus\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-10-14, presumably until 2015-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-15 00:00:00, ended at 2015-10-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-10-16, presumably until 2015-11-04, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-17 00:00:00, ended at 2015-10-17 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2015-10-18, presumably until 2015-11-15, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORLALY 4 TIMES A DAY FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-19 00:00:00, ended at 2015-10-19 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ranitidine 150 MG Oral Tablet, started on 2015-10-21, presumably until 2016-11-10, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-23 00:00:00, ended at 2015-10-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2015-10-28, presumably until 2016-03-03, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-04 00:00:00, ended at 2015-11-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-11-04, presumably until 2015-11-23, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-04 00:00:00, ended at 2015-11-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-11-04, presumably until 2015-11-04, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-09 00:00:00, ended at 2015-11-09 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 600 MG Oral Tablet, started on 2015-11-11, presumably until 2015-11-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-14 00:00:00, ended at 2015-11-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-11-15, presumably until 2015-12-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-12-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-15 08:26:30, ended at 2015-11-15 09:23:07\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Severe major depression, single episode, without psychotic features\n- Borderline personality disorder\n\n### Drug\n- aripiprazole 10 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2016-09-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-12-27, with intended 1 refill(s). Instructions: take 2 Tabs by mouth every bedtime TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- temazepam 15 MG Oral Capsule, through Oral route, started on 2015-11-15, presumably until 2015-12-27, with intended 3 refill(s). Instructions: take 1 Zimmermann by mouth every bedtime as needed\n- 12 HR bupropion hydrochloride 200 MG Extended Release Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2016-03-06, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2016-03-06, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- alprazolam 2 MG Oral Tablet, started on 2015-11-15, presumably until 2016-01-29, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORLALY 4 TIMES A DAY FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-23 00:00:00, ended at 2015-11-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-11-25, presumably until 2015-11-25, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-25 00:00:00, ended at 2015-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-11-27, presumably until 2015-12-13, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-13 00:00:00, ended at 2015-12-13 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-12-13, presumably until 2015-12-30, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-13 09:19:49, ended at 2015-12-13 10:20:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Severe major depression, single episode, without psychotic features\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-12-13, presumably until 2016-01-08, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-12-13, presumably until 2016-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-27 09:16:48, ended at 2015-12-27 10:15:11\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Borderline personality disorder\n- Chronic pain syndrome\n- Primary diagnosis: Severe major depression, single episode, without psychotic features\n\n### Drug\n- temazepam 7.5 MG Oral Capsule, through Oral route, started on 2015-12-27, presumably until 2016-03-06, with intended 2 refill(s). Instructions: take 1 Hinson by mouth every bedtime as needed\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2015-12-27, presumably until 2016-03-06, with intended 1 refill(s). Instructions: take 2 Tabs by mouth every bedtime TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-30 00:00:00, ended at 2015-12-30 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-12-30, presumably until 2016-01-29, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-30 00:00:00, ended at 2015-12-30 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-12-30, presumably until 2016-03-03, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-08 00:00:00, ended at 2016-01-08 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-01-08, presumably until 2016-01-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-01-08, presumably until 2016-01-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-29 00:00:00, ended at 2016-01-29 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-01-29, presumably until 2016-02-19, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-01-29, presumably until 2016-03-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-01-29, presumably until 2016-07-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, started on 2016-01-29, presumably until 2016-05-22, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORLALY 4 TIMES A DAY FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-30 00:00:00, ended at 2016-01-30 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 600 MG Oral Tablet, started on 2016-01-31, presumably until 2017-01-07, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-19 00:00:00, ended at 2016-02-19 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-02-19, presumably until 2016-03-06, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-03 00:00:00, ended at 2016-03-03 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-03-04, presumably until 2016-05-01, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- varenicline 1 MG Oral Tablet, started on 2016-03-04, presumably until 2016-03-31, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-06 00:00:00, ended at 2016-03-06 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 614 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Folate [Mass/volume] in Serum or Plasma: 11.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 78 (microgram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Borderline personality disorder\n- Primary diagnosis: Severe major depression, single episode, without psychotic features\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-06 08:54:36, ended at 2016-03-06 11:53:24\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Obstructive sleep apnea syndrome\n- Borderline personality disorder\n- Primary diagnosis: Severe major depression, single episode, without psychotic features\n\n### Drug\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2016-03-06, presumably until 2016-05-01, with intended 1 refill(s). Instructions: take 2 Tabs by mouth every bedtime TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- 12 HR bupropion hydrochloride 200 MG Extended Release Oral Tablet, through Oral route, started on 2016-03-06, presumably until 2016-11-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2016-03-06, presumably until 2016-09-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-06 09:31:29, ended at 2016-03-06 10:46:08\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 50 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Albumin [Mass/volume] in Urine: 15.3 (microgram per milliliter)\n- Creatinine [Mass/volume] in Urine: 246.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Albumin/Creatinine [Mass Ratio] in Urine: 6.2 (milligram per gram of creatinine)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 48 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Fibromyalgia\n- Polyneuropathy\n- Severe major depression, single episode, without psychotic features\n- Essential hypertension\n- Morbid obesity\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Polyneuropathy due to diabetes mellitus\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-03-06, presumably until 2016-03-27, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-03-06, presumably until 2016-03-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-03-06, presumably until 2016-03-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-25 00:00:00, ended at 2016-03-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, started on 2016-03-25, presumably until 2016-09-25, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-27 00:00:00, ended at 2016-03-27 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-04-01, presumably until 2016-05-01, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-04-01, presumably until 2016-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-27 00:00:00, ended at 2016-03-27 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-03-30, presumably until 2016-04-21, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-31 00:00:00, ended at 2016-03-31 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2016-04-01, presumably until 2016-05-23, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-21 00:00:00, ended at 2016-04-21 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-04-22, presumably until 2016-05-11, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-26 00:00:00, ended at 2016-04-26 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2016-04-27, presumably until 2017-05-16, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERYDAY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-01 08:03:10, ended at 2016-05-01 08:34:12\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Fibromyalgia\n- Obstructive sleep apnea syndrome\n- Borderline personality disorder\n- Primary diagnosis: Major depression, single episode\n- Severe major depression, single episode, without psychotic features\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-01 08:31:53, ended at 2016-05-01 09:41:13\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Hyperlipidemia\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Severe major depression, single episode, without psychotic features\n- Essential hypertension\n- Major depression, single episode\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-05-01, presumably until 2016-06-23, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-05-01, presumably until 2016-05-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-09-25, with intended 1 refill(s). Instructions: take 2-2.5 Tabs by mouth every bedtime\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-11 00:00:00, ended at 2016-05-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-05-11, presumably until 2016-06-01, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-20 00:00:00, ended at 2016-05-20 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-05-22, presumably until 2016-06-23, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-05-22, presumably until 2016-06-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-22 00:00:00, ended at 2016-05-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2016-05-22, presumably until 2016-06-23, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY FOR ANXETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-22 00:00:00, ended at 2016-05-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- divalproex sodium 500 MG Delayed Release Oral Tablet, started on 2016-05-22, presumably until 2016-09-25, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-23 00:00:00, ended at 2016-05-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2016-05-25, presumably until 2016-07-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-01 00:00:00, ended at 2016-06-01 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-06-01, presumably until 2016-06-02, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-02 00:00:00, ended at 2016-06-02 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-06-03, presumably until 2016-06-22, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-22 00:00:00, ended at 2016-06-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n- Chronic pain syndrome\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-06-22, presumably until 2016-06-22, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-06-22, presumably until 2016-07-15, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-06-22, presumably until 2016-06-22, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-06-22, presumably until 2016-12-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, started on 2016-06-22, presumably until 2016-06-22, with intended 1 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-23 00:00:00, ended at 2016-06-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-06-23, presumably until 2016-07-22, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-23 00:00:00, ended at 2016-06-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-06-23, presumably until 2016-07-22, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-06-23, presumably until 2016-07-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2016-06-23, presumably until 2016-08-18, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-26 00:00:00, ended at 2016-06-26 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2016-06-26, presumably until 2017-07-21, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-15 00:00:00, ended at 2016-07-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-07-15, presumably until 2016-08-04, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Chronic pain syndrome\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-07-22, presumably until 2016-08-18, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-07-22, presumably until 2016-08-18, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-07-22, presumably until 2016-08-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-27 00:00:00, ended at 2016-07-27 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, started on 2016-07-27, presumably until 2017-07-27, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY.\n- varenicline 1 MG Oral Tablet, started on 2016-07-27, presumably until 2017-03-29, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-04 00:00:00, ended at 2016-08-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-08-05, presumably until 2016-08-28, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-18 00:00:00, ended at 2016-08-18 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-08-19, presumably until 2016-11-11, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-08-19, presumably until 2016-09-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-08-19, presumably until 2016-09-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2016-08-19, presumably until 2016-09-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-28 00:00:00, ended at 2016-08-28 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-08-28, presumably until 2016-09-11, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-29 00:00:00, ended at 2016-08-29 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-08-30, presumably until 2016-08-30, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-11 00:00:00, ended at 2016-09-11 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-09-16, presumably until 2016-10-13, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-09-11, presumably until 2016-10-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-09-11, presumably until 2017-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-24 00:00:00, ended at 2016-09-24 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, started on 2016-09-24, presumably until 2017-07-19, with intended 2 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-25 12:59:22, ended at 2016-09-25 13:42:58\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Major depression, single episode\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-25 14:35:48, ended at 2016-09-25 15:15:58\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Borderline personality disorder\n- Fibromyalgia\n- Obstructive sleep apnea syndrome\n\n### Drug\n- aripiprazole 10 MG Oral Tablet, through Oral route, started on 2016-09-25, presumably until 2017-07-19, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2016-09-25, presumably until 2017-07-19, with intended 2 refill(s). Instructions: take 2-2.5 Tabs by mouth every bedtime\n- divalproex sodium 500 MG Delayed Release Oral Tablet, started on 2016-09-25, presumably until 2018-03-17, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2016-09-25, presumably until 2016-12-11, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-09 00:00:00, ended at 2016-10-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.12 (nanogram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 6.230 (micro-international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 33 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.66 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 58 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 56 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Borderline personality disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-09 10:19:04, ended at 2016-10-09 11:59:33\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Borderline personality disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-10-19, presumably until 2016-11-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-10-19, presumably until 2016-11-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-10-14, presumably until 2016-11-02, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-02 00:00:00, ended at 2016-11-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-11-04, presumably until 2016-11-24, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-10 00:00:00, ended at 2016-11-10 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-11-11, presumably until 2017-01-07, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- ranitidine 150 MG Oral Tablet, started on 2016-11-11, presumably until 2017-10-06, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-16 00:00:00, ended at 2016-11-16 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-11-16, presumably until 2016-12-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-11-16, presumably until 2016-12-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-20 00:00:00, ended at 2016-11-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR bupropion hydrochloride 200 MG Extended Release Oral Tablet, started on 2016-11-20, presumably until 2017-06-11, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n- divalproex sodium 500 MG Delayed Release Oral Tablet, started on 2016-11-20, presumably until 2016-12-18, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-24 00:00:00, ended at 2016-11-24 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-11-25, presumably until 2016-12-18, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2016-12-11, presumably until 2016-12-18, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-12-14, presumably until 2017-01-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-12-14, presumably until 2017-01-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-18 09:17:21, ended at 2016-12-18 12:16:01\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Cough\n- Essential hypertension\n- Hip pain\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Fibromyalgia\n- Hypothyroidism\n- Major depression, single episode\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-12-18, presumably until 2017-01-07, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2016-12-18, presumably until 2017-11-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2016-12-18, presumably until 2017-07-26, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB or wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-18 09:18:09, ended at 2016-12-18 12:17:08\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Obstructive sleep apnea syndrome\n- Morbid obesity\n- Primary diagnosis: Major depression, single episode\n- Borderline personality disorder\n\n### Drug\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2016-12-18, presumably until 2017-01-07, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed To start 01/10/2017\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-07 00:00:00, ended at 2017-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-01-08, presumably until 2017-02-01, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-07 00:00:00, ended at 2017-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Chronic pain syndrome\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2017-01-08, presumably until 2017-03-03, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-01-08, presumably until 2017-02-01, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-01-08, presumably until 2017-02-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- gabapentin 600 MG Oral Tablet, started on 2017-01-08, presumably until 2017-10-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-07 00:00:00, ended at 2017-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-01-07, presumably until 2017-03-02, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed To start 01/10/2017\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-15 00:00:00, ended at 2017-01-15 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-01-15, presumably until 2017-01-15, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-01 00:00:00, ended at 2017-02-01 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-02-01, presumably until 2017-03-02, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-02-01, presumably until 2017-03-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-01 00:00:00, ended at 2017-02-01 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-02-01, presumably until 2017-02-26, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-02-01, presumably until 2017-07-31, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed To start 01/10/2017\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-02-01, presumably until 2017-07-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-26 00:00:00, ended at 2017-02-26 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-02-26, presumably until 2017-03-22, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-02 00:00:00, ended at 2017-03-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-03-03, presumably until 2017-03-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-03 00:00:00, ended at 2017-03-03 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2017-03-03, presumably until 2017-04-23, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-22 00:00:00, ended at 2017-03-22 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-03-22, presumably until 2017-04-15, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-29 00:00:00, ended at 2017-03-29 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2017-03-29, presumably until 2018-01-05, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-29 10:20:16, ended at 2017-03-29 11:52:13\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Osteoarthritis of knee\n- Hypothyroidism\n- Primary diagnosis: Moderate recurrent major depression\n- Chronic pain syndrome\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Hip pain\n- Polyneuropathy due to type 2 diabetes mellitus\n- Morbid obesity\n- Nicotine dependence\n- Periapical abscess\n\n### Drug\n- penicillin V potassium 500 MG Oral Tablet, through Oral route, started on 2017-03-29, presumably until 2017-04-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 10 days\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-03-29, presumably until 2017-04-23, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-03-29, presumably until 2017-04-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-03-29, presumably until 2017-04-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-15 00:00:00, ended at 2017-04-15 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-04-16, presumably until 2017-05-12, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-23 00:00:00, ended at 2017-04-23 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Chronic pain syndrome\n- Moderate recurrent major depression\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2017-04-26, presumably until 2017-07-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-04-26, presumably until 2017-05-25, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-04-26, presumably until 2017-06-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-04-26, presumably until 2017-06-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-07 00:00:00, ended at 2017-05-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-05-07, presumably until 2017-05-07, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-11 00:00:00, ended at 2017-05-11 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-05-12, presumably until 2017-05-12, with intended 0 refill(s). Instructions: take 5 milliliters (1 teaspoonful) by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-12 00:00:00, ended at 2017-05-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-05-12, presumably until 2017-06-02, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-16 00:00:00, ended at 2017-05-16 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2017-05-17, presumably until 2018-03-17, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERYDAY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-19 00:00:00, ended at 2017-05-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Chronic pain syndrome\n- Moderate recurrent major depression\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2017-05-19, presumably until 2017-05-19, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-05-19, presumably until 2017-05-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-05-19, presumably until 2017-11-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-05-19, presumably until 2017-11-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-25 00:00:00, ended at 2017-05-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-05-25, presumably until 2017-06-24, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-05-25, presumably until 2017-11-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-02 00:00:00, ended at 2017-06-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-06-02, presumably until 2017-11-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-02 00:00:00, ended at 2017-06-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-06-02, presumably until 2017-06-02, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-02 00:00:00, ended at 2017-06-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-06-02, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-04 00:00:00, ended at 2017-06-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-06-04, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hip pain\n- Primary diagnosis: Chronic pain syndrome\n- Osteoarthritis of knee\n- Post-laminectomy syndrome\n\n### Drug\n- 12 HR bupropion hydrochloride 200 MG Extended Release Oral Tablet, started on 2017-06-11, presumably until 2017-11-30, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-10 00:00:00, ended at 2017-06-10 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Urine: <3.0 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 122 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 38 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Moderate recurrent major depression\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Essential hypertension\n- Hypothyroidism\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 255, "cumulated_approximate_token_count": 49098}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-20 00:00:00, ended at 2012-11-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory disorder of digestive tract\n\n### Drug\n- ranitidine 150 MG Oral Tablet, started on 2012-11-20, presumably until 2013-06-21, with intended 6 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-25 10:35:50, ended at 2012-11-25 12:02:19\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Urine: 81.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 86.5 (microgram per milliliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 106.3 (milligram per gram of creatinine)\n- Body height: 5' 4\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 105 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Disorder of muscle\n- Inflammatory disorder of digestive tract\n- Bipolar disorder\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-11-25, presumably until 2012-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-12-09 00:00:00, ended at 2012-12-09 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-09, presumably until 2012-12-26, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-19 00:00:00, ended at 2012-12-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neck pain\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-12-19, presumably until 2013-02-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-21 00:00:00, ended at 2012-12-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of muscle\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-12-21, presumably until 2013-06-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-26 00:00:00, ended at 2012-12-26 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-26, presumably until 2013-01-09, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-09 00:00:00, ended at 2013-01-09 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Cough\n- Disorder of muscle\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-01-09, presumably until 2013-02-07, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-01-09, presumably until 2013-03-31, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-01-09, presumably until 2013-01-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-12 00:00:00, ended at 2013-01-12 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n- Agoraphobia without history of panic disorder without limited symptom attacks\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-01-12, presumably until 2013-07-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2013-01-12, presumably until 2013-01-12. Instructions: take 1 Tab by mouth 2 times a day as needed.  \n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2013-01-13, presumably until 2013-02-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed for Anxiety.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-20 00:00:00, ended at 2013-01-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of muscle\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2013-02-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-02-07 00:00:00, ended at 2013-02-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-02-07, presumably until 2013-02-24, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-02-07, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-20 00:00:00, ended at 2013-02-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Disorder of muscle\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-02-20, presumably until 2013-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 10:28:21, ended at 2013-02-24 11:53:30\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lumbar spine\n- Primary diagnosis: Recurrent major depression\n- Cervical spondylosis without myelopathy\n- Bipolar disorder\n- Hyperlipidemia\n- Insomnia\n- Mucopurulent chronic bronchitis\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-02-24, presumably until 2013-03-20, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- quetiapine 50 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-04-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2013-02-24, presumably until 2013-09-13, with intended 3 refill(s). Instructions: take 1 Felman by mouth every bedtime as needed for Insomnia.\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-06-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-20 00:00:00, ended at 2013-03-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-03-20, presumably until 2013-04-04, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-03-31 00:00:00, ended at 2013-03-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Hyperlipidemia\n- Recurrent major depression\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-06-07, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-04-25, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-04 00:00:00, ended at 2013-04-04 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-04, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-04-05 00:00:00, ended at 2013-04-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-21, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-04-07 00:00:00, ended at 2013-04-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n- Bipolar disorder\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- 24 HR venlafaxine 150 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2014-03-16, with intended 3 refill(s). Instructions: take 2 Tabs by mouth Every Day.\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2013-04-28, with intended 6 refill(s). Instructions: take 3 Tabs by mouth 2 times a day.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2013-04-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-21 00:00:00, ended at 2013-04-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-21, presumably until 2013-05-05, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-06-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-25 00:00:00, ended at 2013-04-25 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-04-25, presumably until 2013-06-21, with intended 5 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-04-25, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-28 11:09:55, ended at 2013-04-28 12:48:57\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Disorder of lumbar spine\n- Disorder of muscle\n- Mucopurulent chronic bronchitis\n- Primary diagnosis: Recurrent major depression\n- Allergic rhinitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2013-04-28, presumably until 2013-06-21, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route Every Day.\n- 12 HR oxycodone hydrochloride 40 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-28, presumably until 2013-05-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. For chronic pain\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2013-04-28, presumably until 2013-06-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2013-04-28, presumably until 2014-07-02, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-03 00:00:00, ended at 2013-05-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-05, presumably until 2013-05-17, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-05-08, presumably until 2013-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-05 00:00:00, ended at 2013-05-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of lumbar spine\n- Disorder of muscle\n\n### Drug\n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2013-05-05, presumably until 2013-06-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-14 00:00:00, ended at 2013-05-14 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-15, presumably until 2013-05-15, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-17 00:00:00, ended at 2013-05-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-17, presumably until 2013-05-31, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-18 00:00:00, ended at 2013-05-18 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-31 00:00:00, ended at 2013-05-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Disorder of muscle\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-31, presumably until 2013-06-12, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2013-06-02, presumably until 2013-08-16, with intended 3 refill(s). Instructions: Use as directed as needed for allergic reaction\n- 12 HR oxycodone hydrochloride 30 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-02, presumably until 2013-06-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-31 00:00:00, ended at 2013-05-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-31, presumably until 2013-05-31, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-07 00:00:00, ended at 2013-06-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Recurrent major depression\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-06-07, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-06-07, presumably until 2013-10-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-12 00:00:00, ended at 2013-06-12 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-06-12, presumably until 2013-06-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-20 00:00:00, ended at 2013-06-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Essential hypertension\n- Hyperlipidemia\n- Inflammatory disorder of digestive tract\n- Mucopurulent chronic bronchitis\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Recurrent major depression\n- Allergic rhinitis\n\n### Drug\n- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2013-06-21, presumably until 2015-05-17, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route Every Day.\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-06-23, presumably until 2013-06-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-10-09, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-04-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-12-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- ranitidine 150 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-07-18, with intended 3 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-07-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-20 00:00:00, ended at 2013-06-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Agoraphobia without history of panic disorder without limited symptom attacks\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-06-20, presumably until 2013-06-28, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-23 00:00:00, ended at 2013-06-23 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-06-23, presumably until 2013-07-05, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-26 00:00:00, ended at 2013-06-26 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-28 00:00:00, ended at 2013-06-28 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-06-28, presumably until 2013-08-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-05 00:00:00, ended at 2013-07-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-07-05, presumably until 2013-07-19, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-07-06 00:00:00, ended at 2013-07-06 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n- Recurrent major depression\n- Primary diagnosis: Bipolar disorder\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-07-07, presumably until 2013-07-24. Instructions: take 1 Tab by mouth 2 times a day.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-07-07, presumably until 2013-08-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-16 00:00:00, ended at 2013-07-16 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2013-07-16, presumably until 2013-07-16, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-17 11:30:09, ended at 2013-07-17 12:59:33\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of lumbar spine\n- Osteoarthritis of knee\n- Mucopurulent chronic bronchitis\n- Chronic pain syndrome\n- Disorder of muscle\n- Recurrent major depression\n- Essential hypertension\n\n### Drug\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2013-07-17, presumably until 2013-12-12, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day. For muscle spasm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-19 00:00:00, ended at 2013-07-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-07-19, presumably until 2013-08-18, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-21 00:00:00, ended at 2013-07-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bipolar disorder\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-07-21, presumably until 2013-10-25, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-15 00:00:00, ended at 2013-08-15 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-08-15, presumably until 2014-05-06, with intended 4 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-16 12:58:26, ended at 2013-08-16 14:26:39\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.400 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Obstructive sleep apnea syndrome\n- Hyperlipidemia\n- Primary diagnosis: Recurrent major depression\n- Cervical spondylosis without myelopathy\n- Backache\n- Bipolar disorder\n- Disorder of muscle\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Chronic sinusitis\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2013-08-16, presumably until 2013-08-18, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n- azithromycin 250 MG Oral Tablet, started on 2013-08-16, presumably until 2013-09-20, with intended 0 refill(s). Instructions: Take 2 tabs today, then 1 tab daily for next 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-08-17 00:00:00, ended at 2013-08-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-08-18, presumably until 2013-10-11, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-30 08:49:35, ended at 2013-08-30 10:39:58\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Borderline personality disorder\n- Primary diagnosis: Disorder of muscle\n- Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2013-09-13, presumably until 2014-03-27, with intended 4 refill(s). Instructions: take 1 Pohl by mouth every bedtime as needed for Insomnia.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-09-13, presumably until 2013-09-13, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-09-13, presumably until 2013-10-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-14 00:00:00, ended at 2013-09-14 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of muscle\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2013-09-14, presumably until 2014-10-03, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-20 12:43:54, ended at 2013-09-20 13:48:20\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Chronic pain syndrome\n- Essential hypertension\n- Disorder of lumbar spine\n- Disorder of muscle\n- Morbid obesity\n- Borderline personality disorder\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, started on 2013-09-20, presumably until 2013-10-30, with intended 0 refill(s). Instructions: Take 60 mg a day per Dr. Pritts\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-09 00:00:00, ended at 2013-10-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n- Primary diagnosis: Recurrent major depression\n- Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-10-09, presumably until 2014-02-21, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2014-10-10, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2013-10-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2014-04-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-10-11, presumably until 2013-11-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n- alprazolam 2 MG Oral Tablet, started on 2013-10-09, presumably until 2013-10-09, with intended 4 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-23 00:00:00, ended at 2013-10-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, started on 2013-10-23, presumably until 2013-12-15, with intended 0 refill(s). Instructions: TAKE 3 TABLETS BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-30 00:00:00, ended at 2013-10-30 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2013-11-08, presumably until 2014-04-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2013-12-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-01 00:00:00, ended at 2013-11-01 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2013-11-01, presumably until 2013-11-01, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-20 09:06:04, ended at 2013-11-20 11:05:24\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Morbid obesity\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Disorder of muscle\n- Backache\n- Chronic pain syndrome\n- Disorder of lumbar spine\n- Chronic pain\n\n### Drug\n- influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension, through Intramuscular route, started on 2013-11-20, presumably until 2013-11-21, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-11 00:00:00, ended at 2013-12-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2013-12-11, presumably until 2014-03-28, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-11 00:00:00, ended at 2013-12-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-12-11, presumably until 2014-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-12 00:00:00, ended at 2013-12-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Backache\n\n### Drug\n- baclofen 10 MG Oral Tablet, started on 2013-12-12, presumably until 2014-04-22, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 3 TIMES A DAY. FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-15 00:00:00, ended at 2013-12-15 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-12-15, presumably until 2015-04-10, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-08 00:00:00, ended at 2014-01-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-01-08, presumably until 2014-02-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-08 00:00:00, ended at 2014-01-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2014-01-08, presumably until 2015-03-26, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-01-08, presumably until 2014-04-09, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-09 08:49:38, ended at 2014-02-09 10:07:01\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoarthritis of knee\n- Primary diagnosis: Carpal tunnel syndrome\n- Chronic pain syndrome\n- Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Disorder of lumbar spine\n- Disorder of muscle\n- Major depression, single episode\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-02-09, presumably until 2014-03-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-02-21 00:00:00, ended at 2014-02-21 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-02-21, presumably until 2014-05-05, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-03-09 00:00:00, ended at 2014-03-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-03-09, presumably until 2014-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-16 00:00:00, ended at 2014-03-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR venlafaxine 150 MG Extended Release Oral Capsule, started on 2014-03-16, presumably until 2014-06-08, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-27 00:00:00, ended at 2014-03-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n- Major depression, single episode\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2014-03-28, presumably until 2014-06-27, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- temazepam 30 MG Oral Capsule, started on 2014-03-27, presumably until 2014-08-20, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AT BEDTIME FOR INSOMNIA\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-04-05 00:00:00, ended at 2014-04-05 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-09 10:28:35, ended at 2014-04-09 11:39:27\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 10.5 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.50 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 36 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.24 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 4.480 (micro-international unit per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Backache\n- Carpal tunnel syndrome\n- Primary diagnosis: Major depression, single episode\n- Essential hypertension\n- Chronic pain syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-04-09, presumably until 2014-05-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-13 10:20:47, ended at 2014-04-13 11:53:05\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Disorder of muscle\n- Borderline personality disorder\n- Primary diagnosis: Major depression, single episode\n- Obstructive sleep apnea syndrome\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2014-04-13, presumably until 2014-05-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. For 2 weeks then 120 mg daily\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2014-04-13, presumably until 2014-05-25, with intended 4 refill(s). Instructions: take 2 Caps by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-22 00:00:00, ended at 2014-04-22 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- baclofen 10 MG Oral Tablet, started on 2014-04-22, presumably until 2014-10-10, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 3 TIMES A DAY. FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-23 00:00:00, ended at 2014-04-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-04-23, presumably until 2014-06-21, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-30 11:21:58, ended at 2014-04-30 12:36:15\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n- Pre-surgery evaluation\n\n### Condition\n- Essential hypertension\n- Obstructive sleep apnea syndrome\n- Major depression, single episode\n- Carpal tunnel syndrome\n- Chronic pain syndrome\n- Disorder of muscle\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-04 00:00:00, ended at 2014-05-04 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n- Disorder of muscle\n- Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-05-04, presumably until 2014-07-11, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-05-04, presumably until 2014-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-06 00:00:00, ended at 2014-05-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-05-06, presumably until 2014-05-06, with intended 0 refill(s). Instructions: TAKE 1 TEASPOONFUL BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-06 00:00:00, ended at 2014-05-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2014-05-06, presumably until 2014-08-29, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY FOUR TIMES DAILY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-05-08, presumably until 2014-06-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-23 00:00:00, ended at 2014-05-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-05-23, presumably until 2014-08-10, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2014-05-25, presumably until 2014-06-08, with intended 4 refill(s). Instructions: take 2 Caps by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-30 00:00:00, ended at 2014-05-30 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-05-30, presumably until 2014-05-30, with intended 4 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-05 00:00:00, ended at 2014-06-05 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of muscle\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-06-05, presumably until 2014-07-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-08 09:18:19, ended at 2014-06-08 10:10:19\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 33 (percent)\n- Body height: 5' 4\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 52 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Chronic pain syndrome\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Carpal tunnel syndrome\n- Disorder of muscle\n- Hyperlipidemia\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2014-06-08, presumably until 2014-06-14, with intended 4 refill(s). Instructions: take 2 Caps by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-14 00:00:00, ended at 2014-06-14 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2014-06-14, presumably until 2020-08-05, with intended 4 refill(s). Instructions: take 2 Caps by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-21 00:00:00, ended at 2014-06-21 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-06-21, presumably until 2014-08-10, with intended 3 refill(s). Instructions: take one tablet orally every 3-4 hours as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-27 00:00:00, ended at 2014-06-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- quetiapine 100 MG Oral Tablet, started on 2014-06-27, presumably until 2015-03-08, with intended 2 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-07-02 00:00:00, ended at 2014-07-02 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-07-02, presumably until 2014-07-02, with intended 0 refill(s). Instructions: take one tablet orally every 3-4 hours as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-02 00:00:00, ended at 2014-07-02 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2014-07-02, presumably until 2014-10-10, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 HOURS AS NEEDED.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-03 00:00:00, ended at 2014-07-03 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2014-07-03, presumably until 2015-07-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-09 00:00:00, ended at 2014-07-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of muscle\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-07-09, presumably until 2014-08-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-11 00:00:00, ended at 2014-07-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-07-11, presumably until 2014-08-10, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-18 00:00:00, ended at 2014-07-18 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ranitidine 150 MG Oral Tablet, started on 2014-07-18, presumably until 2015-10-19, with intended 3 refill(s). Instructions: TAKE 150 MG BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-10 09:08:21, ended at 2014-08-10 10:42:43\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Cough\n- Primary diagnosis: Chronic pain syndrome\n- Type 2 diabetes mellitus without complication\n- Disorder of lumbar spine\n- Major depression, single episode\n- Chronic sinusitis\n- Disorder of muscle\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-08-10, presumably until 2014-08-17, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-08-10, presumably until 2014-09-26, with intended 0 refill(s). Instructions: take one tablet orally every 3-4 hours as needed for breakthrough pain\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-08-10, presumably until 2014-09-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- dextromethorphan hydrobromide 3 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2014-08-10, presumably until 2014-10-10, with intended 3 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-08-16 00:00:00, ended at 2014-08-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tobacco dependence syndrome\n\n### Drug\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2014-08-17, presumably until 2014-08-21, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-19 00:00:00, ended at 2014-08-19 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, started on 2014-08-19, presumably until 2014-08-20, with intended 3 refill(s). Instructions: TAKE 2 TABS BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-20 00:00:00, ended at 2014-08-20 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2014-08-20, presumably until 2014-10-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- temazepam 30 MG Oral Capsule, started on 2014-08-20, presumably until 2015-03-22, with intended 4 refill(s). Instructions: Take on capsule by mouth at bedtime for insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-08-21 00:00:00, ended at 2014-08-21 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2014-08-21, presumably until 2015-03-02, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2014-08-29, presumably until 2014-09-26, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-05 00:00:00, ended at 2014-09-05 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Disorder of muscle\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-09-05, presumably until 2014-10-05, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-14 00:00:00, ended at 2014-09-14 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2014-09-14, presumably until 2014-10-10, with intended 0 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-09-26, presumably until 2014-10-24, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n- alprazolam 2 MG Oral Tablet, started on 2014-09-26, presumably until 2014-12-26, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-03 00:00:00, ended at 2014-10-03 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of muscle\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-10-03, presumably until 2015-10-04, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-03 00:00:00, ended at 2014-10-03 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bronchitis\n- Disorder of muscle\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2014-10-05, presumably until 2014-10-10, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-10-05, presumably until 2015-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-10 00:00:00, ended at 2014-10-10 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2014-10-10, presumably until 2014-10-10, with intended 0 refill(s). Instructions: 3 mL by Nebulization route One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-10 09:18:45, ended at 2014-10-10 10:32:38\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n\n### Condition\n- Major depression, single episode\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Chronic bronchitis\n- Primary diagnosis: Acute bronchitis\n- Tobacco dependence syndrome\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2014-10-10, presumably until 2014-11-09, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2014-10-10, presumably until 2015-11-15, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-11 00:00:00, ended at 2014-10-11 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spasm\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, through Oral route, started on 2014-10-15, presumably until 2015-10-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Muscle spasms.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-23 00:00:00, ended at 2014-10-23 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-10-23, presumably until 2014-11-26, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-24 00:00:00, ended at 2014-10-24 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2014-10-24, presumably until 2014-10-24, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-24 00:00:00, ended at 2014-10-24 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2014-10-24, presumably until 2015-01-21, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Disorder of muscle\n- Acute bronchitis\n- Chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2014-11-09, presumably until 2014-12-07, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-11-05, presumably until 2014-11-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-26 00:00:00, ended at 2014-11-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-11-26, presumably until 2014-12-24, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-28 00:00:00, ended at 2014-11-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Disorder of muscle\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-11-28, presumably until 2014-12-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-07 00:00:00, ended at 2014-12-07 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-12-07, presumably until 2014-12-25, with intended 0 refill(s). Instructions: TAKE 5ML ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-24 00:00:00, ended at 2014-12-24 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2014-12-24, presumably until 2015-01-09, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-12-24, presumably until 2015-01-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-25 00:00:00, ended at 2014-12-25 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2014-12-25, presumably until 2015-02-07, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-25 00:00:00, ended at 2014-12-25 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-12-25, presumably until 2015-01-21, with intended 0 refill(s). Instructions: TAKE 5ML ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-09 09:57:21, ended at 2015-01-09 11:06:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 120 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 5.2 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 4.7 (milligram per gram of creatinine)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 199 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 167 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 110.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 33 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Major depression, single episode\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Primary diagnosis: Burn erythema of abdominal wall\n- Cough\n- Essential hypertension\n- Obstructive sleep apnea syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-01-09, presumably until 2015-02-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-01-09, presumably until 2015-02-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-18 10:07:05, ended at 2015-01-18 12:22:10\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Obstructive sleep apnea syndrome\n- Borderline personality disorder\n- Primary diagnosis: Major depression, single episode\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-18 10:22:16, ended at 2015-01-18 12:21:06\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-21 00:00:00, ended at 2015-01-21 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-01-21, presumably until 2015-03-15, with intended 1 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-01-21, presumably until 2015-02-07, with intended 0 refill(s). Instructions: TAKE 5 MLS ( ONE TEASPOONFUL ) EVERY SIX HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-22 00:00:00, ended at 2015-01-22 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-01-22, presumably until 2015-01-22, with intended 1 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-01-22, presumably until 2015-01-22, with intended 0 refill(s). Instructions: TAKE 5 MLS ( ONE TEASPOONFUL ) EVERY SIX HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-02-07 00:00:00, ended at 2015-02-07 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-02-07, presumably until 2015-03-07, with intended 0 refill(s). Instructions: TAKE 5 MLS ( ONE TEASPOONFUL ) EVERY SIX HOURS AS NEEDED FOR COUGH\n- alprazolam 2 MG Oral Tablet, started on 2015-02-07, presumably until 2015-04-23, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-02-19 00:00:00, ended at 2015-02-19 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-02-19, presumably until 2015-03-15, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-02-19, presumably until 2015-03-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-02 00:00:00, ended at 2015-03-02 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2015-03-02, presumably until 2015-05-17, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-07 00:00:00, ended at 2015-03-07 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-03-07, presumably until 2015-04-01, with intended 0 refill(s). Instructions: TAKE 5 ML ( 1 TEASPOON ) BY MOUTH EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-08 00:00:00, ended at 2015-03-08 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-03-08, presumably until 2015-03-08, with intended 0 refill(s). Instructions: TAKE 5 ML ( 1 TEASPOON ) BY MOUTH EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-08 09:50:28, ended at 2015-03-08 10:39:50\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence syndrome\n- Type 2 diabetes mellitus without complication\n- Headache\n- Primary diagnosis: Major depression, single episode\n- Chronic pain syndrome\n- Cough\n- Essential hypertension\n\n### Drug\n- quetiapine 100 MG Oral Tablet, started on 2015-03-08, presumably until 2015-05-17, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-03-15, presumably until 2015-04-12, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-04-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-03-15, presumably until 2015-05-17, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-15 10:34:21, ended at 2015-03-15 11:16:55\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Disorder of muscle\n- Obstructive sleep apnea syndrome\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-06-14, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-22 00:00:00, ended at 2015-03-22 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- temazepam 30 MG Oral Capsule, started on 2015-03-22, presumably until 2015-05-17, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH AT BEDTIME FOR INSOMNIA\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-26 00:00:00, ended at 2015-03-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2015-03-26, presumably until 2015-04-12, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2015-03-26, presumably until 2015-08-09, with intended 3 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 HOURS AS NEEDED.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-26 00:00:00, ended at 2015-03-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2015-03-26, presumably until 2016-04-26, with intended 5 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERYDAY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-01 00:00:00, ended at 2015-04-01 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-04-01, presumably until 2015-04-23, with intended 0 refill(s). Instructions: TAKE 5 ML ( 1 TEASPOON ) BY MOUTH EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-10 00:00:00, ended at 2015-04-10 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, started on 2015-04-11, presumably until 2015-11-15, with intended 3 refill(s). Instructions: TAKE 2 TABLETS ORALLY 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-12 00:00:00, ended at 2015-04-12 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2015-04-12, presumably until 2015-06-14, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-12 00:00:00, ended at 2015-04-12 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-04-15, presumably until 2015-05-17, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-04-15, presumably until 2015-05-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-23 00:00:00, ended at 2015-04-23 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-04-24, presumably until 2015-05-17, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6HOURS AS NEEDED FOR COUGH\n- alprazolam 2 MG Oral Tablet, started on 2015-04-24, presumably until 2015-06-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET FOUR TIMES DAILY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-06 00:00:00, ended at 2015-05-06 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-05-06, presumably until 2015-05-06, with intended 0 refill(s)\n- alprazolam 2 MG Oral Tablet, started on 2015-05-06, presumably until 2015-05-06, with intended 3 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-14 00:00:00, ended at 2015-05-14 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-05-14, presumably until 2015-05-14, with intended 0 refill(s). Instructions: TAKE 5ML ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-17 09:21:42, ended at 2015-05-17 09:59:51\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Obstructive sleep apnea syndrome\n- Borderline personality disorder\n\n### Drug\n- quetiapine 100 MG Oral Tablet, started on 2015-05-17, presumably until 2015-11-15, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-17 10:04:40, ended at 2015-05-17 13:04:42\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lumbar spine\n- Morbid obesity\n- Essential hypertension\n- Chronic pain syndrome\n- Cough\n- Osteoarthritis of knee\n- Tobacco dependence syndrome\n- Insomnia\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-05-17, presumably until 2015-06-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-05-17, presumably until 2015-06-07, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6HOURS AS NEEDED FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-05-17, presumably until 2015-06-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- temazepam 30 MG Oral Capsule, started on 2015-05-17, presumably until 2015-11-15, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH AT BEDTIME FOR INSOMNIA\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-05-17, presumably until 2015-06-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2015-05-17, presumably until 2015-08-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-07 00:00:00, ended at 2015-06-07 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-06-07, presumably until 2015-06-28, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-14 00:00:00, ended at 2015-06-14 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Major depression, single episode\n- Disorder of lumbar spine\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-06-14, presumably until 2015-06-28, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-06-14, presumably until 2015-07-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- metformin hydrochloride 500 MG Oral Tablet, started on 2015-06-14, presumably until 2016-06-26, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, started on 2015-06-14, presumably until 2015-07-19, with intended 3 refill(s). Instructions: TAKE ONE TABLET FOUR TIMES DAILY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-14 09:51:02, ended at 2015-06-14 11:06:20\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Borderline personality disorder\n- Obstructive sleep apnea syndrome\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-28 00:00:00, ended at 2015-06-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-06-28, presumably until 2015-07-19, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-06-28 00:00:00, ended at 2015-06-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of lumbar spine\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-06-28, presumably until 2015-08-29, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, started on 2015-07-17, presumably until 2016-07-27, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-19 00:00:00, ended at 2015-07-19 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-07-19, presumably until 2015-07-19, with intended 0 refill(s). Instructions: TAKE ONE TEASPOONFUL ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-19 09:23:13, ended at 2015-07-19 11:08:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lumbar spine\n- Essential hypertension\n- Joint pain of pelvic region\n- Carpal tunnel syndrome\n- Type 2 diabetes mellitus without complication\n- Chronic pain syndrome\n- Major depression, single episode\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-07-19, presumably until 2015-08-09, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-07-19, presumably until 2015-08-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-07-19, presumably until 2015-08-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, started on 2015-07-19, presumably until 2015-10-17, with intended 0 refill(s). Instructions: TAKE ONE TABLET FOUR TIMES DAILY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-19 10:17:43, ended at 2015-07-19 12:37:20\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Borderline personality disorder\n- Primary diagnosis: Major depression, single episode\n- Obstructive sleep apnea syndrome\n\n### Drug\n- aripiprazole 10 MG Oral Tablet, through Oral route, started on 2015-07-19, presumably until 2015-11-15, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-08-09, presumably until 2015-08-29, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-08-09, presumably until 2016-12-18, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB or wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-16 00:00:00, ended at 2015-08-16 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tobacco dependence syndrome\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2015-08-16, presumably until 2015-10-23, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-21 00:00:00, ended at 2015-08-21 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-08-21, presumably until 2015-09-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-08-21, presumably until 2015-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-29 00:00:00, ended at 2015-08-29 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-08-30, presumably until 2015-09-12, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-29 00:00:00, ended at 2015-08-29 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of lumbar spine\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-08-30, presumably until 2015-12-30, with intended 3 refill(s). Instructions: TAKE ONE TABLET ORALLY EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-03 00:00:00, ended at 2015-09-03 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, started on 2015-09-09, presumably until 2016-09-24, with intended 4 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-11 00:00:00, ended at 2015-09-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-09-11, presumably until 2015-10-10, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-09-11, presumably until 2015-10-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-12 00:00:00, ended at 2015-09-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-09-13, presumably until 2015-10-10, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-04 00:00:00, ended at 2015-10-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2015-10-07, presumably until 2016-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-10 00:00:00, ended at 2015-10-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-10-11, presumably until 2015-11-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-10 00:00:00, ended at 2015-10-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-10-11, presumably until 2015-10-16, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-12 00:00:00, ended at 2015-10-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-10-12, presumably until 2015-10-12, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-14 14:26:53, ended at 2015-10-14 15:57:48\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Chronic pain syndrome\n- Post-laminectomy syndrome\n- Carpal tunnel syndrome\n- Essential hypertension\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Polyneuropathy\n- Polyneuropathy due to diabetes mellitus\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-10-14, presumably until 2015-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-15 00:00:00, ended at 2015-10-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-10-16, presumably until 2015-11-04, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-17 00:00:00, ended at 2015-10-17 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2015-10-18, presumably until 2015-11-15, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORLALY 4 TIMES A DAY FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-19 00:00:00, ended at 2015-10-19 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ranitidine 150 MG Oral Tablet, started on 2015-10-21, presumably until 2016-11-10, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-23 00:00:00, ended at 2015-10-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2015-10-28, presumably until 2016-03-03, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-04 00:00:00, ended at 2015-11-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-11-04, presumably until 2015-11-23, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-04 00:00:00, ended at 2015-11-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-11-04, presumably until 2015-11-04, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-09 00:00:00, ended at 2015-11-09 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 600 MG Oral Tablet, started on 2015-11-11, presumably until 2015-11-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-14 00:00:00, ended at 2015-11-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-11-15, presumably until 2015-12-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-12-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-15 08:26:30, ended at 2015-11-15 09:23:07\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Severe major depression, single episode, without psychotic features\n- Borderline personality disorder\n\n### Drug\n- aripiprazole 10 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2016-09-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-12-27, with intended 1 refill(s). Instructions: take 2 Tabs by mouth every bedtime TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- temazepam 15 MG Oral Capsule, through Oral route, started on 2015-11-15, presumably until 2015-12-27, with intended 3 refill(s). Instructions: take 1 Zimmermann by mouth every bedtime as needed\n- 12 HR bupropion hydrochloride 200 MG Extended Release Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2016-03-06, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2016-03-06, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- alprazolam 2 MG Oral Tablet, started on 2015-11-15, presumably until 2016-01-29, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORLALY 4 TIMES A DAY FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-23 00:00:00, ended at 2015-11-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-11-25, presumably until 2015-11-25, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-25 00:00:00, ended at 2015-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-11-27, presumably until 2015-12-13, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-13 00:00:00, ended at 2015-12-13 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-12-13, presumably until 2015-12-30, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-13 09:19:49, ended at 2015-12-13 10:20:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Severe major depression, single episode, without psychotic features\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2015-12-13, presumably until 2016-01-08, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-12-13, presumably until 2016-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-27 09:16:48, ended at 2015-12-27 10:15:11\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Borderline personality disorder\n- Chronic pain syndrome\n- Primary diagnosis: Severe major depression, single episode, without psychotic features\n\n### Drug\n- temazepam 7.5 MG Oral Capsule, through Oral route, started on 2015-12-27, presumably until 2016-03-06, with intended 2 refill(s). Instructions: take 1 Hinson by mouth every bedtime as needed\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2015-12-27, presumably until 2016-03-06, with intended 1 refill(s). Instructions: take 2 Tabs by mouth every bedtime TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-30 00:00:00, ended at 2015-12-30 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2015-12-30, presumably until 2016-01-29, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-30 00:00:00, ended at 2015-12-30 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2015-12-30, presumably until 2016-03-03, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-08 00:00:00, ended at 2016-01-08 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-01-08, presumably until 2016-01-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-01-08, presumably until 2016-01-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-29 00:00:00, ended at 2016-01-29 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-01-29, presumably until 2016-02-19, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-01-29, presumably until 2016-03-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-01-29, presumably until 2016-07-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, started on 2016-01-29, presumably until 2016-05-22, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORLALY 4 TIMES A DAY FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-30 00:00:00, ended at 2016-01-30 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 600 MG Oral Tablet, started on 2016-01-31, presumably until 2017-01-07, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-19 00:00:00, ended at 2016-02-19 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-02-19, presumably until 2016-03-06, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-03 00:00:00, ended at 2016-03-03 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-03-04, presumably until 2016-05-01, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- varenicline 1 MG Oral Tablet, started on 2016-03-04, presumably until 2016-03-31, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-06 00:00:00, ended at 2016-03-06 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 614 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Folate [Mass/volume] in Serum or Plasma: 11.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 78 (microgram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Borderline personality disorder\n- Primary diagnosis: Severe major depression, single episode, without psychotic features\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-06 08:54:36, ended at 2016-03-06 11:53:24\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Obstructive sleep apnea syndrome\n- Borderline personality disorder\n- Primary diagnosis: Severe major depression, single episode, without psychotic features\n\n### Drug\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2016-03-06, presumably until 2016-05-01, with intended 1 refill(s). Instructions: take 2 Tabs by mouth every bedtime TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- 12 HR bupropion hydrochloride 200 MG Extended Release Oral Tablet, through Oral route, started on 2016-03-06, presumably until 2016-11-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2016-03-06, presumably until 2016-09-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-06 09:31:29, ended at 2016-03-06 10:46:08\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 50 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Albumin [Mass/volume] in Urine: 15.3 (microgram per milliliter)\n- Creatinine [Mass/volume] in Urine: 246.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Albumin/Creatinine [Mass Ratio] in Urine: 6.2 (milligram per gram of creatinine)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 48 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Fibromyalgia\n- Polyneuropathy\n- Severe major depression, single episode, without psychotic features\n- Essential hypertension\n- Morbid obesity\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Polyneuropathy due to diabetes mellitus\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-03-06, presumably until 2016-03-27, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-03-06, presumably until 2016-03-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-03-06, presumably until 2016-03-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-25 00:00:00, ended at 2016-03-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, started on 2016-03-25, presumably until 2016-09-25, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-27 00:00:00, ended at 2016-03-27 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-04-01, presumably until 2016-05-01, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-04-01, presumably until 2016-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-27 00:00:00, ended at 2016-03-27 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-03-30, presumably until 2016-04-21, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-31 00:00:00, ended at 2016-03-31 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2016-04-01, presumably until 2016-05-23, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-21 00:00:00, ended at 2016-04-21 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-04-22, presumably until 2016-05-11, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-26 00:00:00, ended at 2016-04-26 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2016-04-27, presumably until 2017-05-16, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERYDAY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-01 08:03:10, ended at 2016-05-01 08:34:12\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Fibromyalgia\n- Obstructive sleep apnea syndrome\n- Borderline personality disorder\n- Primary diagnosis: Major depression, single episode\n- Severe major depression, single episode, without psychotic features\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-01 08:31:53, ended at 2016-05-01 09:41:13\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Hyperlipidemia\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Severe major depression, single episode, without psychotic features\n- Essential hypertension\n- Major depression, single episode\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-05-01, presumably until 2016-06-23, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-05-01, presumably until 2016-05-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-09-25, with intended 1 refill(s). Instructions: take 2-2.5 Tabs by mouth every bedtime\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-11 00:00:00, ended at 2016-05-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-05-11, presumably until 2016-06-01, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-20 00:00:00, ended at 2016-05-20 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-05-22, presumably until 2016-06-23, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-05-22, presumably until 2016-06-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-22 00:00:00, ended at 2016-05-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2016-05-22, presumably until 2016-06-23, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY FOR ANXETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-22 00:00:00, ended at 2016-05-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- divalproex sodium 500 MG Delayed Release Oral Tablet, started on 2016-05-22, presumably until 2016-09-25, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-23 00:00:00, ended at 2016-05-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2016-05-25, presumably until 2016-07-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-01 00:00:00, ended at 2016-06-01 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-06-01, presumably until 2016-06-02, with intended 0 refill(s). Instructions: TAKE ONE TEASPOON ORALLY EVERY 6 HOURS FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-02 00:00:00, ended at 2016-06-02 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-06-03, presumably until 2016-06-22, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-22 00:00:00, ended at 2016-06-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n- Chronic pain syndrome\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-06-22, presumably until 2016-06-22, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-06-22, presumably until 2016-07-15, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-06-22, presumably until 2016-06-22, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-06-22, presumably until 2016-12-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, started on 2016-06-22, presumably until 2016-06-22, with intended 1 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-23 00:00:00, ended at 2016-06-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-06-23, presumably until 2016-07-22, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-23 00:00:00, ended at 2016-06-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-06-23, presumably until 2016-07-22, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-06-23, presumably until 2016-07-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2016-06-23, presumably until 2016-08-18, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-26 00:00:00, ended at 2016-06-26 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2016-06-26, presumably until 2017-07-21, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-15 00:00:00, ended at 2016-07-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-07-15, presumably until 2016-08-04, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Chronic pain syndrome\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-07-22, presumably until 2016-08-18, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-07-22, presumably until 2016-08-18, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-07-22, presumably until 2016-08-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-27 00:00:00, ended at 2016-07-27 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, started on 2016-07-27, presumably until 2017-07-27, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY.\n- varenicline 1 MG Oral Tablet, started on 2016-07-27, presumably until 2017-03-29, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-04 00:00:00, ended at 2016-08-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-08-05, presumably until 2016-08-28, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-18 00:00:00, ended at 2016-08-18 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-08-19, presumably until 2016-11-11, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-08-19, presumably until 2016-09-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-08-19, presumably until 2016-09-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2016-08-19, presumably until 2016-09-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-28 00:00:00, ended at 2016-08-28 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-08-28, presumably until 2016-09-11, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-29 00:00:00, ended at 2016-08-29 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-08-30, presumably until 2016-08-30, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-11 00:00:00, ended at 2016-09-11 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-09-16, presumably until 2016-10-13, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-09-11, presumably until 2016-10-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-09-11, presumably until 2017-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-24 00:00:00, ended at 2016-09-24 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, started on 2016-09-24, presumably until 2017-07-19, with intended 2 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-25 12:59:22, ended at 2016-09-25 13:42:58\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Major depression, single episode\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-25 14:35:48, ended at 2016-09-25 15:15:58\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Borderline personality disorder\n- Fibromyalgia\n- Obstructive sleep apnea syndrome\n\n### Drug\n- aripiprazole 10 MG Oral Tablet, through Oral route, started on 2016-09-25, presumably until 2017-07-19, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2016-09-25, presumably until 2017-07-19, with intended 2 refill(s). Instructions: take 2-2.5 Tabs by mouth every bedtime\n- divalproex sodium 500 MG Delayed Release Oral Tablet, started on 2016-09-25, presumably until 2018-03-17, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2016-09-25, presumably until 2016-12-11, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-09 00:00:00, ended at 2016-10-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.12 (nanogram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 6.230 (micro-international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 33 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.66 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 58 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 56 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Borderline personality disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-09 10:19:04, ended at 2016-10-09 11:59:33\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Borderline personality disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-10-19, presumably until 2016-11-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-10-19, presumably until 2016-11-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-10-14, presumably until 2016-11-02, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-02 00:00:00, ended at 2016-11-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-11-04, presumably until 2016-11-24, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-10 00:00:00, ended at 2016-11-10 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2016-11-11, presumably until 2017-01-07, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- ranitidine 150 MG Oral Tablet, started on 2016-11-11, presumably until 2017-10-06, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-16 00:00:00, ended at 2016-11-16 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-11-16, presumably until 2016-12-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-11-16, presumably until 2016-12-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-20 00:00:00, ended at 2016-11-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR bupropion hydrochloride 200 MG Extended Release Oral Tablet, started on 2016-11-20, presumably until 2017-06-11, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n- divalproex sodium 500 MG Delayed Release Oral Tablet, started on 2016-11-20, presumably until 2016-12-18, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-24 00:00:00, ended at 2016-11-24 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-11-25, presumably until 2016-12-18, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2016-12-11, presumably until 2016-12-18, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2016-12-14, presumably until 2017-01-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-12-14, presumably until 2017-01-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-18 09:17:21, ended at 2016-12-18 12:16:01\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Cough\n- Essential hypertension\n- Hip pain\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Fibromyalgia\n- Hypothyroidism\n- Major depression, single episode\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2016-12-18, presumably until 2017-01-07, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2016-12-18, presumably until 2017-11-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2016-12-18, presumably until 2017-07-26, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB or wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-18 09:18:09, ended at 2016-12-18 12:17:08\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Obstructive sleep apnea syndrome\n- Morbid obesity\n- Primary diagnosis: Major depression, single episode\n- Borderline personality disorder\n\n### Drug\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2016-12-18, presumably until 2017-01-07, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed To start 01/10/2017\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-07 00:00:00, ended at 2017-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-01-08, presumably until 2017-02-01, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-07 00:00:00, ended at 2017-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Chronic pain syndrome\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2017-01-08, presumably until 2017-03-03, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-01-08, presumably until 2017-02-01, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-01-08, presumably until 2017-02-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- gabapentin 600 MG Oral Tablet, started on 2017-01-08, presumably until 2017-10-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-07 00:00:00, ended at 2017-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-01-07, presumably until 2017-03-02, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed To start 01/10/2017\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-15 00:00:00, ended at 2017-01-15 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-01-15, presumably until 2017-01-15, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-01 00:00:00, ended at 2017-02-01 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-02-01, presumably until 2017-03-02, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-02-01, presumably until 2017-03-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-01 00:00:00, ended at 2017-02-01 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-02-01, presumably until 2017-02-26, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-02-01, presumably until 2017-07-31, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed To start 01/10/2017\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-02-01, presumably until 2017-07-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-26 00:00:00, ended at 2017-02-26 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-02-26, presumably until 2017-03-22, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-02 00:00:00, ended at 2017-03-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-03-03, presumably until 2017-03-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-03 00:00:00, ended at 2017-03-03 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2017-03-03, presumably until 2017-04-23, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-22 00:00:00, ended at 2017-03-22 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-03-22, presumably until 2017-04-15, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-29 00:00:00, ended at 2017-03-29 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- varenicline 1 MG Oral Tablet, started on 2017-03-29, presumably until 2018-01-05, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-29 10:20:16, ended at 2017-03-29 11:52:13\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Osteoarthritis of knee\n- Hypothyroidism\n- Primary diagnosis: Moderate recurrent major depression\n- Chronic pain syndrome\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Hip pain\n- Polyneuropathy due to type 2 diabetes mellitus\n- Morbid obesity\n- Nicotine dependence\n- Periapical abscess\n\n### Drug\n- penicillin V potassium 500 MG Oral Tablet, through Oral route, started on 2017-03-29, presumably until 2017-04-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 10 days\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-03-29, presumably until 2017-04-23, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-03-29, presumably until 2017-04-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-03-29, presumably until 2017-04-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-15 00:00:00, ended at 2017-04-15 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-04-16, presumably until 2017-05-12, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-23 00:00:00, ended at 2017-04-23 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Chronic pain syndrome\n- Moderate recurrent major depression\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2017-04-26, presumably until 2017-07-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-04-26, presumably until 2017-05-25, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-04-26, presumably until 2017-06-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-04-26, presumably until 2017-06-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-07 00:00:00, ended at 2017-05-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-05-07, presumably until 2017-05-07, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-11 00:00:00, ended at 2017-05-11 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-05-12, presumably until 2017-05-12, with intended 0 refill(s). Instructions: take 5 milliliters (1 teaspoonful) by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-12 00:00:00, ended at 2017-05-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-05-12, presumably until 2017-06-02, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-16 00:00:00, ended at 2017-05-16 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2017-05-17, presumably until 2018-03-17, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERYDAY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-19 00:00:00, ended at 2017-05-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Chronic pain syndrome\n- Moderate recurrent major depression\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2017-05-19, presumably until 2017-05-19, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY 6 HOURS AS NEEDED FOR MUSCLE SPASM\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-05-19, presumably until 2017-05-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- diazepam 10 MG Oral Tablet, through Oral route, started on 2017-05-19, presumably until 2017-11-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-05-19, presumably until 2017-11-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-25 00:00:00, ended at 2017-05-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2017-05-25, presumably until 2017-06-24, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR BREAKTHROUGH PAIN\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-05-25, presumably until 2017-11-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-02 00:00:00, ended at 2017-06-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-06-02, presumably until 2017-11-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-02 00:00:00, ended at 2017-06-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-06-02, presumably until 2017-06-02, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-02 00:00:00, ended at 2017-06-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2017-06-02, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 1 teaspoonful by mouth every 6 hours for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-04 00:00:00, ended at 2017-06-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-06-04, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hip pain\n- Primary diagnosis: Chronic pain syndrome\n- Osteoarthritis of knee\n- Post-laminectomy syndrome\n\n### Drug\n- 12 HR bupropion hydrochloride 200 MG Extended Release Oral Tablet, started on 2017-06-11, presumably until 2017-11-30, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-10 00:00:00, ended at 2017-06-10 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Urine: <3.0 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 122 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 38 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Moderate recurrent major depression\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Essential hypertension\n- Hypothyroidism\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 122.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "9b3e7564c3c81d617000528fa7d96a0fb0b2e635185bcd276ffcf977a281e994", "prompt_hash": "59ede986b3788d08991cd7078fa79a4c0034dca390cd781c27ce9240744e0a75", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115970544, "visit_occurrence_id": 176801917, "visit_start_datetime": "2021-03-27 00:00:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 81.0, "current_label": 0, "next_value": 54.0, "next_label": 0, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2012-03-03 11:28:06, ended at 2012-03-03 12:22:05\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary arteriosclerosis\n- Pure hypercholesterolemia\n- Open wound of face without complication\n- Acute myocardial infarction\n- Diabetes mellitus without complication\n- Gastroparesis syndrome\n- Diabetic - poor control\n- Benign essential hypertension\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, presumably until 2014-10-18. Instructions: take 12.5 mg by mouth 2 times a day.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-14 00:00:00, ended at 2012-03-14 00:00:00\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2012-03-14, presumably until 2012-07-30, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-10 09:07:38, ended at 2012-06-10 10:32:30\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetes mellitus without complication\n- Pure hypercholesterolemia\n- Benign essential hypertension\n- Diabetic - poor control\n- Acute myocardial infarction\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-05 11:23:20, ended at 2012-07-05 12:46:43\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Hearing loss\n- Coronary atherosclerosis\n- Benign essential hypertension\n- Diabetic - poor control\n- Sebaceous cyst of skin\n- Diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-14 00:00:00, ended at 2012-07-14 00:00:00\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2012-07-14, presumably until 2012-08-15, with intended 1 refill(s). Instructions: take 1 tablet by mouth three times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-30 00:00:00, ended at 2012-07-30 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2012-07-30, presumably until 2012-09-21, with intended 3 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-15 00:00:00, ended at 2012-08-15 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2012-08-15, presumably until 2014-12-28, with intended 1 refill(s). Instructions: take 1 tablet by mouth three times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-17 00:00:00, ended at 2012-08-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2012-08-17, presumably until 2013-01-19, with intended 4 refill(s). Instructions: take 1 tablet by mouth AT ONSET OF HEADACHE. REPEAT ONE TIME IN 2 HOURS IF NO RELIEF.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-21 00:00:00, ended at 2012-09-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2012-09-21, presumably until 2012-11-03, with intended 3 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-06 09:43:31, ended at 2012-10-06 10:28:54\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Benign essential hypertension\n- Coronary arteriosclerosis\n- Pure hypercholesterolemia\n- Diabetic - poor control\n- Primary diagnosis: Derangement of knee\n- Diabetes mellitus without complication\n- Gastroparesis syndrome\n- Coronary atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-26 09:03:38, ended at 2012-10-26 10:05:49\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.36 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.8 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Derangement of knee\n- Diabetes mellitus without complication\n- Coronary arteriosclerosis\n- Coronary atherosclerosis\n- Diabetic - poor control\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2016-10-02. Instructions: take 40 mg by mouth daily.  \n- bimatoprost 0.3 MG/ML Ophthalmic Solution, through Intraocular route, presumably until 2016-10-22. Instructions: instill 1 Drop to both eyes daily in the evening.  \n- 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution, through Transdermal route, presumably until 2013-07-20. Instructions: apply 1 Application to skin. Each armpit   \n- glimepiride 2 MG Oral Tablet, through Oral route, presumably until 2015-02-12. Instructions: take 2 mg by mouth 2 times a day.  \n- alprazolam 0.5 MG Oral Tablet, through Oral route, presumably until 2013-07-20. Instructions: take 1 Tab by mouth every bedtime.  \n- citalopram 40 MG Oral Tablet, through Oral route, presumably until 2014-10-18. Instructions: take 40 mg by mouth daily.  \n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, through Oral route, presumably until 2012-10-26. Instructions: take 1 Tab by mouth daily.  \n- atorvastatin 40 MG Oral Tablet, through Oral route, presumably until 2014-10-18. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-03 00:00:00, ended at 2012-11-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2012-11-03, presumably until 2013-01-03, with intended 3 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-30 07:54:40, ended at 2012-12-30 08:23:18\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-30, presumably until 2013-06-28, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2012-12-30, presumably until 2014-12-28, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2012-12-30, presumably until 2013-07-20, with intended 0 refill(s). Instructions: take 250 mg by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-03 00:00:00, ended at 2013-01-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-01-03, presumably until 2013-01-31, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-19 00:00:00, ended at 2013-01-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2013-01-19, presumably until 2013-06-25, with intended 4 refill(s). Instructions: take 1 tablet by mouth AT ONSET OF HEADACHE. REPEAT ONE TIME IN 2 HOURS IF NO RELIEF.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-31 00:00:00, ended at 2013-01-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-01-31, presumably until 2013-02-27, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-27 00:00:00, ended at 2013-02-27 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-02-27, presumably until 2013-03-06, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-06 00:00:00, ended at 2013-03-06 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-03-06, presumably until 2013-03-28, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-03-28 00:00:00, ended at 2013-03-28 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-03-28, presumably until 2013-04-15, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-15 00:00:00, ended at 2013-04-15 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-04-15, presumably until 2013-05-29, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-03 00:00:00, ended at 2013-05-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2013-05-03, presumably until 2013-12-24, with intended 6 refill(s). Instructions: take 1 tablet by mouth four times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-29 00:00:00, ended at 2013-05-29 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-05-29, presumably until 2013-07-05, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-25 00:00:00, ended at 2013-06-25 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2013-06-25, presumably until 2013-11-06, with intended 4 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-05 00:00:00, ended at 2013-07-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-07-05, presumably until 2013-08-07, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-20 08:22:42, ended at 2013-07-20 08:51:49\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety state\n- Diabetes mellitus without complication\n- Primary diagnosis: Insomnia\n- Type 2 diabetes mellitus without complication\n- Cough\n- Diabetic - poor control\n- Verruca plantaris\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2013-07-20, presumably until 2014-01-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Anxiety.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2013-07-20, presumably until 2013-10-29, with intended 2 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-07-24 00:00:00, ended at 2013-07-24 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.0 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 45.2 (microgram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 54 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 18 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 381 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 133 (international unit per liter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.070 (micro-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-07 00:00:00, ended at 2013-08-07 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-08-07, presumably until 2013-09-06, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-08 08:31:24, ended at 2013-08-08 09:31:20\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign essential hypertension\n- Coronary arteriosclerosis\n- Primary diagnosis: Pleural effusion\n- Diabetes mellitus without complication\n- Pure hypercholesterolemia\n- Diabetic - poor control\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-08-09 00:00:00, ended at 2013-08-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 64 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.13 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign essential hypertension\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Diabetic - poor control\n- Pure hypercholesterolemia\n- Diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-06 00:00:00, ended at 2013-09-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-09-06, presumably until 2013-10-12, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-12 00:00:00, ended at 2013-10-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-10-12, presumably until 2013-11-13, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-29 00:00:00, ended at 2013-10-29 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2013-10-29, presumably until 2014-10-18, with intended 2 refill(s). Instructions: take 1 tablet by mouth at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-06 00:00:00, ended at 2013-11-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2013-11-06, presumably until 2014-05-01, with intended 4 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-13 00:00:00, ended at 2013-11-13 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-11-13, presumably until 2013-12-26, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-24 00:00:00, ended at 2013-12-24 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2013-12-24, presumably until 2014-10-13, with intended 6 refill(s). Instructions: take 1 tablet by mouth four times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-26 00:00:00, ended at 2013-12-26 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-12-26, presumably until 2014-01-29, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-23 09:44:26, ended at 2014-01-23 11:07:35\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Diabetes mellitus without complication\n- Pure hypercholesterolemia\n- Diabetic - poor control\n- Gastroparesis syndrome\n- Benign essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-29 00:00:00, ended at 2014-01-29 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Derangement of knee\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-01-29, presumably until 2014-02-02, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-02-02 00:00:00, ended at 2014-02-02 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-02-02, presumably until 2014-03-10, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-10 00:00:00, ended at 2014-03-10 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-03-10, presumably until 2014-04-07, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-07 00:00:00, ended at 2014-04-07 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2014-04-07, presumably until 2015-02-12, with intended 1 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for anxiety\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-04-07, presumably until 2014-05-02, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-01 00:00:00, ended at 2014-05-01 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2014-05-01, presumably until 2014-09-10, with intended 4 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-01 13:02:14, ended at 2014-05-01 13:41:17\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Headache\n- Primary diagnosis: Eye / vision finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-02 00:00:00, ended at 2014-05-02 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-05-02, presumably until 2014-05-24, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-05-24, presumably until 2014-06-27, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-27 00:00:00, ended at 2014-06-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-06-27, presumably until 2014-07-31, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-31 00:00:00, ended at 2014-07-31 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-07-31, presumably until 2014-08-30, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-30 00:00:00, ended at 2014-08-30 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-08-30, presumably until 2014-10-18, with intended 1 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-10 00:00:00, ended at 2014-09-10 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2014-09-10, presumably until 2014-10-18, with intended 4 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-13 00:00:00, ended at 2014-10-13 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-10-13, presumably until 2014-10-18, with intended 6 refill(s). Instructions: take 1 tablet by mouth four times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-18 08:57:36, ended at 2014-10-18 09:23:47\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign essential hypertension\n- Pure hypercholesterolemia\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Coronary atherosclerosis\n- Depressive disorder\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-12-02, with intended 12 refill(s). Instructions: take 1 Tab by mouth 4 times a day.\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-11-12, with intended 12 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2016-10-02, with intended 2 refill(s). Instructions: take 1 Tab by mouth every bedtime. at bedtime.\n- sumatriptan 100 MG Oral Tablet, started on 2014-10-18, presumably until 2015-12-31, with intended 12 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-10-26, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-12-02, with intended 12 refill(s). Instructions: take 1 Tab by mouth Every Day.\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-12-02, with intended 12 refill(s). Instructions: take 1 Tab by mouth Every Day.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-10-18, presumably until 2015-02-12, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-28 11:04:25, ended at 2014-12-28 12:20:03\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n- Acute bronchitis\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-12-28, presumably until 2022-03-20, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-12-28, presumably until 2015-02-12, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-08 08:34:25, ended at 2015-01-08 09:10:53\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Trigeminal neuralgia\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Tablet, through Oral route, started on 2015-01-08, presumably until 2015-07-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-01-08, presumably until 2015-07-07, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-01-11 00:00:00, ended at 2015-01-11 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2015-01-11, presumably until 2016-01-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-02-12 00:00:00, ended at 2015-02-12 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2015-02-12, presumably until 2015-08-16, with intended 1 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-12 10:49:26, ended at 2015-02-12 11:47:23\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-02-12, presumably until 2018-04-21, with intended 1 refill(s). Instructions: 2 Sprays by Nasal route 2 times a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-02-12, presumably until 2015-04-04, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-04 00:00:00, ended at 2015-04-04 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-04-05, presumably until 2015-06-06, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-06-06 00:00:00, ended at 2015-06-06 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-06-06, presumably until 2015-07-09, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-07-02 00:00:00, ended at 2015-07-02 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.3 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 404 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 210.0 (microgram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.6 (percent)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: Comment (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.660 (micro-international unit per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: Comment (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.9 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Poisoning by drug AND/OR medicinal substance\n- Diabetes mellitus without complication\n- Diabetic - poor control\n- Pure hypercholesterolemia\n- Secondary erectile dysfunction\n- Benign essential hypertension\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-09 08:06:35, ended at 2015-07-09 09:18:29\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal breathing\n- Coronary arteriosclerosis\n- Pure hypercholesterolemia\n- Sleep apnea\n- Benign essential hypertension\n- Diabetic - poor control\n- Diabetes mellitus without complication\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-07-09, presumably until 2015-08-09, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-08-12, presumably until 2015-09-26, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-16 00:00:00, ended at 2015-08-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2015-08-16, presumably until 2016-10-02, with intended 1 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-26 00:00:00, ended at 2015-09-26 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-09-27, presumably until 2015-11-25, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-26 00:00:00, ended at 2015-10-26 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 40 MG Oral Tablet, started on 2015-10-28, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-12 00:00:00, ended at 2015-11-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, started on 2015-11-13, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1/2 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-25 00:00:00, ended at 2015-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-11-26, presumably until 2016-01-16, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-02 00:00:00, ended at 2015-12-02 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2015-12-02, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth four times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, started on 2015-12-02, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth once daily\n- atorvastatin 40 MG Oral Tablet, started on 2015-12-02, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-31 00:00:00, ended at 2015-12-31 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2015-12-31, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth IMMEDIATELY MAY REPEAT AFTER 2 HOURS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-01-16 00:00:00, ended at 2016-01-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-01-16, presumably until 2016-02-11, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-11 00:00:00, ended at 2016-02-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Albumin [Mass/volume] in Urine: 128.3 (microgram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 71 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 40 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 198 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Type 2 diabetes mellitus\n- Essential hypertension\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-11 00:00:00, ended at 2016-02-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-02-11, presumably until 2016-03-16, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 08:32:29, ended at 2016-02-27 09:46:02\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 49 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 244 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Snoring\n- Hypersomnia\n- Type 2 diabetes mellitus\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Osteoarthritis\n- Autonomic neuropathy due to type 2 diabetes mellitus\n\n### Drug\n- glimepiride 2 MG Oral Tablet, started on 2016-02-27, presumably until 2016-04-13, with intended 0 refill(s). Instructions: 1 in the morning and 2 in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-16 00:00:00, ended at 2016-03-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-03-17, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-04-10 00:00:00, ended at 2016-04-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 2 MG Oral Tablet, started on 2016-04-13, presumably until 2016-10-02, with intended 6 refill(s). Instructions: 1 in the morning and 2 in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-08 00:00:00, ended at 2016-05-08 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-05-11, presumably until 2016-06-23, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-23 00:00:00, ended at 2016-06-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-06-23, presumably until 2016-07-15, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-15 00:00:00, ended at 2016-07-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-07-16, presumably until 2016-08-12, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-12 00:00:00, ended at 2016-08-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-08-14, presumably until 2016-10-02, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-02 00:00:00, ended at 2016-10-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day\n- glimepiride 2 MG Oral Tablet, started on 2016-10-06, presumably until 2016-10-22, with intended 6 refill(s). Instructions: 1 in the morning and 2 in the evening.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 2 refill(s). Instructions: take 1 Tab by mouth every bedtime at bedtime.\n- sumatriptan 100 MG Oral Tablet, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 tablet by mouth IMMEDIATELY MAY REPEAT AFTER 2 HOURS\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-10-06, presumably until 2016-10-08, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-07 00:00:00, ended at 2016-10-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-08 09:21:07, ended at 2016-10-08 11:30:03\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 373 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Body height: 5' 7\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 75 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 302 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 193 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 85 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 202 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (international unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- acetic acid 20 MG/ML / hydrocortisone 10 MG/ML Otic Solution, through Otic route, started on 2016-10-08, presumably until 2016-10-22, with intended 3 refill(s). Instructions: instill 5 Drops to both ears 4 times a day\n- permethrin 50 MG/ML Topical Cream, started on 2016-10-08, presumably until 2016-10-22, with intended 1 refill(s). Instructions: Apply to entire body, head to toe, leave on for 12-14 hours then wash off\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-10-08, presumably until 2016-10-22, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-22 00:00:00, ended at 2016-10-22 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2016-11-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2019-11-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- bimatoprost 0.3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-10-26, presumably until 2019-08-17, with intended 3 refill(s). Instructions: instill 1 Drop to both eyes Daily at night\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day\n- glimepiride 2 MG Oral Tablet, started on 2016-10-26, presumably until 2016-11-04, with intended 6 refill(s). Instructions: 1 in the morning and 2 in the evening.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime at bedtime.\n- ferrous sulfate 160 MG Extended Release Oral Tablet, started on 2016-10-26, presumably until 2019-08-17, with intended 1 refill(s). Instructions: Ferogon:  tid\n- sumatriptan 100 MG Oral Tablet, started on 2016-10-26, presumably until 2018-04-06, with intended 3 refill(s). Instructions: take 1 tablet by mouth IMMEDIATELY MAY REPEAT x1  AFTER 2 HOURS\n- acetic acid 20 MG/ML / hydrocortisone 10 MG/ML Otic Solution, through Otic route, started on 2016-10-26, presumably until 2017-07-01, with intended 3 refill(s). Instructions: instill 5 Drops to both ears 4 times a day\n- permethrin 50 MG/ML Topical Cream, started on 2016-10-26, presumably until 2017-07-01, with intended 1 refill(s). Instructions: Apply to entire body, head to toe, leave on for 12-14 hours then wash off\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2017-03-12, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2016-10-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-10-26, presumably until 2016-10-28, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-10-30, presumably until 2016-11-24, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-04 09:22:17, ended at 2016-11-04 11:27:09\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Gastroparesis syndrome\n- Pruritic rash\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2016-11-04, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n- glimepiride 2 MG Oral Tablet, through Oral route, started on 2016-11-04, presumably until 2017-11-04, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- triamcinolone acetonide 1 MG/ML Topical Cream, started on 2016-11-04, presumably until 2018-04-21, with intended 3 refill(s). Instructions: Apply BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-24 00:00:00, ended at 2016-11-24 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-11-26, presumably until 2016-12-15, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-15 00:00:00, ended at 2016-12-15 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-12-15, presumably until 2016-12-29, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-29 00:00:00, ended at 2016-12-29 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-12-30, presumably until 2017-02-09, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-09 00:00:00, ended at 2017-02-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-02-11, presumably until 2017-03-18, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-12 00:00:00, ended at 2017-03-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2017-03-15, presumably until 2017-03-18, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-18 00:00:00, ended at 2017-03-18 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2017-03-21, presumably until 2018-04-21, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-18 00:00:00, ended at 2017-03-18 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-03-21, presumably until 2017-04-20, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-20 00:00:00, ended at 2017-04-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-04-22, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-20 00:00:00, ended at 2017-05-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-05-28, presumably until 2017-06-30, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-30 00:00:00, ended at 2017-06-30 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-06-30, presumably until 2017-08-09, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-01 08:19:23, ended at 2017-07-01 08:49:34\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Malaise\n- Pure hypercholesterolemia\n- Atherosclerosis of coronary artery without angina pectoris\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-09 00:00:00, ended at 2017-08-09 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-08-10, presumably until 2017-08-31, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-31 00:00:00, ended at 2017-08-31 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-09-03, presumably until 2018-04-21, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-05 00:00:00, ended at 2018-04-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2018-04-06, presumably until 2018-04-06, with intended 12 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-06 00:00:00, ended at 2018-04-06 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2018-04-06, presumably until 2018-04-21, with intended 12 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-28 00:00:00, ended at 2018-04-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-28 00:00:00, ended at 2018-04-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-13 00:00:00, ended at 2018-05-13 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-27 00:00:00, ended at 2018-05-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-05-31, presumably until 2018-06-30, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-06-16 00:00:00, ended at 2018-06-16 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-30 00:00:00, ended at 2018-06-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-30 00:00:00, ended at 2018-06-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-06-30, presumably until 2018-07-27, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-11 00:00:00, ended at 2018-07-11 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2018-07-12, presumably until 2018-07-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-17 00:00:00, ended at 2018-07-17 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2018-07-19, presumably until 2018-10-18, with intended 3 refill(s). Instructions: take 1 tablet by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-07-28, presumably until 2018-08-15, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-21 09:45:56, ended at 2018-07-21 10:25:15\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2018-07-21, presumably until 2019-09-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-29 09:25:53, ended at 2018-07-29 10:30:25\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-15 00:00:00, ended at 2018-08-15 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-08-23, presumably until 2018-09-14, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-15 00:00:00, ended at 2018-08-15 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2018-08-23, presumably until 2018-08-24, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-24 00:00:00, ended at 2018-08-24 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2018-08-24, presumably until 2019-03-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-14 00:00:00, ended at 2018-09-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-09-14, presumably until 2018-11-02, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-16 00:00:00, ended at 2018-10-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2018-10-18, presumably until 2019-11-30, with intended 3 refill(s). Instructions: take 1 tablet by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-11-02, presumably until 2018-12-22, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-22 00:00:00, ended at 2018-12-22 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2018-12-26, presumably until 2019-11-01, with intended 12 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-12-26, presumably until 2019-01-25, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-10 00:00:00, ended at 2019-01-10 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-25 08:46:27, ended at 2019-01-25 10:10:07\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- General finding of observation of patient\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Polyneuropathy due to type 2 diabetes mellitus\n\n### Drug\n- fluocinonide 0.0005 MG/MG Topical Ointment, started on 2019-01-25, presumably until 2019-11-01, with intended 3 refill(s). Instructions: Apply twice a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-01-25, presumably until 2019-03-06, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-03-06, presumably until 2019-03-08, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-03-08, presumably until 2019-03-29, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-29 00:00:00, ended at 2019-03-29 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2020-06-21, with intended 12 refill(s). Instructions: take 1 Tab (40 mg total) by mouth every bedtime at bedtime.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2019-04-26, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime at bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-03-29, presumably until 2019-04-26, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-12 08:27:52, ended at 2019-04-12 10:41:41\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute frontal sinusitis\n\n### Drug\n- cefuroxime 500 MG Oral Tablet, through Oral route, started on 2019-04-12, presumably until 2023-02-02, with intended 0 refill(s). Instructions: take 1 Tab (500 mg total) by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-18, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime at bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-04-26, presumably until 2019-08-01, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-18 00:00:00, ended at 2019-05-18 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2019-05-19, presumably until 2019-09-06, with intended 2 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-19 00:00:00, ended at 2019-06-19 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 60.4 (microgram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 107 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.7 (percent)\n- Albumin/Creatinine [Mass Ratio] in Urine: 54.5 (milligram per gram of creatinine)\n- Creatinine [Mass/volume] in Urine: 110.9 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-01 00:00:00, ended at 2019-08-01 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-08-03, presumably until 2019-09-01, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-17 09:19:06, ended at 2019-08-17 10:44:15\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Herpes zoster without complication\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2019-08-17, presumably until 2019-08-24, with intended 0 refill(s). Instructions: take 1 Tab (1,000 mg total) by mouth 3 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-01 08:24:01, ended at 2019-09-01 14:03:31\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Herpes zoster without complication\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-09-01, presumably until 2019-10-02, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-06 00:00:00, ended at 2019-09-06 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, started on 2019-09-07, presumably until 2019-11-01, with intended 3 refill(s). Instructions: take 1 tablet by mouth twice a day\n- alprazolam 0.5 MG Oral Tablet, started on 2019-09-07, presumably until 2019-11-15, with intended 2 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-20 00:00:00, ended at 2019-09-20 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-02 00:00:00, ended at 2019-10-02 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-10-02, presumably until 2019-11-14, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-01 15:24:03, ended at 2019-11-01 16:31:59\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Primary diagnosis: Acute non-ST segment elevation myocardial infarction\n- Ulcer of duodenum\n- Gastrointestinal hemorrhage\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2020-01-16, with intended 0 refill(s). Instructions: take 30 mg by mouth 2 times a day\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2019-10-25, presumably until 2019-12-04, with intended 0 refill(s). Instructions: BID@0900,2100\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-14 00:00:00, ended at 2019-11-14 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 111 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Gastrointestinal hemorrhage\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Angina co-occurrent and due to coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-14 00:00:00, ended at 2019-11-14 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-11-14, presumably until 2019-12-29, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-15 00:00:00, ended at 2019-11-15 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2019-11-15, presumably until 2020-02-27, with intended 2 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-17 00:00:00, ended at 2019-11-17 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-04-18, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 8 hours as needed (muscle spasm)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-30 00:00:00, ended at 2019-11-30 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2019-12-04, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-03 00:00:00, ended at 2019-12-03 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2019-12-04, presumably until 2019-12-04, with intended 0 refill(s)\n- citalopram 20 MG Oral Tablet, started on 2019-12-04, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-04, presumably until 2020-01-16, with intended 0 refill(s). Instructions: take 1 Tab (1,000 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-06 10:19:49, ended at 2019-12-06 11:14:01\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Essential hypertension\n- Gastrointestinal hemorrhage\n- Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Generalized anxiety disorder\n- Acute non-ST segment elevation myocardial infarction\n- Type 2 diabetes mellitus\n\n### Drug\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2020-01-01, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-26 00:00:00, ended at 2019-12-26 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-11-12, presumably until 2021-04-23, with intended 3 refill(s). Instructions: take 5 mg by mouth every bedtime at bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-12-29, presumably until 2020-02-04, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2020-01-01, presumably until 2020-01-01, with intended 0 refill(s). Instructions: take 1 Tablet (80 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-01-16, presumably until 2020-04-22, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-16 00:00:00, ended at 2020-01-16 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2020-01-16, presumably until 2020-04-22, with intended 3 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-31 00:00:00, ended at 2020-01-31 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-02-04, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 1 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.0 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 87 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 204 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 265 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n- Generalized anxiety disorder\n- Hyperglycemia due to type 2 diabetes mellitus\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Essential hypertension\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-02-27, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-04 00:00:00, ended at 2020-03-04 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2020-09-06, with intended 0 refill(s). Instructions: take 1 Tab (40 mg total) by mouth 2 times a day\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2020-04-29, with intended 0 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2020-04-10, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-03-04, presumably until 2020-03-15, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth  6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-03-15, presumably until 2020-04-10, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-04-10, presumably until 2020-05-15, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-04-10, presumably until 2020-05-15, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-16 00:00:00, ended at 2020-04-16 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2020-04-18, presumably until 2020-10-31, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for muscle spasm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-04-22, presumably until 2020-07-12, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-22 00:00:00, ended at 2020-04-22 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, through Oral route, started on 2020-04-24, presumably until 2020-08-29, with intended 3 refill(s). Instructions: take 1 Tab (1,000 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2020-04-29, presumably until 2020-06-21, with intended 0 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-14 00:00:00, ended at 2020-05-14 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-05-15, presumably until 2020-07-12, with intended 1 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-05-15, presumably until 2020-06-13, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-11 00:00:00, ended at 2020-06-11 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-06-13, presumably until 2020-07-12, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-20 00:00:00, ended at 2020-06-20 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2020-06-21, presumably until 2021-04-18, with intended 3 refill(s). Instructions: take 1 tablet by mouth once daily\n- pravastatin sodium 40 MG Oral Tablet, started on 2020-06-21, presumably until 2020-10-18, with intended 3 refill(s). Instructions: take 1 tablet by mouth at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-11 00:00:00, ended at 2020-07-11 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 20 MG Oral Tablet, started on 2020-07-12, presumably until 2021-08-20, with intended 4 refill(s). Instructions: take 1 tablet by mouth once daily\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-07-12, presumably until 2020-08-13, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-12 00:00:00, ended at 2020-07-12 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-07-12, presumably until 2020-10-10, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n- alprazolam 0.5 MG Oral Tablet, started on 2020-07-12, presumably until 2020-07-26, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-16 00:00:00, ended at 2020-07-16 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-07-26, presumably until 2020-08-27, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin degludec 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-08-01, presumably until 2020-12-25, with intended 12 refill(s). Instructions: inject 44 Units subcutaneous (under the skin) every bedtime\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-08-01, presumably until 2020-10-31, with intended 6 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-12 00:00:00, ended at 2020-08-12 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-08-13, presumably until 2020-09-11, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-25 00:00:00, ended at 2020-08-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-08-27, presumably until 2020-10-10, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-29 00:00:00, ended at 2020-08-29 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2020-08-29, presumably until 2020-10-02, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-04 00:00:00, ended at 2020-09-04 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-09-06, presumably until 2020-12-18, with intended 2 refill(s). Instructions: take 1 tablet by mouth BEFORE BREAKFAST AND  DINNER as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-11 00:00:00, ended at 2020-09-11 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-09-11, presumably until 2020-10-07, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-01 00:00:00, ended at 2020-10-01 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2020-10-02, presumably until 2020-11-05, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-07 00:00:00, ended at 2020-10-07 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2020-10-10, presumably until 2020-10-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-10 00:00:00, ended at 2020-10-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-10-10, presumably until 2020-12-24, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-10 00:00:00, ended at 2020-10-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-10-10, presumably until 2020-10-18, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-21 00:00:00, ended at 2020-10-21 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2020-10-25, presumably until 2020-12-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-31 08:44:49, ended at 2020-10-31 10:01:54\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Chronic pain\n- Cervical disc disorder with radiculopathy\n- Essential hypertension\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Lumbago with sciatica\n\n### Drug\n- pregabalin 25 MG Oral Capsule, through Oral route, started on 2020-10-31, presumably until 2021-03-21, with intended 1 refill(s). Instructions: take 1 Amir (25 mg total) by mouth 3 times a day\n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-10-31, presumably until 2021-04-23, with intended 0 refill(s). Instructions: inject 54 Units subcutaneous (under the skin) daily\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-10-31, presumably until 2020-12-04, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-03 00:00:00, ended at 2020-11-03 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2020-11-05, presumably until 2020-11-05, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-29 00:00:00, ended at 2020-11-29 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-12-04, presumably until 2020-12-25, with intended 4 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-05 00:00:00, ended at 2020-12-05 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2020-12-06, presumably until 2021-01-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-18 00:00:00, ended at 2020-12-18 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-12-18, presumably until 2021-04-17, with intended 2 refill(s). Instructions: take 1 tablet by mouth BEFORE BREAKFAST AND  DINNER as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-23 00:00:00, ended at 2020-12-23 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-12-24, presumably until 2021-03-14, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-25 00:00:00, ended at 2020-12-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin degludec 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-12-25, presumably until 2021-08-11, with intended 12 refill(s). Instructions: inject 44 Units subcutaneous (under the skin) every bedtime\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-12-25, presumably until 2022-07-16, with intended 4 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-06 00:00:00, ended at 2021-01-06 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2021-01-07, presumably until 2021-02-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-11 00:00:00, ended at 2021-02-11 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2021-02-12, presumably until 2021-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-10 00:00:00, ended at 2021-03-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2021-03-10, presumably until 2021-04-18, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-14 00:00:00, ended at 2021-03-14 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2021-03-14, presumably until 2021-03-31, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-15 00:00:00, ended at 2021-03-15 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2021-03-19, presumably until 2021-04-28, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for muscle spasm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-19 00:00:00, ended at 2021-03-19 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pregabalin 25 MG Oral Capsule, started on 2021-03-21, presumably until 2021-04-18, with intended 2 refill(s). Instructions: take 1 capsule by mouth three times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-27 00:00:00, ended at 2021-03-27 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2021-03-31, presumably until 2021-05-28, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-03-27 00:00:00, ended at 2021-03-27 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 127 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 334 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.9 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 81 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 21 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 189, "cumulated_approximate_token_count": 35626}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-03 11:28:06, ended at 2012-03-03 12:22:05\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary arteriosclerosis\n- Pure hypercholesterolemia\n- Open wound of face without complication\n- Acute myocardial infarction\n- Diabetes mellitus without complication\n- Gastroparesis syndrome\n- Diabetic - poor control\n- Benign essential hypertension\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, presumably until 2014-10-18. Instructions: take 12.5 mg by mouth 2 times a day.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-14 00:00:00, ended at 2012-03-14 00:00:00\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2012-03-14, presumably until 2012-07-30, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-10 09:07:38, ended at 2012-06-10 10:32:30\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetes mellitus without complication\n- Pure hypercholesterolemia\n- Benign essential hypertension\n- Diabetic - poor control\n- Acute myocardial infarction\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-05 11:23:20, ended at 2012-07-05 12:46:43\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Hearing loss\n- Coronary atherosclerosis\n- Benign essential hypertension\n- Diabetic - poor control\n- Sebaceous cyst of skin\n- Diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-14 00:00:00, ended at 2012-07-14 00:00:00\nThe patient in this visit was 49 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2012-07-14, presumably until 2012-08-15, with intended 1 refill(s). Instructions: take 1 tablet by mouth three times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-30 00:00:00, ended at 2012-07-30 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2012-07-30, presumably until 2012-09-21, with intended 3 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-15 00:00:00, ended at 2012-08-15 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, started on 2012-08-15, presumably until 2014-12-28, with intended 1 refill(s). Instructions: take 1 tablet by mouth three times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-17 00:00:00, ended at 2012-08-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2012-08-17, presumably until 2013-01-19, with intended 4 refill(s). Instructions: take 1 tablet by mouth AT ONSET OF HEADACHE. REPEAT ONE TIME IN 2 HOURS IF NO RELIEF.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-21 00:00:00, ended at 2012-09-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2012-09-21, presumably until 2012-11-03, with intended 3 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-06 09:43:31, ended at 2012-10-06 10:28:54\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Benign essential hypertension\n- Coronary arteriosclerosis\n- Pure hypercholesterolemia\n- Diabetic - poor control\n- Primary diagnosis: Derangement of knee\n- Diabetes mellitus without complication\n- Gastroparesis syndrome\n- Coronary atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-26 09:03:38, ended at 2012-10-26 10:05:49\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.36 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.8 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Derangement of knee\n- Diabetes mellitus without complication\n- Coronary arteriosclerosis\n- Coronary atherosclerosis\n- Diabetic - poor control\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2016-10-02. Instructions: take 40 mg by mouth daily.  \n- bimatoprost 0.3 MG/ML Ophthalmic Solution, through Intraocular route, presumably until 2016-10-22. Instructions: instill 1 Drop to both eyes daily in the evening.  \n- 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution, through Transdermal route, presumably until 2013-07-20. Instructions: apply 1 Application to skin. Each armpit   \n- glimepiride 2 MG Oral Tablet, through Oral route, presumably until 2015-02-12. Instructions: take 2 mg by mouth 2 times a day.  \n- alprazolam 0.5 MG Oral Tablet, through Oral route, presumably until 2013-07-20. Instructions: take 1 Tab by mouth every bedtime.  \n- citalopram 40 MG Oral Tablet, through Oral route, presumably until 2014-10-18. Instructions: take 40 mg by mouth daily.  \n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, through Oral route, presumably until 2012-10-26. Instructions: take 1 Tab by mouth daily.  \n- atorvastatin 40 MG Oral Tablet, through Oral route, presumably until 2014-10-18. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-03 00:00:00, ended at 2012-11-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2012-11-03, presumably until 2013-01-03, with intended 3 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-30 07:54:40, ended at 2012-12-30 08:23:18\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-30, presumably until 2013-06-28, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2012-12-30, presumably until 2014-12-28, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2012-12-30, presumably until 2013-07-20, with intended 0 refill(s). Instructions: take 250 mg by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-03 00:00:00, ended at 2013-01-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-01-03, presumably until 2013-01-31, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-19 00:00:00, ended at 2013-01-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2013-01-19, presumably until 2013-06-25, with intended 4 refill(s). Instructions: take 1 tablet by mouth AT ONSET OF HEADACHE. REPEAT ONE TIME IN 2 HOURS IF NO RELIEF.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-31 00:00:00, ended at 2013-01-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-01-31, presumably until 2013-02-27, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-27 00:00:00, ended at 2013-02-27 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-02-27, presumably until 2013-03-06, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-06 00:00:00, ended at 2013-03-06 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-03-06, presumably until 2013-03-28, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-03-28 00:00:00, ended at 2013-03-28 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-03-28, presumably until 2013-04-15, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-15 00:00:00, ended at 2013-04-15 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-04-15, presumably until 2013-05-29, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-03 00:00:00, ended at 2013-05-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2013-05-03, presumably until 2013-12-24, with intended 6 refill(s). Instructions: take 1 tablet by mouth four times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-29 00:00:00, ended at 2013-05-29 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-05-29, presumably until 2013-07-05, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-25 00:00:00, ended at 2013-06-25 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2013-06-25, presumably until 2013-11-06, with intended 4 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-05 00:00:00, ended at 2013-07-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-07-05, presumably until 2013-08-07, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-20 08:22:42, ended at 2013-07-20 08:51:49\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety state\n- Diabetes mellitus without complication\n- Primary diagnosis: Insomnia\n- Type 2 diabetes mellitus without complication\n- Cough\n- Diabetic - poor control\n- Verruca plantaris\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2013-07-20, presumably until 2014-01-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Anxiety.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2013-07-20, presumably until 2013-10-29, with intended 2 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-07-24 00:00:00, ended at 2013-07-24 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.0 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 45.2 (microgram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 54 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 18 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 381 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 133 (international unit per liter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.070 (micro-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-07 00:00:00, ended at 2013-08-07 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-08-07, presumably until 2013-09-06, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-08 08:31:24, ended at 2013-08-08 09:31:20\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign essential hypertension\n- Coronary arteriosclerosis\n- Primary diagnosis: Pleural effusion\n- Diabetes mellitus without complication\n- Pure hypercholesterolemia\n- Diabetic - poor control\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-08-09 00:00:00, ended at 2013-08-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 64 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.13 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign essential hypertension\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Diabetic - poor control\n- Pure hypercholesterolemia\n- Diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-06 00:00:00, ended at 2013-09-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-09-06, presumably until 2013-10-12, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-12 00:00:00, ended at 2013-10-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-10-12, presumably until 2013-11-13, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-29 00:00:00, ended at 2013-10-29 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2013-10-29, presumably until 2014-10-18, with intended 2 refill(s). Instructions: take 1 tablet by mouth at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-06 00:00:00, ended at 2013-11-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2013-11-06, presumably until 2014-05-01, with intended 4 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-13 00:00:00, ended at 2013-11-13 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-11-13, presumably until 2013-12-26, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-24 00:00:00, ended at 2013-12-24 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2013-12-24, presumably until 2014-10-13, with intended 6 refill(s). Instructions: take 1 tablet by mouth four times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-26 00:00:00, ended at 2013-12-26 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2013-12-26, presumably until 2014-01-29, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-23 09:44:26, ended at 2014-01-23 11:07:35\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Diabetes mellitus without complication\n- Pure hypercholesterolemia\n- Diabetic - poor control\n- Gastroparesis syndrome\n- Benign essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-29 00:00:00, ended at 2014-01-29 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Derangement of knee\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-01-29, presumably until 2014-02-02, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-02-02 00:00:00, ended at 2014-02-02 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-02-02, presumably until 2014-03-10, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-10 00:00:00, ended at 2014-03-10 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-03-10, presumably until 2014-04-07, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-07 00:00:00, ended at 2014-04-07 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2014-04-07, presumably until 2015-02-12, with intended 1 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for anxiety\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-04-07, presumably until 2014-05-02, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-01 00:00:00, ended at 2014-05-01 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2014-05-01, presumably until 2014-09-10, with intended 4 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-01 13:02:14, ended at 2014-05-01 13:41:17\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Headache\n- Primary diagnosis: Eye / vision finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-02 00:00:00, ended at 2014-05-02 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-05-02, presumably until 2014-05-24, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-05-24, presumably until 2014-06-27, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-27 00:00:00, ended at 2014-06-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-06-27, presumably until 2014-07-31, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-31 00:00:00, ended at 2014-07-31 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-07-31, presumably until 2014-08-30, with intended 1 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-30 00:00:00, ended at 2014-08-30 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-08-30, presumably until 2014-10-18, with intended 1 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-10 00:00:00, ended at 2014-09-10 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2014-09-10, presumably until 2014-10-18, with intended 4 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-13 00:00:00, ended at 2014-10-13 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-10-13, presumably until 2014-10-18, with intended 6 refill(s). Instructions: take 1 tablet by mouth four times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-18 08:57:36, ended at 2014-10-18 09:23:47\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign essential hypertension\n- Pure hypercholesterolemia\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Coronary atherosclerosis\n- Depressive disorder\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-12-02, with intended 12 refill(s). Instructions: take 1 Tab by mouth 4 times a day.\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-11-12, with intended 12 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2016-10-02, with intended 2 refill(s). Instructions: take 1 Tab by mouth every bedtime. at bedtime.\n- sumatriptan 100 MG Oral Tablet, started on 2014-10-18, presumably until 2015-12-31, with intended 12 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-10-26, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-12-02, with intended 12 refill(s). Instructions: take 1 Tab by mouth Every Day.\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-10-18, presumably until 2015-12-02, with intended 12 refill(s). Instructions: take 1 Tab by mouth Every Day.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-10-18, presumably until 2015-02-12, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-28 11:04:25, ended at 2014-12-28 12:20:03\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n- Acute bronchitis\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-12-28, presumably until 2022-03-20, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2014-12-28, presumably until 2015-02-12, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-08 08:34:25, ended at 2015-01-08 09:10:53\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Trigeminal neuralgia\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Tablet, through Oral route, started on 2015-01-08, presumably until 2015-07-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-01-08, presumably until 2015-07-07, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-01-11 00:00:00, ended at 2015-01-11 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2015-01-11, presumably until 2016-01-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-02-12 00:00:00, ended at 2015-02-12 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2015-02-12, presumably until 2015-08-16, with intended 1 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-12 10:49:26, ended at 2015-02-12 11:47:23\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-02-12, presumably until 2018-04-21, with intended 1 refill(s). Instructions: 2 Sprays by Nasal route 2 times a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-02-12, presumably until 2015-04-04, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-04 00:00:00, ended at 2015-04-04 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-04-05, presumably until 2015-06-06, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-06-06 00:00:00, ended at 2015-06-06 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-06-06, presumably until 2015-07-09, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-07-02 00:00:00, ended at 2015-07-02 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.3 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 404 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 210.0 (microgram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.6 (percent)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: Comment (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.660 (micro-international unit per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: Comment (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.9 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Poisoning by drug AND/OR medicinal substance\n- Diabetes mellitus without complication\n- Diabetic - poor control\n- Pure hypercholesterolemia\n- Secondary erectile dysfunction\n- Benign essential hypertension\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-09 08:06:35, ended at 2015-07-09 09:18:29\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal breathing\n- Coronary arteriosclerosis\n- Pure hypercholesterolemia\n- Sleep apnea\n- Benign essential hypertension\n- Diabetic - poor control\n- Diabetes mellitus without complication\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-07-09, presumably until 2015-08-09, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-08-12, presumably until 2015-09-26, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-16 00:00:00, ended at 2015-08-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2015-08-16, presumably until 2016-10-02, with intended 1 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-26 00:00:00, ended at 2015-09-26 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-09-27, presumably until 2015-11-25, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-26 00:00:00, ended at 2015-10-26 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 40 MG Oral Tablet, started on 2015-10-28, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-12 00:00:00, ended at 2015-11-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, started on 2015-11-13, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1/2 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-25 00:00:00, ended at 2015-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2015-11-26, presumably until 2016-01-16, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-02 00:00:00, ended at 2015-12-02 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2015-12-02, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth four times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, started on 2015-12-02, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth once daily\n- atorvastatin 40 MG Oral Tablet, started on 2015-12-02, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-31 00:00:00, ended at 2015-12-31 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2015-12-31, presumably until 2016-10-02, with intended 12 refill(s). Instructions: take 1 tablet by mouth IMMEDIATELY MAY REPEAT AFTER 2 HOURS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-01-16 00:00:00, ended at 2016-01-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-01-16, presumably until 2016-02-11, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-11 00:00:00, ended at 2016-02-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Albumin [Mass/volume] in Urine: 128.3 (microgram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 71 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 40 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 198 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Type 2 diabetes mellitus\n- Essential hypertension\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-11 00:00:00, ended at 2016-02-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-02-11, presumably until 2016-03-16, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 08:32:29, ended at 2016-02-27 09:46:02\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 49 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 244 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Snoring\n- Hypersomnia\n- Type 2 diabetes mellitus\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Osteoarthritis\n- Autonomic neuropathy due to type 2 diabetes mellitus\n\n### Drug\n- glimepiride 2 MG Oral Tablet, started on 2016-02-27, presumably until 2016-04-13, with intended 0 refill(s). Instructions: 1 in the morning and 2 in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-16 00:00:00, ended at 2016-03-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-03-17, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-04-10 00:00:00, ended at 2016-04-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 2 MG Oral Tablet, started on 2016-04-13, presumably until 2016-10-02, with intended 6 refill(s). Instructions: 1 in the morning and 2 in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-08 00:00:00, ended at 2016-05-08 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-05-11, presumably until 2016-06-23, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-23 00:00:00, ended at 2016-06-23 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-06-23, presumably until 2016-07-15, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-15 00:00:00, ended at 2016-07-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-07-16, presumably until 2016-08-12, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-12 00:00:00, ended at 2016-08-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-08-14, presumably until 2016-10-02, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-02 00:00:00, ended at 2016-10-02 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day\n- glimepiride 2 MG Oral Tablet, started on 2016-10-06, presumably until 2016-10-22, with intended 6 refill(s). Instructions: 1 in the morning and 2 in the evening.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 2 refill(s). Instructions: take 1 Tab by mouth every bedtime at bedtime.\n- sumatriptan 100 MG Oral Tablet, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 tablet by mouth IMMEDIATELY MAY REPEAT AFTER 2 HOURS\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2016-10-06, presumably until 2016-10-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-10-06, presumably until 2016-10-08, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-07 00:00:00, ended at 2016-10-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-08 09:21:07, ended at 2016-10-08 11:30:03\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 373 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Body height: 5' 7\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 75 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 302 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 193 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 85 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 202 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (international unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- acetic acid 20 MG/ML / hydrocortisone 10 MG/ML Otic Solution, through Otic route, started on 2016-10-08, presumably until 2016-10-22, with intended 3 refill(s). Instructions: instill 5 Drops to both ears 4 times a day\n- permethrin 50 MG/ML Topical Cream, started on 2016-10-08, presumably until 2016-10-22, with intended 1 refill(s). Instructions: Apply to entire body, head to toe, leave on for 12-14 hours then wash off\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-10-08, presumably until 2016-10-22, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-22 00:00:00, ended at 2016-10-22 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2016-11-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2019-11-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- bimatoprost 0.3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-10-26, presumably until 2019-08-17, with intended 3 refill(s). Instructions: instill 1 Drop to both eyes Daily at night\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day\n- glimepiride 2 MG Oral Tablet, started on 2016-10-26, presumably until 2016-11-04, with intended 6 refill(s). Instructions: 1 in the morning and 2 in the evening.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime at bedtime.\n- ferrous sulfate 160 MG Extended Release Oral Tablet, started on 2016-10-26, presumably until 2019-08-17, with intended 1 refill(s). Instructions: Ferogon:  tid\n- sumatriptan 100 MG Oral Tablet, started on 2016-10-26, presumably until 2018-04-06, with intended 3 refill(s). Instructions: take 1 tablet by mouth IMMEDIATELY MAY REPEAT x1  AFTER 2 HOURS\n- acetic acid 20 MG/ML / hydrocortisone 10 MG/ML Otic Solution, through Otic route, started on 2016-10-26, presumably until 2017-07-01, with intended 3 refill(s). Instructions: instill 5 Drops to both ears 4 times a day\n- permethrin 50 MG/ML Topical Cream, started on 2016-10-26, presumably until 2017-07-01, with intended 1 refill(s). Instructions: Apply to entire body, head to toe, leave on for 12-14 hours then wash off\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2017-03-12, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- hydrochlorothiazide 12.5 MG / losartan potassium 100 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2016-10-26, presumably until 2016-10-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-10-26, presumably until 2016-10-28, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-10-30, presumably until 2016-11-24, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-04 09:22:17, ended at 2016-11-04 11:27:09\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Gastroparesis syndrome\n- Pruritic rash\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2016-11-04, presumably until 2018-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n- glimepiride 2 MG Oral Tablet, through Oral route, started on 2016-11-04, presumably until 2017-11-04, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- triamcinolone acetonide 1 MG/ML Topical Cream, started on 2016-11-04, presumably until 2018-04-21, with intended 3 refill(s). Instructions: Apply BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-24 00:00:00, ended at 2016-11-24 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-11-26, presumably until 2016-12-15, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-15 00:00:00, ended at 2016-12-15 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-12-15, presumably until 2016-12-29, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-29 00:00:00, ended at 2016-12-29 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2016-12-30, presumably until 2017-02-09, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-09 00:00:00, ended at 2017-02-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-02-11, presumably until 2017-03-18, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-12 00:00:00, ended at 2017-03-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2017-03-15, presumably until 2017-03-18, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-18 00:00:00, ended at 2017-03-18 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 40 MG Oral Tablet, through Oral route, started on 2017-03-21, presumably until 2018-04-21, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-18 00:00:00, ended at 2017-03-18 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-03-21, presumably until 2017-04-20, with intended 0 refill(s). Instructions: take 1 or 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-20 00:00:00, ended at 2017-04-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-04-22, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-20 00:00:00, ended at 2017-05-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-05-28, presumably until 2017-06-30, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-30 00:00:00, ended at 2017-06-30 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-06-30, presumably until 2017-08-09, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-01 08:19:23, ended at 2017-07-01 08:49:34\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Malaise\n- Pure hypercholesterolemia\n- Atherosclerosis of coronary artery without angina pectoris\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-09 00:00:00, ended at 2017-08-09 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-08-10, presumably until 2017-08-31, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-31 00:00:00, ended at 2017-08-31 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2017-09-03, presumably until 2018-04-21, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-05 00:00:00, ended at 2018-04-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2018-04-06, presumably until 2018-04-06, with intended 12 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-06 00:00:00, ended at 2018-04-06 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2018-04-06, presumably until 2018-04-21, with intended 12 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-28 00:00:00, ended at 2018-04-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-28 00:00:00, ended at 2018-04-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-13 00:00:00, ended at 2018-05-13 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-27 00:00:00, ended at 2018-05-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-05-31, presumably until 2018-06-30, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-06-16 00:00:00, ended at 2018-06-16 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-30 00:00:00, ended at 2018-06-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-30 00:00:00, ended at 2018-06-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-06-30, presumably until 2018-07-27, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-11 00:00:00, ended at 2018-07-11 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2018-07-12, presumably until 2018-07-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-17 00:00:00, ended at 2018-07-17 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2018-07-19, presumably until 2018-10-18, with intended 3 refill(s). Instructions: take 1 tablet by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-07-28, presumably until 2018-08-15, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-21 09:45:56, ended at 2018-07-21 10:25:15\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2018-07-21, presumably until 2019-09-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-29 09:25:53, ended at 2018-07-29 10:30:25\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-15 00:00:00, ended at 2018-08-15 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-08-23, presumably until 2018-09-14, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-15 00:00:00, ended at 2018-08-15 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2018-08-23, presumably until 2018-08-24, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-24 00:00:00, ended at 2018-08-24 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2018-08-24, presumably until 2019-03-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-14 00:00:00, ended at 2018-09-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-09-14, presumably until 2018-11-02, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-16 00:00:00, ended at 2018-10-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2018-10-18, presumably until 2019-11-30, with intended 3 refill(s). Instructions: take 1 tablet by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-11-02, presumably until 2018-12-22, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-22 00:00:00, ended at 2018-12-22 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sumatriptan 100 MG Oral Tablet, started on 2018-12-26, presumably until 2019-11-01, with intended 12 refill(s). Instructions: take 1 tablet by mouth immediately may repeat after 2 hours\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2018-12-26, presumably until 2019-01-25, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-10 00:00:00, ended at 2019-01-10 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-25 08:46:27, ended at 2019-01-25 10:10:07\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- General finding of observation of patient\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Polyneuropathy due to type 2 diabetes mellitus\n\n### Drug\n- fluocinonide 0.0005 MG/MG Topical Ointment, started on 2019-01-25, presumably until 2019-11-01, with intended 3 refill(s). Instructions: Apply twice a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-01-25, presumably until 2019-03-06, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-03-06, presumably until 2019-03-08, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-03-08, presumably until 2019-03-29, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-29 00:00:00, ended at 2019-03-29 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2020-06-21, with intended 12 refill(s). Instructions: take 1 Tab (40 mg total) by mouth every bedtime at bedtime.\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2019-04-26, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime at bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-03-29, presumably until 2019-04-26, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-12 08:27:52, ended at 2019-04-12 10:41:41\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute frontal sinusitis\n\n### Drug\n- cefuroxime 500 MG Oral Tablet, through Oral route, started on 2019-04-12, presumably until 2023-02-02, with intended 0 refill(s). Instructions: take 1 Tab (500 mg total) by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-18, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime at bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-04-26, presumably until 2019-08-01, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-18 00:00:00, ended at 2019-05-18 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2019-05-19, presumably until 2019-09-06, with intended 2 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-19 00:00:00, ended at 2019-06-19 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 60.4 (microgram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 107 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.7 (percent)\n- Albumin/Creatinine [Mass Ratio] in Urine: 54.5 (milligram per gram of creatinine)\n- Creatinine [Mass/volume] in Urine: 110.9 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-01 00:00:00, ended at 2019-08-01 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-08-03, presumably until 2019-09-01, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-17 09:19:06, ended at 2019-08-17 10:44:15\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Herpes zoster without complication\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2019-08-17, presumably until 2019-08-24, with intended 0 refill(s). Instructions: take 1 Tab (1,000 mg total) by mouth 3 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-01 08:24:01, ended at 2019-09-01 14:03:31\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Herpes zoster without complication\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-09-01, presumably until 2019-10-02, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-06 00:00:00, ended at 2019-09-06 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, started on 2019-09-07, presumably until 2019-11-01, with intended 3 refill(s). Instructions: take 1 tablet by mouth twice a day\n- alprazolam 0.5 MG Oral Tablet, started on 2019-09-07, presumably until 2019-11-15, with intended 2 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-20 00:00:00, ended at 2019-09-20 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-02 00:00:00, ended at 2019-10-02 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-10-02, presumably until 2019-11-14, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-01 15:24:03, ended at 2019-11-01 16:31:59\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Primary diagnosis: Acute non-ST segment elevation myocardial infarction\n- Ulcer of duodenum\n- Gastrointestinal hemorrhage\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2020-01-16, with intended 0 refill(s). Instructions: take 30 mg by mouth 2 times a day\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2019-10-25, presumably until 2019-12-04, with intended 0 refill(s). Instructions: BID@0900,2100\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-14 00:00:00, ended at 2019-11-14 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 111 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Gastrointestinal hemorrhage\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Angina co-occurrent and due to coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-14 00:00:00, ended at 2019-11-14 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-11-14, presumably until 2019-12-29, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-15 00:00:00, ended at 2019-11-15 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2019-11-15, presumably until 2020-02-27, with intended 2 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-17 00:00:00, ended at 2019-11-17 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-04-18, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 8 hours as needed (muscle spasm)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-30 00:00:00, ended at 2019-11-30 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2019-12-04, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-03 00:00:00, ended at 2019-12-03 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2019-12-04, presumably until 2019-12-04, with intended 0 refill(s)\n- citalopram 20 MG Oral Tablet, started on 2019-12-04, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-04, presumably until 2020-01-16, with intended 0 refill(s). Instructions: take 1 Tab (1,000 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-06 10:19:49, ended at 2019-12-06 11:14:01\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Essential hypertension\n- Gastrointestinal hemorrhage\n- Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Generalized anxiety disorder\n- Acute non-ST segment elevation myocardial infarction\n- Type 2 diabetes mellitus\n\n### Drug\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2020-01-01, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-26 00:00:00, ended at 2019-12-26 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-11-12, presumably until 2021-04-23, with intended 3 refill(s). Instructions: take 5 mg by mouth every bedtime at bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2019-12-29, presumably until 2020-02-04, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2020-01-01, presumably until 2020-01-01, with intended 0 refill(s). Instructions: take 1 Tablet (80 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-01-16, presumably until 2020-04-22, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-16 00:00:00, ended at 2020-01-16 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2020-01-16, presumably until 2020-04-22, with intended 3 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-31 00:00:00, ended at 2020-01-31 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-02-04, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 1 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.0 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 87 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 204 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 265 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n- Generalized anxiety disorder\n- Hyperglycemia due to type 2 diabetes mellitus\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Essential hypertension\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-02-27, presumably until 2020-03-04, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-04 00:00:00, ended at 2020-03-04 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2020-09-06, with intended 0 refill(s). Instructions: take 1 Tab (40 mg total) by mouth 2 times a day\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2020-04-29, with intended 0 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2020-04-10, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth every bedtime as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-03-04, presumably until 2020-03-15, with intended 0 refill(s). Instructions: take 1 to 2 tablets by mouth  6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-03-15, presumably until 2020-04-10, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-04-10, presumably until 2020-05-15, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-04-10, presumably until 2020-05-15, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-16 00:00:00, ended at 2020-04-16 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2020-04-18, presumably until 2020-10-31, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for muscle spasm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-04-22, presumably until 2020-07-12, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-22 00:00:00, ended at 2020-04-22 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, through Oral route, started on 2020-04-24, presumably until 2020-08-29, with intended 3 refill(s). Instructions: take 1 Tab (1,000 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2020-04-29, presumably until 2020-06-21, with intended 0 refill(s). Instructions: take 1 tablet by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-14 00:00:00, ended at 2020-05-14 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-05-15, presumably until 2020-07-12, with intended 1 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-05-15, presumably until 2020-06-13, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-11 00:00:00, ended at 2020-06-11 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-06-13, presumably until 2020-07-12, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-20 00:00:00, ended at 2020-06-20 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- citalopram 20 MG Oral Tablet, started on 2020-06-21, presumably until 2021-04-18, with intended 3 refill(s). Instructions: take 1 tablet by mouth once daily\n- pravastatin sodium 40 MG Oral Tablet, started on 2020-06-21, presumably until 2020-10-18, with intended 3 refill(s). Instructions: take 1 tablet by mouth at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-11 00:00:00, ended at 2020-07-11 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 20 MG Oral Tablet, started on 2020-07-12, presumably until 2021-08-20, with intended 4 refill(s). Instructions: take 1 tablet by mouth once daily\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-07-12, presumably until 2020-08-13, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-12 00:00:00, ended at 2020-07-12 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-07-12, presumably until 2020-10-10, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n- alprazolam 0.5 MG Oral Tablet, started on 2020-07-12, presumably until 2020-07-26, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-16 00:00:00, ended at 2020-07-16 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-07-26, presumably until 2020-08-27, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin degludec 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-08-01, presumably until 2020-12-25, with intended 12 refill(s). Instructions: inject 44 Units subcutaneous (under the skin) every bedtime\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-08-01, presumably until 2020-10-31, with intended 6 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-12 00:00:00, ended at 2020-08-12 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-08-13, presumably until 2020-09-11, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-25 00:00:00, ended at 2020-08-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-08-27, presumably until 2020-10-10, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-29 00:00:00, ended at 2020-08-29 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2020-08-29, presumably until 2020-10-02, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-04 00:00:00, ended at 2020-09-04 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-09-06, presumably until 2020-12-18, with intended 2 refill(s). Instructions: take 1 tablet by mouth BEFORE BREAKFAST AND  DINNER as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-11 00:00:00, ended at 2020-09-11 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2020-09-11, presumably until 2020-10-07, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 to 6 hours AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-01 00:00:00, ended at 2020-10-01 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2020-10-02, presumably until 2020-11-05, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-07 00:00:00, ended at 2020-10-07 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2020-10-10, presumably until 2020-10-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain take 1 tablet by mouth every 4 to 6 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-10 00:00:00, ended at 2020-10-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-10-10, presumably until 2020-12-24, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-10 00:00:00, ended at 2020-10-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 0.5 MG Oral Tablet, started on 2020-10-10, presumably until 2020-10-18, with intended 0 refill(s). Instructions: take 1 tablet by mouth at bedtime if needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-21 00:00:00, ended at 2020-10-21 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2020-10-25, presumably until 2020-12-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-31 08:44:49, ended at 2020-10-31 10:01:54\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Chronic pain\n- Cervical disc disorder with radiculopathy\n- Essential hypertension\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Lumbago with sciatica\n\n### Drug\n- pregabalin 25 MG Oral Capsule, through Oral route, started on 2020-10-31, presumably until 2021-03-21, with intended 1 refill(s). Instructions: take 1 Amir (25 mg total) by mouth 3 times a day\n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2020-10-31, presumably until 2021-04-23, with intended 0 refill(s). Instructions: inject 54 Units subcutaneous (under the skin) daily\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-10-31, presumably until 2020-12-04, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-03 00:00:00, ended at 2020-11-03 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR ranolazine 1000 MG Extended Release Oral Tablet, started on 2020-11-05, presumably until 2020-11-05, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-29 00:00:00, ended at 2020-11-29 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-12-04, presumably until 2020-12-25, with intended 4 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-05 00:00:00, ended at 2020-12-05 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2020-12-06, presumably until 2021-01-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-18 00:00:00, ended at 2020-12-18 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-12-18, presumably until 2021-04-17, with intended 2 refill(s). Instructions: take 1 tablet by mouth BEFORE BREAKFAST AND  DINNER as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-23 00:00:00, ended at 2020-12-23 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2020-12-24, presumably until 2021-03-14, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-25 00:00:00, ended at 2020-12-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin degludec 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-12-25, presumably until 2021-08-11, with intended 12 refill(s). Instructions: inject 44 Units subcutaneous (under the skin) every bedtime\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-12-25, presumably until 2022-07-16, with intended 4 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-06 00:00:00, ended at 2021-01-06 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2021-01-07, presumably until 2021-02-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-11 00:00:00, ended at 2021-02-11 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, through Oral route, started on 2021-02-12, presumably until 2021-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-10 00:00:00, ended at 2021-03-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet, started on 2021-03-10, presumably until 2021-04-18, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-14 00:00:00, ended at 2021-03-14 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2021-03-14, presumably until 2021-03-31, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-15 00:00:00, ended at 2021-03-15 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diazepam 5 MG Oral Tablet, started on 2021-03-19, presumably until 2021-04-28, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 8 hours if needed for muscle spasm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-19 00:00:00, ended at 2021-03-19 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pregabalin 25 MG Oral Capsule, started on 2021-03-21, presumably until 2021-04-18, with intended 2 refill(s). Instructions: take 1 capsule by mouth three times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-27 00:00:00, ended at 2021-03-27 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, started on 2021-03-31, presumably until 2021-05-28, with intended 2 refill(s). Instructions: take 1 tablet by mouth twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-03-27 00:00:00, ended at 2021-03-27 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 127 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 334 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.9 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 81 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 21 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 81.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8252c0c3ee5f3fd31d71a95d92e8c4a9b433b15c391e0ed0c328db75196188c1", "prompt_hash": "915c276c6335ce3feba257ecefea0ea8e6c92c4493e1196ac7af05c73d4dd487", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115967742, "visit_occurrence_id": 52803964, "visit_start_datetime": "2013-01-29 08:28:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 69.0, "current_label": 0, "next_value": 146.0, "next_label": 1, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-28 00:00:00, ended at 2009-09-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-02 09:00:00, ended at 2009-10-02 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Mitral valve disorder\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-11 12:13:45, ended at 2009-11-11 14:52:52\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Tricuspid valve disorder\n- Hypertrophic cardiomyopathy\n- Congestive heart failure\n\n### Drug\n- metolazone 2.5 MG Oral Tablet, through Oral route, started on 2009-11-11, presumably until 2009-12-08. Instructions: take 2.5 mg by mouth as needed \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-11, presumably until 2009-12-08. Instructions: take 0.5 Tabs by mouth as needed Takes 10meq on zaroxolyn days. \n- torsemide 20 MG Oral Tablet, through Oral route, started on 2009-11-11, presumably until 2009-12-08. Instructions: take 1 Tab by mouth as directed. Takes 2 tabs qam & 1 tab qpm. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-11-18 16:10:00, ended at 2009-12-03 15:20:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Sodium [Moles/volume] in Blood: 127 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 9.6 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Base excess in Blood by calculation: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.32 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Body height: 5' 5\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 17.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.9 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Prothrombin time (PT): 34.3 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 51 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 98 (percent)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 151 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 4.75 (micro-international unit per milliliter)\n- Base deficit in Blood: 8.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 33.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.17 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.8 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.9 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 3.0 (nanogram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.01 (thousand per microliter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy re-evaluation\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Controlled ventilation procedure and therapy, initiation and management\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Operative external blood circulation\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transfusion of other serum\n- Packed blood cell transfusion\n- Pooling of platelets or other blood products\n- Transplantation of heart\n- Duplex scan of extracranial arteries; complete bilateral study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Occupational therapy evaluation\n- Computed tomography, thorax, diagnostic; without contrast material\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Venous catheterization, not elsewhere classified\n- Collection of venous blood by venipuncture\n- Occupational therapy re-evaluation\n- Catheterization of right heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chronic kidney disease stage 3\n- Congestive heart failure\n- Hypokalemia\n- Lung field abnormal\n- Ascites\n- Benign hypertensive renal disease with renal failure\n- Cardiogenic shock\n- Hypo-osmolality and or hyponatremia\n- Malnutrition (calorie)\n- Acute renal failure syndrome\n- Postprocedural state finding\n- Cirrhosis - non-alcoholic\n- Pleural effusion\n- Primary cardiomyopathy\n- Hyperkalemia\n- Hypertrophic cardiomyopathy\n- Pulmonary congestion and hypostasis\n- Tricuspid valve disorder, non-rheumatic\n- Acute tubular necrosis\n- Atelectasis\n- Atrial fibrillation\n- Chronic cor pulmonale\n- Diabetes mellitus without complication\n- Disorder of gallbladder\n- Atrial flutter\n- Cardiomegaly\n- Chronic systolic heart failure\n- Diabetic - poor control\n\n### Drug\n- temazepam 7.5 MG Oral Capsule, through Oral route, started on 2009-11-24, presumably until 2009-12-02\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2009-11-19, presumably until 2009-11-23\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2009-11-25, presumably until 2009-11-30\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- sennosides, USP 1.76 MG/ML Oral Solution, through Oral route, started on 2009-11-29, presumably until 2009-11-29\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-23\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2009-11-20, presumably until 2009-11-20\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2009-11-25, presumably until 2009-11-30\n- 250 ML dopamine hydrochloride 3.2 MG/ML Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-12-01\n- menthol, through Submucosal route, started on 2009-11-20, presumably until 2009-11-21\n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2009-11-23, presumably until 2009-11-23\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2009-11-23, presumably until 2009-12-02\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2009-11-25, presumably until 2009-12-01\n- 250 ML dobutamine 2 MG/ML Injection, through Intravenous route, started on 2009-11-18, presumably until 2009-11-22\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2009-11-30, presumably until 2009-12-02\n- ganciclovir 500 MG Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-11-18, presumably until 2009-12-01\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2009-12-02\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2009-11-21\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-11-19, presumably until 2009-11-19\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-30\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-11-27, presumably until 2009-12-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-20, presumably until 2009-11-27\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- amphotericin B 50 MG Injection, started on 2009-11-23, presumably until 2009-12-03\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2009-11-25, presumably until 2009-11-25\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-11-22, presumably until 2009-11-23\n- cetylpyridinium, through Submucosal route, started on 2009-11-20, presumably until 2009-11-21\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2009-11-24, presumably until 2009-11-24\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2009-12-01, presumably until 2009-12-02\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2009-11-19\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-11-24, presumably until 2009-11-25\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-11-21, presumably until 2009-12-01\n- temazepam 15 MG Oral Capsule, through Oral route, started on 2009-11-18, presumably until 2009-11-21\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2009-11-26, presumably until 2009-11-26\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-02\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2009-11-24, presumably until 2009-12-01\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-23\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2009-11-24, presumably until 2009-12-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-11-18, presumably until 2009-11-24\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2009-11-30, presumably until 2009-12-02\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-30\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2009-11-19, presumably until 2009-11-19\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-11-21, presumably until 2009-12-02\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2009-11-23, presumably until 2009-11-23\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2009-11-21, presumably until 2009-11-21\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2009-11-19, presumably until 2009-11-23\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2009-11-21, presumably until 2009-11-21\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-11-25, presumably until 2009-11-30\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-11-19, presumably until 2009-11-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2009-11-22, presumably until 2009-11-25\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2009-11-24, presumably until 2009-12-01\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2009-11-30, presumably until 2009-12-03\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-02\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2009-11-30, presumably until 2009-12-01\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-23\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2009-11-24, presumably until 2009-12-01\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2009-11-25, presumably until 2009-12-02\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2009-11-24, presumably until 2009-12-01\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- midazolam 1 MG/ML Injectable Solution, started on 2009-11-23, presumably until 2009-11-23\n- methylprednisolone 125 MG Injection, started on 2009-11-23, presumably until 2009-11-23\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2009-11-19, presumably until 2009-11-19\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-21, presumably until 2009-11-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 17:00:00, ended at 2009-11-18 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Mitral valve disorder\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-23 16:00:00, ended at 2009-11-23 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-11-25 10:30:00, ended at 2009-11-25 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-30 07:00:00, ended at 2009-11-30 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-02 00:00:00, ended at 2009-12-02 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-07 09:09:01, ended at 2009-12-07 11:09:55\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.1 (nanogram per milliliter)\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2014-01-01. Instructions: take 40 mg by mouth daily. \n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, presumably until 2009-12-17. Instructions: take 10 mg by mouth daily. \n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2009-12-21. Instructions: take 20 mg by mouth 2 times a day. \n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2009-12-17. Instructions: take 1 mg by mouth 2 times a day. \n- prednisone 10 MG Oral Tablet, through Oral route, presumably until 2009-12-17. Instructions: take 15 mg by mouth 2 times a day. \n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, presumably until 2009-12-21. Instructions: take by mouth. \n- temazepam 30 MG Oral Capsule, through Oral route, presumably until 2010-11-15. Instructions: take 0.5 Tabs by mouth every bedtime as needed. \n- clotrimazole 10 MG Oral Lozenge, through Oral route, presumably until 2011-05-23. Instructions: take 10 mg by mouth 3 times a day. \n- aspirin 81 MG Oral Tablet, through Oral route. Instructions: Take 1 tablet (81 mg total) by mouth daily\n- glipizide 5 MG Oral Tablet, through Oral route, presumably until 2009-12-17. Instructions: take 5 mg by mouth daily. \n- pravastatin sodium 20 MG Oral Tablet, through Oral route, presumably until 2015-04-13. Instructions: take 60 mg by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule, through Oral route, started on 2009-12-07, presumably until 2009-12-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Olivas by mouth every morning. \n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, presumably until 2010-02-18. Instructions: take 1 Tab by mouth daily. \n- 1 ML epoetin alfa 40000 UNT/ML Injection, through Subcutaneous route, presumably until 2009-12-31. Instructions: 60000 Units by SUBCUTANEOUS route every 7 days. \n- itraconazole 10 MG/ML Oral Solution, through Oral route, presumably until 2010-03-22. Instructions: take 200 mg by mouth every morning. \n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route. Instructions: Take 1 tablet by mouth 2 times a day with meals\n- valganciclovir 450 MG Oral Tablet, through Oral route, presumably until 2009-12-17. Instructions: take 900 mg by mouth 2 times a day. \n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2014-01-01. Instructions: take 500 mg by mouth 2 times a day.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2010-01-21. Instructions: take 1 Tab by mouth every 4 hours as needed \n- ferrous sulfate 325 MG Oral Tablet, through Oral route, presumably until 2010-03-22. Instructions: take 1 Tab by mouth 3 times a day. \n- lactulose 20000 MG Powder for Oral Solution, through Oral route, presumably until 2009-12-17. Instructions: take 20 g by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-07 11:10:00, ended at 2009-12-07 13:28:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-07 13:29:00, ended at 2009-12-07 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Endomyocardial biopsy\n\n### Condition\n- Pleural effusion\n- Cardiomegaly\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-09 00:00:00, ended at 2009-12-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-09 08:58:00, ended at 2009-12-09 11:08:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.51 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 260 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.43 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- daclizumab 5 MG/ML Injectable Solution, through Intravenous route, started on 2009-12-09, presumably until 2009-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-09 11:09:00, ended at 2009-12-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-14 00:00:00, ended at 2009-12-14 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 09:13:00, ended at 2009-12-14 10:39:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.86 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-14 09:38:47, ended at 2009-12-14 11:28:47\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 10:40:00, ended at 2009-12-14 12:40:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 13:17:00, ended at 2009-12-14 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Effect of exposure to physical force\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-17 08:35:00, ended at 2009-12-17 09:09:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 14.0 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-17 09:10:00, ended at 2009-12-17 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-17 09:30:05, ended at 2009-12-17 11:51:14\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-12-17, presumably until 2009-12-21, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1-2 mg by mouth 2 times a day. \n- prednisone 10 MG Oral Tablet, through Oral route, started on 2009-12-17, presumably until 2010-02-18, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2009-12-17, presumably until 2010-03-22, with quantity of 60.0, with intended 11 refill(s). Instructions: take 900 mg by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-21 09:19:59, ended at 2009-12-21 12:25:14\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-21 10:08:17, ended at 2009-12-21 12:04:24\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-12-21, presumably until 2010-02-18, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-21 12:23:31, ended at 2009-12-21 17:17:16\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-21 14:40:00, ended at 2009-12-21 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Endomyocardial biopsy\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-22 14:30:00, ended at 2009-12-22 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- methylprednisolone 500 MG Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-23 00:00:00, ended at 2009-12-23 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-23 08:30:00, ended at 2009-12-23 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- methylprednisolone 500 MG Injection, through Intravenous route, started on 2009-12-23, presumably until 2009-12-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 08:00:00, ended at 2009-12-24 11:01:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 26.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n- MCV [Entitic volume] by Automated count: 102.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.49 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- methylprednisolone 500 MG Injection, through Intravenous route, started on 2009-12-24, presumably until 2009-12-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-24 09:26:59, ended at 2009-12-24 10:44:21\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 11:02:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Lung field abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-29 00:00:00, ended at 2009-12-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-29 08:30:00, ended at 2009-12-29 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-30 00:00:00, ended at 2009-12-30 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Muscle atrophy\n- Transplanted heart present\n- Incoordination\n- Muscle weakness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-31 08:29:00, ended at 2009-12-31 08:42:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 251 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 26.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.41 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- MCV [Entitic volume] by Automated count: 103.5 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 13.7 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-31 09:01:46, ended at 2009-12-31 10:06:59\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Effect of exposure to physical force\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-31 10:12:00, ended at 2009-12-31 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 05:53:00, ended at 2010-01-04 16:05:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 8 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.9 (gram per deciliter)\n- Body height: 5' 5.748\" (inch (US))\n- Potassium [Moles/volume] in Blood: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n\n### Procedure\n- Coronary arteriography using two catheters\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n- Biopsy of heart\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Catheter placement in coronary artery(s), arterial coronary conduit(s), and/or venous coronary bypass graft(s) for coronary angiography without concomitant left heart catheterization\n- Endomyocardial biopsy\n- Catheterization of right heart\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2010-01-21. Instructions: take by mouth daily. \n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-01-04\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-01-04\n- acetylcysteine 200 MG/ML Inhalation Solution, through Inhalation, presumably until 2010-01-14. Instructions: 3 mL by Inhalation route every 4 hours. One dose on 01/03/2010 and one on1/25/10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-01-04, presumably until 2010-01-04\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-04\n- 24 HR glipizide 2.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-01-14. Instructions: take 2.5 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-07 08:37:00, ended at 2010-01-07 09:15:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.24 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 104.7 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.62 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-07 09:16:00, ended at 2010-01-07 11:17:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-07 09:48:43, ended at 2010-01-07 11:11:02\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-07 11:18:00, ended at 2010-01-07 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-14 08:00:00, ended at 2010-01-14 08:29:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-14 08:30:00, ended at 2010-01-14 08:52:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.23 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.42 (micro-international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.5 (percent)\n- Tacrolimus [Mass/volume] in Blood: 11.3 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-14 08:53:00, ended at 2010-01-14 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-14 09:12:15, ended at 2010-01-14 10:27:32\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- 24 HR glipizide 2.5 MG Extended Release Oral Tablet, through Oral route, started on 2010-01-14, presumably until 2010-01-21. Instructions: take 1 Tab by mouth daily. On hold for episodes of hypoglycemia \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-21 08:23:00, ended at 2010-01-21 08:54:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 104.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 369 (picogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.67 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.75 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 226 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.4 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-21 08:55:00, ended at 2010-01-21 14:32:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-21 09:13:50, ended at 2010-01-21 09:59:03\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-01-21, presumably until 2010-11-15. Instructions: take by mouth daily as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-21 14:33:00, ended at 2010-01-21 17:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-22 08:06:00, ended at 2010-01-22 08:49:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-01-25 09:01:26, ended at 2010-01-25 12:20:42\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-01-25 09:53:00, ended at 2010-01-26 12:15:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Prothrombin time (PT): 14.6 (second)\n- Tacrolimus [Mass/volume] in Blood: 10.8 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.38 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.8 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Fever\n- Nausea and vomiting\n- Secondary diabetes mellitus\n- Infectious diarrheal disease\n- Headache\n- Transplanted heart present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-01-26\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-01-26\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2010-01-25, presumably until 2010-01-25\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-02-18, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2010-01-25, presumably until 2010-01-26\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-01-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-01-25, presumably until 2010-01-25\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-11-15. Instructions: take 1 Tab by mouth daily. \n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-01-26\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-01-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-04 08:31:21, ended at 2010-02-04 12:58:30\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-04 09:17:40, ended at 2010-02-04 11:10:37\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 11:22:00, ended at 2010-02-04 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Fever\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-18 08:45:35, ended at 2010-02-18 13:03:28\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-18 09:08:35, ended at 2010-02-18 10:10:49\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- magnesium oxide 500 MG Oral Capsule, through Oral route, started on 2010-02-18, presumably until 2015-07-27. Instructions: take 500 mg by mouth Every Day. \n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-02-18, presumably until 2011-05-23, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 mg by mouth 2 times a day.   Take 2 mg in AM and 1.5 mg in PM\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-02-18, presumably until 2011-03-08, with quantity of 10.0, with intended 0 refill(s). Instructions: take 2 mg by mouth 2 times a day. 2mg in AM , 2mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-18 10:20:00, ended at 2010-02-18 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Biopsy of heart\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-22 08:32:28, ended at 2010-03-22 17:09:27\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-22 08:40:40, ended at 2010-03-22 08:58:43\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-22 09:04:49, ended at 2010-03-22 09:50:10\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2010-03-22, presumably until 2010-11-15, with quantity of 30.0, with intended 11 refill(s). Instructions: take 450 mg by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-22 10:03:00, ended at 2010-03-22 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-26 08:09:22, ended at 2010-04-26 17:09:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Imaging of thorax abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-26 09:52:32, ended at 2010-04-26 12:08:27\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-26 12:21:00, ended at 2010-04-26 13:08:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-24 08:35:44, ended at 2010-05-24 17:07:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-24 08:50:37, ended at 2010-05-24 11:12:49\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-24 09:16:13, ended at 2010-05-24 10:16:04\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-24 10:25:00, ended at 2010-05-24 11:19:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-19 09:20:18, ended at 2010-07-19 13:20:22\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-19 11:11:56, ended at 2010-07-19 11:44:04\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-19 11:22:44, ended at 2010-07-19 17:16:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-19 11:42:00, ended at 2010-07-19 14:58:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-04 00:00:00, ended at 2010-08-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-16 08:27:56, ended at 2010-09-16 13:14:06\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-16 09:12:45, ended at 2010-09-16 13:11:57\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-16 10:32:59, ended at 2010-09-16 17:05:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-16 11:11:00, ended at 2010-09-16 13:50:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-15 00:00:00, ended at 2010-11-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-15 07:55:00, ended at 2010-11-15 16:50:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 116 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 55 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- Body height: 5' 5.354\" (inch (US))\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 179 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.63 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n\n### Procedure\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Catheter placement in coronary artery(s), arterial coronary conduit(s), and/or venous coronary bypass graft(s) for coronary angiography without concomitant left heart catheterization\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n- Endomyocardial biopsy\n- Coronary arteriography using two catheters\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Catheterization of right heart\n- Biopsy of heart\n- Intravascular pressure measurement of coronary arteries\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Collection of venous blood by venipuncture\n- Intravascular imaging of coronary vessels\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, presumably until 2013-01-30. Instructions: take 1500 mg by mouth daily. 10 ml \n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2012-09-24. Instructions: take 5 mg by mouth daily.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-11-15, presumably until 2010-11-15\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n- temazepam 7.5 MG Oral Capsule, through Oral route, presumably until 2014-01-01. Instructions: take 7.5 mg by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-16 10:51:00, ended at 2010-11-16 11:49:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-16 11:50:00, ended at 2010-11-16 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-16 12:15:29, ended at 2010-11-16 13:34:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-04 00:00:00, ended at 2011-03-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-07 08:00:00, ended at 2011-03-07 08:51:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-03-07 08:03:31, ended at 2011-03-07 17:18:43\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Imaging of thorax abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-07 08:52:00, ended at 2011-03-07 10:50:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-03-07 08:53:12, ended at 2011-03-07 09:43:10\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Effect of exposure to physical force\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-20 00:00:00, ended at 2011-05-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-23 08:00:00, ended at 2011-05-23 10:08:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-23 08:38:53, ended at 2011-05-23 20:47:26\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-23 09:04:16, ended at 2011-05-23 10:01:55\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-05-23, presumably until 2011-09-12, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day.   Take 2 mg in AM and 1.5 mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-23 10:09:00, ended at 2011-05-23 11:11:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.99 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.89 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.5 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n\n### Procedure\n- Biopsy of heart\n- Endomyocardial biopsy\n- Long-term drug therapy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-09 00:00:00, ended at 2011-09-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-12 07:30:00, ended at 2011-09-12 07:35:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-12 07:36:00, ended at 2011-09-12 07:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.9 (percent)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-12 08:00:00, ended at 2011-09-12 09:41:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-12 09:42:00, ended at 2011-09-12 11:14:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-11-07 00:00:00, ended at 2011-11-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2011-11-07, presumably until 2012-01-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-12-13 00:00:00, ended at 2011-12-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-13 09:29:00, ended at 2011-12-13 10:35:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 3.2 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.14 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n\n### Procedure\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-13 09:53:29, ended at 2011-12-13 14:25:31\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Congestive heart failure\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-13 13:00:00, ended at 2011-12-13 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-18 08:53:00, ended at 2012-01-18 09:37:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.5 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.6 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 7.1 (micromole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 195 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 183 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 40.7 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.05 (thousand per microliter)\n- Prothrombin time (PT): 12.9 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.0 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-18 09:38:00, ended at 2012-01-18 09:51:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-18 10:35:00, ended at 2012-01-18 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-19 06:00:00, ended at 2012-01-19 14:06:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.748\" (inch (US))\n\n### Procedure\n- Biopsy of heart\n- Collection of venous blood by venipuncture\n- Coronary arteriography using two catheters\n- Intravascular imaging of coronary vessels\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Endomyocardial biopsy\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Catheterization of right heart\n- Arteriography of femoral and other lower extremity arteries\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Hypertrophic cardiomyopathy\n- Congestive heart failure\n- Essential hypertension\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2012-01-19, presumably until 2012-01-19\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2012-01-19, presumably until 2012-01-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-01-19, presumably until 2012-01-19\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2012-01-19, presumably until 2012-01-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-18 00:00:00, ended at 2012-05-18 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-21 07:49:00, ended at 2012-05-21 10:25:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-21 09:33:00, ended at 2012-05-21 10:06:22\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Essential hypertension\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-21 10:26:00, ended at 2012-05-21 11:33:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 55 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 11.7 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.34 (thousand per microliter)\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Imaging of thorax abnormal\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-09-21 00:00:00, ended at 2012-09-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-24 07:42:00, ended at 2012-09-24 07:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.11 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 50 (milliliter per minute per square meter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 176 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 17.1 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n\n### Procedure\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-24 08:00:00, ended at 2012-09-24 08:51:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-24 08:52:00, ended at 2012-09-24 10:06:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-24 10:07:00, ended at 2012-09-24 11:16:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-09-28 00:00:00, ended at 2012-09-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-01 00:00:00, ended at 2012-10-01 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-29 08:28:00, ended at 2013-01-29 09:40:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 79 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.2 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 6.8 (micromole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.54 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 17.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Prothrombin time (PT): 13.4 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 124, "cumulated_approximate_token_count": 33678}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-28 00:00:00, ended at 2009-09-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-02 09:00:00, ended at 2009-10-02 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Mitral valve disorder\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-11 12:13:45, ended at 2009-11-11 14:52:52\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Tricuspid valve disorder\n- Hypertrophic cardiomyopathy\n- Congestive heart failure\n\n### Drug\n- metolazone 2.5 MG Oral Tablet, through Oral route, started on 2009-11-11, presumably until 2009-12-08. Instructions: take 2.5 mg by mouth as needed \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-11, presumably until 2009-12-08. Instructions: take 0.5 Tabs by mouth as needed Takes 10meq on zaroxolyn days. \n- torsemide 20 MG Oral Tablet, through Oral route, started on 2009-11-11, presumably until 2009-12-08. Instructions: take 1 Tab by mouth as directed. Takes 2 tabs qam & 1 tab qpm. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-11-18 16:10:00, ended at 2009-12-03 15:20:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Sodium [Moles/volume] in Blood: 127 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 9.6 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Base excess in Blood by calculation: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.32 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Body height: 5' 5\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 17.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.9 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Prothrombin time (PT): 34.3 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 51 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 98 (percent)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 151 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 4.75 (micro-international unit per milliliter)\n- Base deficit in Blood: 8.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 33.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.17 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.8 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.9 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 3.0 (nanogram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.01 (thousand per microliter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy re-evaluation\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Controlled ventilation procedure and therapy, initiation and management\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Operative external blood circulation\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transfusion of other serum\n- Packed blood cell transfusion\n- Pooling of platelets or other blood products\n- Transplantation of heart\n- Duplex scan of extracranial arteries; complete bilateral study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Occupational therapy evaluation\n- Computed tomography, thorax, diagnostic; without contrast material\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Venous catheterization, not elsewhere classified\n- Collection of venous blood by venipuncture\n- Occupational therapy re-evaluation\n- Catheterization of right heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chronic kidney disease stage 3\n- Congestive heart failure\n- Hypokalemia\n- Lung field abnormal\n- Ascites\n- Benign hypertensive renal disease with renal failure\n- Cardiogenic shock\n- Hypo-osmolality and or hyponatremia\n- Malnutrition (calorie)\n- Acute renal failure syndrome\n- Postprocedural state finding\n- Cirrhosis - non-alcoholic\n- Pleural effusion\n- Primary cardiomyopathy\n- Hyperkalemia\n- Hypertrophic cardiomyopathy\n- Pulmonary congestion and hypostasis\n- Tricuspid valve disorder, non-rheumatic\n- Acute tubular necrosis\n- Atelectasis\n- Atrial fibrillation\n- Chronic cor pulmonale\n- Diabetes mellitus without complication\n- Disorder of gallbladder\n- Atrial flutter\n- Cardiomegaly\n- Chronic systolic heart failure\n- Diabetic - poor control\n\n### Drug\n- temazepam 7.5 MG Oral Capsule, through Oral route, started on 2009-11-24, presumably until 2009-12-02\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2009-11-19, presumably until 2009-11-23\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2009-11-25, presumably until 2009-11-30\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- sennosides, USP 1.76 MG/ML Oral Solution, through Oral route, started on 2009-11-29, presumably until 2009-11-29\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-23\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2009-11-20, presumably until 2009-11-20\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2009-11-25, presumably until 2009-11-30\n- 250 ML dopamine hydrochloride 3.2 MG/ML Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-12-01\n- menthol, through Submucosal route, started on 2009-11-20, presumably until 2009-11-21\n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2009-11-23, presumably until 2009-11-23\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2009-11-23, presumably until 2009-12-02\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2009-11-25, presumably until 2009-12-01\n- 250 ML dobutamine 2 MG/ML Injection, through Intravenous route, started on 2009-11-18, presumably until 2009-11-22\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2009-11-30, presumably until 2009-12-02\n- ganciclovir 500 MG Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-11-18, presumably until 2009-12-01\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2009-12-02\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2009-11-21\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-11-19, presumably until 2009-11-19\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-30\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-11-27, presumably until 2009-12-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-20, presumably until 2009-11-27\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- amphotericin B 50 MG Injection, started on 2009-11-23, presumably until 2009-12-03\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2009-11-25, presumably until 2009-11-25\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-11-22, presumably until 2009-11-23\n- cetylpyridinium, through Submucosal route, started on 2009-11-20, presumably until 2009-11-21\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2009-11-24, presumably until 2009-11-24\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2009-12-01, presumably until 2009-12-02\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2009-11-19\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-11-24, presumably until 2009-11-25\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-11-21, presumably until 2009-12-01\n- temazepam 15 MG Oral Capsule, through Oral route, started on 2009-11-18, presumably until 2009-11-21\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2009-11-26, presumably until 2009-11-26\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-02\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2009-11-24, presumably until 2009-12-01\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-23\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2009-11-24, presumably until 2009-12-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-11-18, presumably until 2009-11-24\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2009-11-30, presumably until 2009-12-02\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-30\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2009-11-19, presumably until 2009-11-19\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-11-21, presumably until 2009-12-02\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2009-11-23, presumably until 2009-11-23\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2009-11-21, presumably until 2009-11-21\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2009-11-19, presumably until 2009-11-23\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2009-11-21, presumably until 2009-11-21\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-11-25, presumably until 2009-11-30\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-11-19, presumably until 2009-11-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2009-11-22, presumably until 2009-11-25\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2009-11-24, presumably until 2009-12-01\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2009-11-30, presumably until 2009-12-03\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-02\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2009-11-30, presumably until 2009-12-01\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2009-11-23, presumably until 2009-11-23\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2009-11-24, presumably until 2009-12-01\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2009-11-25, presumably until 2009-12-02\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2009-11-24, presumably until 2009-12-01\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-01, presumably until 2009-12-01\n- midazolam 1 MG/ML Injectable Solution, started on 2009-11-23, presumably until 2009-11-23\n- methylprednisolone 125 MG Injection, started on 2009-11-23, presumably until 2009-11-23\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2009-11-19, presumably until 2009-11-19\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-21, presumably until 2009-11-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 17:00:00, ended at 2009-11-18 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Mitral valve disorder\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-23 16:00:00, ended at 2009-11-23 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-11-25 10:30:00, ended at 2009-11-25 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-30 07:00:00, ended at 2009-11-30 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-02 00:00:00, ended at 2009-12-02 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-07 09:09:01, ended at 2009-12-07 11:09:55\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.1 (nanogram per milliliter)\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2014-01-01. Instructions: take 40 mg by mouth daily. \n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, presumably until 2009-12-17. Instructions: take 10 mg by mouth daily. \n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2009-12-21. Instructions: take 20 mg by mouth 2 times a day. \n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2009-12-17. Instructions: take 1 mg by mouth 2 times a day. \n- prednisone 10 MG Oral Tablet, through Oral route, presumably until 2009-12-17. Instructions: take 15 mg by mouth 2 times a day. \n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, presumably until 2009-12-21. Instructions: take by mouth. \n- temazepam 30 MG Oral Capsule, through Oral route, presumably until 2010-11-15. Instructions: take 0.5 Tabs by mouth every bedtime as needed. \n- clotrimazole 10 MG Oral Lozenge, through Oral route, presumably until 2011-05-23. Instructions: take 10 mg by mouth 3 times a day. \n- aspirin 81 MG Oral Tablet, through Oral route. Instructions: Take 1 tablet (81 mg total) by mouth daily\n- glipizide 5 MG Oral Tablet, through Oral route, presumably until 2009-12-17. Instructions: take 5 mg by mouth daily. \n- pravastatin sodium 20 MG Oral Tablet, through Oral route, presumably until 2015-04-13. Instructions: take 60 mg by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule, through Oral route, started on 2009-12-07, presumably until 2009-12-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Olivas by mouth every morning. \n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, presumably until 2010-02-18. Instructions: take 1 Tab by mouth daily. \n- 1 ML epoetin alfa 40000 UNT/ML Injection, through Subcutaneous route, presumably until 2009-12-31. Instructions: 60000 Units by SUBCUTANEOUS route every 7 days. \n- itraconazole 10 MG/ML Oral Solution, through Oral route, presumably until 2010-03-22. Instructions: take 200 mg by mouth every morning. \n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route. Instructions: Take 1 tablet by mouth 2 times a day with meals\n- valganciclovir 450 MG Oral Tablet, through Oral route, presumably until 2009-12-17. Instructions: take 900 mg by mouth 2 times a day. \n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2014-01-01. Instructions: take 500 mg by mouth 2 times a day.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2010-01-21. Instructions: take 1 Tab by mouth every 4 hours as needed \n- ferrous sulfate 325 MG Oral Tablet, through Oral route, presumably until 2010-03-22. Instructions: take 1 Tab by mouth 3 times a day. \n- lactulose 20000 MG Powder for Oral Solution, through Oral route, presumably until 2009-12-17. Instructions: take 20 g by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-07 11:10:00, ended at 2009-12-07 13:28:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-07 13:29:00, ended at 2009-12-07 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Endomyocardial biopsy\n\n### Condition\n- Pleural effusion\n- Cardiomegaly\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-09 00:00:00, ended at 2009-12-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-09 08:58:00, ended at 2009-12-09 11:08:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.51 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 260 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.43 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- daclizumab 5 MG/ML Injectable Solution, through Intravenous route, started on 2009-12-09, presumably until 2009-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-09 11:09:00, ended at 2009-12-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-14 00:00:00, ended at 2009-12-14 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 09:13:00, ended at 2009-12-14 10:39:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.86 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-14 09:38:47, ended at 2009-12-14 11:28:47\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 10:40:00, ended at 2009-12-14 12:40:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 13:17:00, ended at 2009-12-14 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Effect of exposure to physical force\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-17 08:35:00, ended at 2009-12-17 09:09:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 14.0 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-17 09:10:00, ended at 2009-12-17 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-17 09:30:05, ended at 2009-12-17 11:51:14\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-12-17, presumably until 2009-12-21, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1-2 mg by mouth 2 times a day. \n- prednisone 10 MG Oral Tablet, through Oral route, started on 2009-12-17, presumably until 2010-02-18, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2009-12-17, presumably until 2010-03-22, with quantity of 60.0, with intended 11 refill(s). Instructions: take 900 mg by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-21 09:19:59, ended at 2009-12-21 12:25:14\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-21 10:08:17, ended at 2009-12-21 12:04:24\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-12-21, presumably until 2010-02-18, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-21 12:23:31, ended at 2009-12-21 17:17:16\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-21 14:40:00, ended at 2009-12-21 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Endomyocardial biopsy\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-22 14:30:00, ended at 2009-12-22 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- methylprednisolone 500 MG Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-23 00:00:00, ended at 2009-12-23 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-23 08:30:00, ended at 2009-12-23 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- methylprednisolone 500 MG Injection, through Intravenous route, started on 2009-12-23, presumably until 2009-12-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 08:00:00, ended at 2009-12-24 11:01:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 26.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n- MCV [Entitic volume] by Automated count: 102.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.49 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- methylprednisolone 500 MG Injection, through Intravenous route, started on 2009-12-24, presumably until 2009-12-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-24 09:26:59, ended at 2009-12-24 10:44:21\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 11:02:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Lung field abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-29 00:00:00, ended at 2009-12-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-29 08:30:00, ended at 2009-12-29 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-30 00:00:00, ended at 2009-12-30 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Muscle atrophy\n- Transplanted heart present\n- Incoordination\n- Muscle weakness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-31 08:29:00, ended at 2009-12-31 08:42:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 251 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 26.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.41 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- MCV [Entitic volume] by Automated count: 103.5 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 13.7 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-31 09:01:46, ended at 2009-12-31 10:06:59\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Effect of exposure to physical force\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-31 10:12:00, ended at 2009-12-31 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 05:53:00, ended at 2010-01-04 16:05:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 8 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.9 (gram per deciliter)\n- Body height: 5' 5.748\" (inch (US))\n- Potassium [Moles/volume] in Blood: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n\n### Procedure\n- Coronary arteriography using two catheters\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n- Biopsy of heart\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Catheter placement in coronary artery(s), arterial coronary conduit(s), and/or venous coronary bypass graft(s) for coronary angiography without concomitant left heart catheterization\n- Endomyocardial biopsy\n- Catheterization of right heart\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2010-01-21. Instructions: take by mouth daily. \n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-01-04\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-01-04\n- acetylcysteine 200 MG/ML Inhalation Solution, through Inhalation, presumably until 2010-01-14. Instructions: 3 mL by Inhalation route every 4 hours. One dose on 01/03/2010 and one on1/25/10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-01-04, presumably until 2010-01-04\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-04\n- 24 HR glipizide 2.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-01-14. Instructions: take 2.5 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-07 08:37:00, ended at 2010-01-07 09:15:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.24 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 104.7 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.62 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-07 09:16:00, ended at 2010-01-07 11:17:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-07 09:48:43, ended at 2010-01-07 11:11:02\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-07 11:18:00, ended at 2010-01-07 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-14 08:00:00, ended at 2010-01-14 08:29:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-14 08:30:00, ended at 2010-01-14 08:52:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.23 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.42 (micro-international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.5 (percent)\n- Tacrolimus [Mass/volume] in Blood: 11.3 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-14 08:53:00, ended at 2010-01-14 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-14 09:12:15, ended at 2010-01-14 10:27:32\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- 24 HR glipizide 2.5 MG Extended Release Oral Tablet, through Oral route, started on 2010-01-14, presumably until 2010-01-21. Instructions: take 1 Tab by mouth daily. On hold for episodes of hypoglycemia \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-21 08:23:00, ended at 2010-01-21 08:54:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 104.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 369 (picogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.67 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.75 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 226 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.4 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-21 08:55:00, ended at 2010-01-21 14:32:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-21 09:13:50, ended at 2010-01-21 09:59:03\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-01-21, presumably until 2010-11-15. Instructions: take by mouth daily as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-21 14:33:00, ended at 2010-01-21 17:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-22 08:06:00, ended at 2010-01-22 08:49:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-01-25 09:01:26, ended at 2010-01-25 12:20:42\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-01-25 09:53:00, ended at 2010-01-26 12:15:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Prothrombin time (PT): 14.6 (second)\n- Tacrolimus [Mass/volume] in Blood: 10.8 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.38 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.8 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Fever\n- Nausea and vomiting\n- Secondary diabetes mellitus\n- Infectious diarrheal disease\n- Headache\n- Transplanted heart present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-01-26\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-01-26\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2010-01-25, presumably until 2010-01-25\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-02-18, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2010-01-25, presumably until 2010-01-26\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-01-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-01-25, presumably until 2010-01-25\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-11-15. Instructions: take 1 Tab by mouth daily. \n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2010-01-25, presumably until 2010-01-26\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-01-26\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2010-01-26, presumably until 2010-01-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-04 08:31:21, ended at 2010-02-04 12:58:30\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-04 09:17:40, ended at 2010-02-04 11:10:37\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 11:22:00, ended at 2010-02-04 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Fever\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-18 08:45:35, ended at 2010-02-18 13:03:28\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-18 09:08:35, ended at 2010-02-18 10:10:49\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- magnesium oxide 500 MG Oral Capsule, through Oral route, started on 2010-02-18, presumably until 2015-07-27. Instructions: take 500 mg by mouth Every Day. \n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-02-18, presumably until 2011-05-23, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 mg by mouth 2 times a day.   Take 2 mg in AM and 1.5 mg in PM\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-02-18, presumably until 2011-03-08, with quantity of 10.0, with intended 0 refill(s). Instructions: take 2 mg by mouth 2 times a day. 2mg in AM , 2mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-18 10:20:00, ended at 2010-02-18 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Biopsy of heart\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-22 08:32:28, ended at 2010-03-22 17:09:27\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-22 08:40:40, ended at 2010-03-22 08:58:43\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-22 09:04:49, ended at 2010-03-22 09:50:10\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2010-03-22, presumably until 2010-11-15, with quantity of 30.0, with intended 11 refill(s). Instructions: take 450 mg by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-22 10:03:00, ended at 2010-03-22 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-26 08:09:22, ended at 2010-04-26 17:09:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Imaging of thorax abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-26 09:52:32, ended at 2010-04-26 12:08:27\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-26 12:21:00, ended at 2010-04-26 13:08:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-24 08:35:44, ended at 2010-05-24 17:07:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-24 08:50:37, ended at 2010-05-24 11:12:49\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-24 09:16:13, ended at 2010-05-24 10:16:04\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-24 10:25:00, ended at 2010-05-24 11:19:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-19 09:20:18, ended at 2010-07-19 13:20:22\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-19 11:11:56, ended at 2010-07-19 11:44:04\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-19 11:22:44, ended at 2010-07-19 17:16:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-19 11:42:00, ended at 2010-07-19 14:58:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-04 00:00:00, ended at 2010-08-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-16 08:27:56, ended at 2010-09-16 13:14:06\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-16 09:12:45, ended at 2010-09-16 13:11:57\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-16 10:32:59, ended at 2010-09-16 17:05:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-16 11:11:00, ended at 2010-09-16 13:50:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-15 00:00:00, ended at 2010-11-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-15 07:55:00, ended at 2010-11-15 16:50:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 116 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 55 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- Body height: 5' 5.354\" (inch (US))\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 179 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.63 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n\n### Procedure\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Catheter placement in coronary artery(s), arterial coronary conduit(s), and/or venous coronary bypass graft(s) for coronary angiography without concomitant left heart catheterization\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n- Endomyocardial biopsy\n- Coronary arteriography using two catheters\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Catheterization of right heart\n- Biopsy of heart\n- Intravascular pressure measurement of coronary arteries\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Collection of venous blood by venipuncture\n- Intravascular imaging of coronary vessels\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, presumably until 2013-01-30. Instructions: take 1500 mg by mouth daily. 10 ml \n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2012-09-24. Instructions: take 5 mg by mouth daily.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-11-15, presumably until 2010-11-15\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n- temazepam 7.5 MG Oral Capsule, through Oral route, presumably until 2014-01-01. Instructions: take 7.5 mg by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-16 10:51:00, ended at 2010-11-16 11:49:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-16 11:50:00, ended at 2010-11-16 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-16 12:15:29, ended at 2010-11-16 13:34:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-04 00:00:00, ended at 2011-03-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-07 08:00:00, ended at 2011-03-07 08:51:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-03-07 08:03:31, ended at 2011-03-07 17:18:43\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Imaging of thorax abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-07 08:52:00, ended at 2011-03-07 10:50:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-03-07 08:53:12, ended at 2011-03-07 09:43:10\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Effect of exposure to physical force\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-20 00:00:00, ended at 2011-05-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-23 08:00:00, ended at 2011-05-23 10:08:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-23 08:38:53, ended at 2011-05-23 20:47:26\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-23 09:04:16, ended at 2011-05-23 10:01:55\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-05-23, presumably until 2011-09-12, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day.   Take 2 mg in AM and 1.5 mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-23 10:09:00, ended at 2011-05-23 11:11:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.99 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.89 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.5 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n\n### Procedure\n- Biopsy of heart\n- Endomyocardial biopsy\n- Long-term drug therapy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-09 00:00:00, ended at 2011-09-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-12 07:30:00, ended at 2011-09-12 07:35:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-12 07:36:00, ended at 2011-09-12 07:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.9 (percent)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-12 08:00:00, ended at 2011-09-12 09:41:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-12 09:42:00, ended at 2011-09-12 11:14:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-11-07 00:00:00, ended at 2011-11-07 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2011-11-07, presumably until 2012-01-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-12-13 00:00:00, ended at 2011-12-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-13 09:29:00, ended at 2011-12-13 10:35:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 3.2 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.14 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n\n### Procedure\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-13 09:53:29, ended at 2011-12-13 14:25:31\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Congestive heart failure\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-13 13:00:00, ended at 2011-12-13 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-18 08:53:00, ended at 2012-01-18 09:37:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.5 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.6 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 7.1 (micromole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 195 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 183 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 40.7 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.05 (thousand per microliter)\n- Prothrombin time (PT): 12.9 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.0 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-18 09:38:00, ended at 2012-01-18 09:51:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-18 10:35:00, ended at 2012-01-18 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-19 06:00:00, ended at 2012-01-19 14:06:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.748\" (inch (US))\n\n### Procedure\n- Biopsy of heart\n- Collection of venous blood by venipuncture\n- Coronary arteriography using two catheters\n- Intravascular imaging of coronary vessels\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Endomyocardial biopsy\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Catheterization of right heart\n- Arteriography of femoral and other lower extremity arteries\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Hypertrophic cardiomyopathy\n- Congestive heart failure\n- Essential hypertension\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2012-01-19, presumably until 2012-01-19\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2012-01-19, presumably until 2012-01-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-01-19, presumably until 2012-01-19\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2012-01-19, presumably until 2012-01-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-18 00:00:00, ended at 2012-05-18 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-21 07:49:00, ended at 2012-05-21 10:25:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-21 09:33:00, ended at 2012-05-21 10:06:22\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Essential hypertension\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-21 10:26:00, ended at 2012-05-21 11:33:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 55 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 11.7 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.34 (thousand per microliter)\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Imaging of thorax abnormal\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-09-21 00:00:00, ended at 2012-09-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-24 07:42:00, ended at 2012-09-24 07:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.11 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 50 (milliliter per minute per square meter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 176 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 17.1 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n\n### Procedure\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-24 08:00:00, ended at 2012-09-24 08:51:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-24 08:52:00, ended at 2012-09-24 10:06:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-24 10:07:00, ended at 2012-09-24 11:16:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-09-28 00:00:00, ended at 2012-09-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-01 00:00:00, ended at 2012-10-01 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-29 08:28:00, ended at 2013-01-29 09:40:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 79 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.2 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 6.8 (micromole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.54 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 17.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Prothrombin time (PT): 13.4 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 69.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "dc71f81f6f70e3cfd6e7855512453c7d4ddc4730acce4713659e0b3667423155", "prompt_hash": "65a19e4643fd4e41d5cbf28f9a216d0b80bbdbec3abe71283f7296ad7bd7a71e", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 8, "doc": {"person_id": 115970369, "visit_occurrence_id": 46538202, "visit_start_datetime": "2012-01-23 08:53:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 134.0, "current_label": 1, "next_value": 103.0, "next_label": 0, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-01 12:24:00, ended at 2009-11-01 15:09:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.16 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 233 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.47 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Graft complications\n- Mechanical complication of device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-01 15:10:00, ended at 2009-11-01 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted bone marrow\n- Mechanical complication of device\n- Chronic graft-versus-host disease\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-04-17 00:00:00, ended at 2010-04-17 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic myeloid leukemia\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2010-04-17, presumably until 2010-05-25, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-25 11:23:00, ended at 2010-05-25 13:17:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.76 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 299 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n\n### Procedure\n- Molecular diagnostics; reverse transcription\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; nucleic acid probe, each\n\n### Condition\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-25 13:18:00, ended at 2010-05-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic myeloid leukemia\n- Disorder affecting transplanted structure\n- Graft complications\n- Mechanical complication of device\n- Acute graft-versus-host disease\n- Disorder of transplanted bone marrow\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Tablet, through Oral route, presumably until 2010-06-08. Instructions: take by mouth Every Day. Unknown dose- prn lower extremity swelling- approx. Every 3 days \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-06-06 00:00:00, ended at 2010-06-06 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-08 11:35:00, ended at 2010-06-08 14:50:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 4.7 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.96 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 7.50 (micro-international unit per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 6.3 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 233 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 1344 (nanogram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 317 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Proteinuria\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-08 13:48:04, ended at 2010-06-08 14:45:38\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Hematuria syndrome\n\n### Drug\n- triamterene 50 MG Oral Capsule, through Oral route, presumably until 2010-06-08. Instructions: take 50 mg by mouth 2 times a day. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-06-08, presumably until 2010-06-20, with quantity of 30.0, with intended 3 refill(s). Instructions: take 10 mg by mouth 2 times a day. \n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2010-06-08, presumably until 2010-06-20, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-06-08. Instructions: take 25 mg by mouth 3 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-08 14:51:00, ended at 2010-06-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 37.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma by Electrophoresis: 3.1 (gram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-08 14:51:00, ended at 2010-06-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Complement C3 [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Hematuria syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-14 11:31:00, ended at 2010-06-14 14:16:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Prothrombin time (PT): 12.7 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.4 (second)\n- Body height: 5' 7.323\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-06-14, presumably until 2010-06-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-06-19 00:00:00, ended at 2010-06-19 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Coag./bleeding tests abnormal\n- Hematuria syndrome\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-06-20 00:00:00, ended at 2010-06-20 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hematuria syndrome\n- Essential hypertension\n- Proteinuria\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-06-20, presumably until 2010-07-11, with quantity of 60.0, with intended 3 refill(s). Instructions: take 20 mg by mouth 2 times a day. \n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2010-06-20, presumably until 2011-02-01, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-20 08:59:00, ended at 2010-06-20 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Coag./bleeding tests abnormal\n- Proteinuria\n- Hematuria syndrome\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-06-21 00:00:00, ended at 2010-06-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-25 10:58:00, ended at 2010-06-25 13:02:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Prothrombin time (PT): 13.0 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.6 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-25 13:03:00, ended at 2010-06-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-06-26 00:00:00, ended at 2010-06-26 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hematuria syndrome\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 10:47:00, ended at 2010-07-06 14:45:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.76 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Body height: 5' 8.11\" (inch (US))\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Closed [percutaneous] [needle] biopsy of kidney\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Collection of venous blood by venipuncture\n- Renal biopsy; percutaneous, by trocar or needle\n- Ultrasonography of urinary system\n\n### Condition\n- Hematuria syndrome\n- Essential hypertension\n- Proteinuria\n- Kidney disease\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-07-05, presumably until 2010-07-06\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-07-05, presumably until 2010-07-05\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-07-05, presumably until 2010-07-05\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2010-07-05, presumably until 2010-07-05\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-07-05, presumably until 2010-07-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-07-05, presumably until 2010-07-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-07-05, presumably until 2010-07-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-07-11 00:00:00, ended at 2010-07-11 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Proteinuria\n- Hematuria syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-11 14:40:36, ended at 2010-07-11 15:10:22\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Essential hypertension\n- Hematuria syndrome\n- Primary diagnosis: Disorder affecting transplanted structure\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2010-07-11, presumably until 2010-09-05, with quantity of 60.0, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-11 15:15:00, ended at 2010-07-11 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.91 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.99 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 425 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.76 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 124 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Proteinuria\n- Graft complications\n- Mechanical complication of device\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-07-13 00:00:00, ended at 2010-07-13 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Hematuria syndrome\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2010-07-13, presumably until 2010-10-05, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth One Time. \n- prednisone 20 MG Oral Tablet, through Oral route, started on 2010-07-13, presumably until 2010-10-05, with quantity of 150.0, with intended 1 refill(s). Instructions: take 3 Tabs by mouth daily. \n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2010-07-13, presumably until 2010-10-05, with quantity of 150.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. Start with 1 tab by mouth 2 times a day.  If no side effects after 2 weeks, increase to 2 tabs by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-18 14:20:00, ended at 2010-07-18 15:55:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.61 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 381 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.97 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-18 15:56:00, ended at 2010-07-18 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic myeloid leukemia\n- Acute graft-versus-host disease\n- Graft complications\n- Disorder of transplanted bone marrow\n- Mechanical complication of device\n\n### Drug\n- testosterone enanthate 200 MG/ML Injectable Solution, through Intramuscular route, presumably until 2011-06-07. Instructions: by Intramuscular route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-09 17:41:00, ended at 2010-08-09 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-08-15 13:04:19, ended at 2010-08-15 13:42:52\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-15 13:52:00, ended at 2010-08-15 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-22 00:00:00, ended at 2010-08-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-05 11:22:00, ended at 2010-09-05 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-05 12:47:06, ended at 2010-09-05 13:46:29\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hematuria syndrome\n- Proteinuria\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2010-09-05, presumably until 2010-12-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. Take 40 mg daily x 2 weeks, then 30 mg daily x 2 weeks, then 20 mg daily  2 weeks, then 10 mg daily until further notice. \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2010-09-05, presumably until 2010-10-05, with quantity of 60.0, with intended 3 refill(s). Instructions: take 20 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-06 00:00:00, ended at 2010-09-06 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- dapsone 100 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-12-05, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-19, with quantity of 60.0, with intended 0 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-19 00:00:00, ended at 2010-09-19 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-09-19, presumably until 2010-11-01, with quantity of 180.0, with intended 3 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-10-05 00:00:00, ended at 2010-10-05 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-05 09:38:00, ended at 2010-10-05 10:07:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.70 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCV [Entitic volume] by Automated count: 101.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.22 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-05 10:08:00, ended at 2010-10-05 10:45:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Graft complications\n- Mechanical complication of device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-05 10:46:00, ended at 2010-10-05 10:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 306 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.3 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.26 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 285 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 221 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 5.4 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 347 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 3.4 (ratio)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.72 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-05 11:00:00, ended at 2010-10-05 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Mechanical complication of device\n- Proteinuria\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-05 13:18:47, ended at 2010-10-05 14:22:16\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Kidney disease\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-02-01, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-01 00:00:00, ended at 2010-11-01 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-11-01, presumably until 2011-02-01, with quantity of 180.0, with intended 3 refill(s). Instructions: take 3 mg by mouth as directed.   Take 3 mg every morning, 4 mg every evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-01 09:46:00, ended at 2010-11-01 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 5.90 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 108.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.8 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.80 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-21 11:24:00, ended at 2010-11-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.9 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.53 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 3.7 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.74 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 14.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.6 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-21 13:44:00, ended at 2010-11-21 14:11:44\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney disease\n- Leukocytosis\n- Essential hypertension\n- Proteinuria\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-11-21, presumably until 2011-02-08, with quantity of 30.0, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily. Start 12/03/2024 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-12-05 00:00:00, ended at 2010-12-05 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney disease\n\n### Drug\n- dapsone 100 MG Oral Tablet, through Oral route, started on 2010-12-05, presumably until 2011-02-01, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-07 12:04:00, ended at 2010-12-07 13:35:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- MCV [Entitic volume] by Automated count: 103.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 10.3 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukocytosis\n- Proteinuria\n- Hyperlipidemia\n- Kidney disease\n- Disorder affecting transplanted structure\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-07 13:36:00, ended at 2010-12-07 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Disorder affecting transplanted structure\n- Essential hypertension\n- Kidney disease\n- Hyperlipidemia\n\n### Drug\n- penicillin V potassium 500 MG Oral Tablet, through Oral route, started on 2010-12-07, presumably until 2011-12-07, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-03 10:45:00, ended at 2011-01-03 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- MCV [Entitic volume] by Automated count: 107.6 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.2 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.35 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Kidney disease\n- Hyperlipidemia\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-03 13:46:52, ended at 2011-01-03 18:31:29\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney disease\n- Essential hypertension\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-02-01 00:00:00, ended at 2011-02-01 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Hematuria syndrome\n- Hyperlipidemia\n- Disorder affecting transplanted structure\n- Essential hypertension\n- Kidney disease\n\n### Drug\n- dapsone 100 MG Oral Tablet, through Oral route, started on 2011-02-01, presumably until 2012-02-01, with quantity of 90.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-02-01, presumably until 2012-02-01, with quantity of 630.0, with intended 3 refill(s). Instructions: take 3 mg by mouth as directed.     Take 3 mg every morning, 4 mg every evening.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2011-02-01, presumably until 2012-02-01, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2011-02-01, presumably until 2012-02-01, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 09:43:00, ended at 2011-02-08 10:39:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.6 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.01 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.31 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Kidney disease\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 10:40:00, ended at 2011-02-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic graft-versus-host disease\n- Disorder affecting transplanted structure\n- Essential hypertension\n- Kidney disease\n- Hyperlipidemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-01-29, presumably until 2011-02-19. Instructions: take 5 mg by mouth every other day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-12 15:00:10, ended at 2011-02-12 16:35:02\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tear film insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-21 09:03:00, ended at 2011-02-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Disorder of bone and articular cartilage\n- Transplant present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-08 15:01:00, ended at 2011-03-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.09 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.91 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Essential hypertension\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-03-08 16:07:11, ended at 2011-03-08 16:29:15\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Kidney disease\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2011-03-08, presumably until 2012-03-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-07 09:53:00, ended at 2011-06-07 14:21:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 148 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.2 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.07 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 270 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.2 (percent)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Kidney disease\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-07 14:22:00, ended at 2011-06-07 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Chronic graft-versus-host disease\n- Chronic myeloid leukemia\n- Hyperlipidemia\n- Kidney disease\n- Disorder of transplanted bone marrow\n- Essential hypertension\n\n### Drug\n- 5000 MG testosterone 0.01 MG/MG Topical Gel, through Transdermal route, started on 2011-06-07, presumably until 2011-09-13, with intended 6 refill(s). Instructions: apply 50 mg to skin Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-06-11 00:00:00, ended at 2011-06-11 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Kidney disease\n\n### Drug\n- sirolimus 2 MG Oral Tablet, through Oral route, started on 2011-06-11, presumably until 2012-04-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 10:43:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.40 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.66 (million per microliter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.28 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Essential hypertension\n- Kidney disease\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 08:41:00, ended at 2011-09-13 09:40:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.56 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 289 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.84 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Kidney disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 09:41:00, ended at 2011-09-13 11:10:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted bone marrow\n- Chronic graft-versus-host disease\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- 5000 MG testosterone 0.01 MG/MG Topical Gel, through Transdermal route, started on 2011-09-13, presumably until 2012-05-22, with intended 6 refill(s). Instructions: apply 50 Each to skin Every Day. 50 mg daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 11:11:00, ended at 2011-09-13 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic graft-versus-host disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-25 00:00:00, ended at 2011-09-25 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-10 09:44:05, ended at 2011-10-10 17:59:42\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic graft-versus-host disease\n- Dental caries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-31 14:40:00, ended at 2011-10-31 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 1.6 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.98 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.30 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-07 11:49:17, ended at 2011-11-07 12:40:06\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dental caries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-23 08:53:00, ended at 2012-01-23 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 134 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 40 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 37 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.6 (ratio)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 4.2 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Kidney disease\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Chronic graft-versus-host disease\n- Hematuria syndrome\n- Essential hypertension\n- Proteinuria\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 68, "cumulated_approximate_token_count": 22631}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-01 12:24:00, ended at 2009-11-01 15:09:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.16 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 233 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.47 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Graft complications\n- Mechanical complication of device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-01 15:10:00, ended at 2009-11-01 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted bone marrow\n- Mechanical complication of device\n- Chronic graft-versus-host disease\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-04-17 00:00:00, ended at 2010-04-17 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic myeloid leukemia\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2010-04-17, presumably until 2010-05-25, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-25 11:23:00, ended at 2010-05-25 13:17:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.76 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 299 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n\n### Procedure\n- Molecular diagnostics; reverse transcription\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; nucleic acid probe, each\n\n### Condition\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-25 13:18:00, ended at 2010-05-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic myeloid leukemia\n- Disorder affecting transplanted structure\n- Graft complications\n- Mechanical complication of device\n- Acute graft-versus-host disease\n- Disorder of transplanted bone marrow\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Tablet, through Oral route, presumably until 2010-06-08. Instructions: take by mouth Every Day. Unknown dose- prn lower extremity swelling- approx. Every 3 days \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-06-06 00:00:00, ended at 2010-06-06 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-08 11:35:00, ended at 2010-06-08 14:50:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 4.7 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.96 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 7.50 (micro-international unit per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 6.3 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 233 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 1344 (nanogram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 317 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Proteinuria\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-08 13:48:04, ended at 2010-06-08 14:45:38\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Hematuria syndrome\n\n### Drug\n- triamterene 50 MG Oral Capsule, through Oral route, presumably until 2010-06-08. Instructions: take 50 mg by mouth 2 times a day. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-06-08, presumably until 2010-06-20, with quantity of 30.0, with intended 3 refill(s). Instructions: take 10 mg by mouth 2 times a day. \n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2010-06-08, presumably until 2010-06-20, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-06-08. Instructions: take 25 mg by mouth 3 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-08 14:51:00, ended at 2010-06-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 37.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma by Electrophoresis: 3.1 (gram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-08 14:51:00, ended at 2010-06-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Complement C3 [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Hematuria syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-14 11:31:00, ended at 2010-06-14 14:16:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Prothrombin time (PT): 12.7 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.4 (second)\n- Body height: 5' 7.323\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-06-14, presumably until 2010-06-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-06-19 00:00:00, ended at 2010-06-19 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Coag./bleeding tests abnormal\n- Hematuria syndrome\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-06-20 00:00:00, ended at 2010-06-20 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hematuria syndrome\n- Essential hypertension\n- Proteinuria\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-06-20, presumably until 2010-07-11, with quantity of 60.0, with intended 3 refill(s). Instructions: take 20 mg by mouth 2 times a day. \n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2010-06-20, presumably until 2011-02-01, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-20 08:59:00, ended at 2010-06-20 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Coag./bleeding tests abnormal\n- Proteinuria\n- Hematuria syndrome\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-06-21 00:00:00, ended at 2010-06-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-25 10:58:00, ended at 2010-06-25 13:02:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Prothrombin time (PT): 13.0 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.6 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-25 13:03:00, ended at 2010-06-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-06-26 00:00:00, ended at 2010-06-26 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hematuria syndrome\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 10:47:00, ended at 2010-07-06 14:45:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.76 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Body height: 5' 8.11\" (inch (US))\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Closed [percutaneous] [needle] biopsy of kidney\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Collection of venous blood by venipuncture\n- Renal biopsy; percutaneous, by trocar or needle\n- Ultrasonography of urinary system\n\n### Condition\n- Hematuria syndrome\n- Essential hypertension\n- Proteinuria\n- Kidney disease\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-07-05, presumably until 2010-07-06\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-07-05, presumably until 2010-07-05\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-07-05, presumably until 2010-07-05\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2010-07-05, presumably until 2010-07-05\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-07-05, presumably until 2010-07-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-07-05, presumably until 2010-07-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-07-05, presumably until 2010-07-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-07-11 00:00:00, ended at 2010-07-11 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Proteinuria\n- Hematuria syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-11 14:40:36, ended at 2010-07-11 15:10:22\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Essential hypertension\n- Hematuria syndrome\n- Primary diagnosis: Disorder affecting transplanted structure\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2010-07-11, presumably until 2010-09-05, with quantity of 60.0, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-11 15:15:00, ended at 2010-07-11 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.91 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.99 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 425 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.76 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 124 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Proteinuria\n- Graft complications\n- Mechanical complication of device\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-07-13 00:00:00, ended at 2010-07-13 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Hematuria syndrome\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2010-07-13, presumably until 2010-10-05, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth One Time. \n- prednisone 20 MG Oral Tablet, through Oral route, started on 2010-07-13, presumably until 2010-10-05, with quantity of 150.0, with intended 1 refill(s). Instructions: take 3 Tabs by mouth daily. \n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2010-07-13, presumably until 2010-10-05, with quantity of 150.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. Start with 1 tab by mouth 2 times a day.  If no side effects after 2 weeks, increase to 2 tabs by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-18 14:20:00, ended at 2010-07-18 15:55:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.61 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 381 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.97 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-18 15:56:00, ended at 2010-07-18 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic myeloid leukemia\n- Acute graft-versus-host disease\n- Graft complications\n- Disorder of transplanted bone marrow\n- Mechanical complication of device\n\n### Drug\n- testosterone enanthate 200 MG/ML Injectable Solution, through Intramuscular route, presumably until 2011-06-07. Instructions: by Intramuscular route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-09 17:41:00, ended at 2010-08-09 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-08-15 13:04:19, ended at 2010-08-15 13:42:52\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-15 13:52:00, ended at 2010-08-15 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-22 00:00:00, ended at 2010-08-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-05 11:22:00, ended at 2010-09-05 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-05 12:47:06, ended at 2010-09-05 13:46:29\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hematuria syndrome\n- Proteinuria\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2010-09-05, presumably until 2010-12-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. Take 40 mg daily x 2 weeks, then 30 mg daily x 2 weeks, then 20 mg daily  2 weeks, then 10 mg daily until further notice. \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2010-09-05, presumably until 2010-10-05, with quantity of 60.0, with intended 3 refill(s). Instructions: take 20 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-06 00:00:00, ended at 2010-09-06 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- dapsone 100 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-12-05, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-19, with quantity of 60.0, with intended 0 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-19 00:00:00, ended at 2010-09-19 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-09-19, presumably until 2010-11-01, with quantity of 180.0, with intended 3 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-10-05 00:00:00, ended at 2010-10-05 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-05 09:38:00, ended at 2010-10-05 10:07:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.70 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCV [Entitic volume] by Automated count: 101.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.22 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Mechanical complication of device\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-05 10:08:00, ended at 2010-10-05 10:45:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Graft complications\n- Mechanical complication of device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-05 10:46:00, ended at 2010-10-05 10:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 306 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.3 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.26 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 285 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 221 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 5.4 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 347 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 3.4 (ratio)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.72 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-05 11:00:00, ended at 2010-10-05 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Mechanical complication of device\n- Proteinuria\n- Graft complications\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-05 13:18:47, ended at 2010-10-05 14:22:16\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Kidney disease\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-02-01, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-01 00:00:00, ended at 2010-11-01 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney disease\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-11-01, presumably until 2011-02-01, with quantity of 180.0, with intended 3 refill(s). Instructions: take 3 mg by mouth as directed.   Take 3 mg every morning, 4 mg every evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-01 09:46:00, ended at 2010-11-01 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 5.90 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 108.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.8 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.80 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-21 11:24:00, ended at 2010-11-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.9 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.53 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 3.7 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.74 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 14.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.6 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-21 13:44:00, ended at 2010-11-21 14:11:44\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney disease\n- Leukocytosis\n- Essential hypertension\n- Proteinuria\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-11-21, presumably until 2011-02-08, with quantity of 30.0, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily. Start 12/03/2024 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-12-05 00:00:00, ended at 2010-12-05 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney disease\n\n### Drug\n- dapsone 100 MG Oral Tablet, through Oral route, started on 2010-12-05, presumably until 2011-02-01, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-07 12:04:00, ended at 2010-12-07 13:35:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- MCV [Entitic volume] by Automated count: 103.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 10.3 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukocytosis\n- Proteinuria\n- Hyperlipidemia\n- Kidney disease\n- Disorder affecting transplanted structure\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-07 13:36:00, ended at 2010-12-07 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Disorder affecting transplanted structure\n- Essential hypertension\n- Kidney disease\n- Hyperlipidemia\n\n### Drug\n- penicillin V potassium 500 MG Oral Tablet, through Oral route, started on 2010-12-07, presumably until 2011-12-07, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-03 10:45:00, ended at 2011-01-03 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- MCV [Entitic volume] by Automated count: 107.6 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.2 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.35 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Kidney disease\n- Hyperlipidemia\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-03 13:46:52, ended at 2011-01-03 18:31:29\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney disease\n- Essential hypertension\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-02-01 00:00:00, ended at 2011-02-01 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Hematuria syndrome\n- Hyperlipidemia\n- Disorder affecting transplanted structure\n- Essential hypertension\n- Kidney disease\n\n### Drug\n- dapsone 100 MG Oral Tablet, through Oral route, started on 2011-02-01, presumably until 2012-02-01, with quantity of 90.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-02-01, presumably until 2012-02-01, with quantity of 630.0, with intended 3 refill(s). Instructions: take 3 mg by mouth as directed.     Take 3 mg every morning, 4 mg every evening.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2011-02-01, presumably until 2012-02-01, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2011-02-01, presumably until 2012-02-01, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 09:43:00, ended at 2011-02-08 10:39:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.6 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.01 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.31 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Kidney disease\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 10:40:00, ended at 2011-02-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic graft-versus-host disease\n- Disorder affecting transplanted structure\n- Essential hypertension\n- Kidney disease\n- Hyperlipidemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-01-29, presumably until 2011-02-19. Instructions: take 5 mg by mouth every other day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-12 15:00:10, ended at 2011-02-12 16:35:02\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tear film insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-21 09:03:00, ended at 2011-02-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Disorder of bone and articular cartilage\n- Transplant present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-08 15:01:00, ended at 2011-03-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.09 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.91 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Essential hypertension\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-03-08 16:07:11, ended at 2011-03-08 16:29:15\nThe patient in this visit was 56 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Kidney disease\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2011-03-08, presumably until 2012-03-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-07 09:53:00, ended at 2011-06-07 14:21:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 148 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.2 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.07 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 270 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.2 (percent)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Kidney disease\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-07 14:22:00, ended at 2011-06-07 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Chronic graft-versus-host disease\n- Chronic myeloid leukemia\n- Hyperlipidemia\n- Kidney disease\n- Disorder of transplanted bone marrow\n- Essential hypertension\n\n### Drug\n- 5000 MG testosterone 0.01 MG/MG Topical Gel, through Transdermal route, started on 2011-06-07, presumably until 2011-09-13, with intended 6 refill(s). Instructions: apply 50 mg to skin Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-06-11 00:00:00, ended at 2011-06-11 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proteinuria\n- Kidney disease\n\n### Drug\n- sirolimus 2 MG Oral Tablet, through Oral route, started on 2011-06-11, presumably until 2012-04-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 10:43:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.40 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.66 (million per microliter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.28 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Essential hypertension\n- Kidney disease\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 08:41:00, ended at 2011-09-13 09:40:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.56 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 289 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.84 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Kidney disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 09:41:00, ended at 2011-09-13 11:10:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted bone marrow\n- Chronic graft-versus-host disease\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- 5000 MG testosterone 0.01 MG/MG Topical Gel, through Transdermal route, started on 2011-09-13, presumably until 2012-05-22, with intended 6 refill(s). Instructions: apply 50 Each to skin Every Day. 50 mg daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 11:11:00, ended at 2011-09-13 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic graft-versus-host disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-25 00:00:00, ended at 2011-09-25 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-10 09:44:05, ended at 2011-10-10 17:59:42\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic graft-versus-host disease\n- Dental caries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-31 14:40:00, ended at 2011-10-31 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 1.6 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.98 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.30 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Kidney disease\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-07 11:49:17, ended at 2011-11-07 12:40:06\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dental caries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-23 08:53:00, ended at 2012-01-23 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 134 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 40 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 37 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.6 (ratio)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 4.2 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Kidney disease\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Chronic graft-versus-host disease\n- Hematuria syndrome\n- Essential hypertension\n- Proteinuria\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 134.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "2e97f73a2cd87e6ebc97c2e4f70b443861ed85c41baee52edd1ed404e12a8ea9", "prompt_hash": "fe879d516f02492295364ea534d44e85c1e77cb0beb33a6c1fdacbfa0f6a0ebf", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 9, "doc": {"person_id": 115970629, "visit_occurrence_id": 41698396, "visit_start_datetime": "2010-12-23 13:49:00", "measurement_name": "ldl", "measurement_concept_name": "Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma", "current_value": 130.0, "current_label": 0, "next_value": 134.0, "next_label": 1, "threshold": "130", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Telehealth, started at 2009-01-24 00:00:00, ended at 2009-01-24 00:00:00\nThe patient in this visit was 65 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-03-17 00:00:00, ended at 2009-03-17 00:00:00\nThe patient in this visit was 65 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2009-03-18, presumably until 2009-09-21, with quantity of 90.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily. \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-03-18, presumably until 2009-09-21, with quantity of 180.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Please note that this replaces Toprol XL 50 mg. \n- irbesartan 150 MG Oral Tablet, through Oral route, started on 2009-03-18, presumably until 2009-09-21, with quantity of 90.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime. PLEASE DISPENSE GENERIC FORMULATION.  PATIENT WAS TOLD BY PHARMACY THAT THERE IS A GENERIC BRAND FOR AVAPRO. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-21 00:00:00, ended at 2009-09-21 00:00:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2009-09-21, presumably until 2009-12-22, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. FAX: 999-999-9999 \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-09-21, presumably until 2009-12-22, with quantity of 180.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Please note that this replaces Toprol XL 50 mg. FAX: 999-999-9999 \n- irbesartan 150 MG Oral Tablet, through Oral route, started on 2009-09-21, presumably until 2009-12-22, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime. PLEASE DISPENSE GENERIC FORMULATION.  PATIENT WAS TOLD BY PHARMACY THAT THERE IS A GENERIC BRAND FOR AVAPRO. FAX: 999-999-9999 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-29 14:11:01, ended at 2009-09-29 14:32:30\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-09-29, presumably until 2009-12-22, with intended 0 refill(s). Instructions: 1-2 Puffs by Inhalation route every 6 hours as needed \n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2009-09-29, presumably until 2009-12-22, with intended 0 refill(s). Instructions: take 5 mL by mouth every bedtime as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-22 10:54:12, ended at 2009-12-22 11:54:43\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- Body height: 5' 8.75\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2010-12-23, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. FAX: 999-999-9999 \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2010-12-23, with quantity of 180.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Please note that this replaces Toprol XL 50 mg. FAX: 999-999-9999 \n- valsartan 80 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2010-12-23, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-22 12:03:00, ended at 2009-12-22 23:59:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 135 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 246 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.3 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.51 (micro-international unit per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.4 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.9 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 10:49:00, ended at 2009-12-30 14:55:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 14:56:00, ended at 2009-12-30 23:59:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Heart murmur\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-12 09:54:00, ended at 2010-05-12 23:59:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Mammography; bilateral\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; diagnostic mammography (List separately in addition to code\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-23 12:50:06, ended at 2010-12-23 13:45:27\nThe patient in this visit was 67 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Primary malignant neoplasm of female breast\n- Insomnia\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2010-12-23, presumably until 2011-12-29, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. FAX: 999-999-9999 \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2010-12-23, presumably until 2011-12-29, with quantity of 180.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Please note that this replaces Toprol XL 50 mg. FAX: 999-999-9999 \n- valsartan 80 MG Oral Tablet, through Oral route, started on 2010-12-23, presumably until 2011-12-29, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2010-12-23, presumably until 2011-06-21, with quantity of 20.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every bedtime as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-23 13:49:00, ended at 2010-12-23 23:59:00\nThe patient in this visit was 67 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 6.98 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.5 (femtoliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 130 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Insomnia\n- Primary malignant neoplasm of female breast\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 11, "cumulated_approximate_token_count": 3314}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-01-24 00:00:00, ended at 2009-01-24 00:00:00\nThe patient in this visit was 65 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-03-17 00:00:00, ended at 2009-03-17 00:00:00\nThe patient in this visit was 65 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2009-03-18, presumably until 2009-09-21, with quantity of 90.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily. \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-03-18, presumably until 2009-09-21, with quantity of 180.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Please note that this replaces Toprol XL 50 mg. \n- irbesartan 150 MG Oral Tablet, through Oral route, started on 2009-03-18, presumably until 2009-09-21, with quantity of 90.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime. PLEASE DISPENSE GENERIC FORMULATION.  PATIENT WAS TOLD BY PHARMACY THAT THERE IS A GENERIC BRAND FOR AVAPRO. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-21 00:00:00, ended at 2009-09-21 00:00:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2009-09-21, presumably until 2009-12-22, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. FAX: 999-999-9999 \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-09-21, presumably until 2009-12-22, with quantity of 180.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Please note that this replaces Toprol XL 50 mg. FAX: 999-999-9999 \n- irbesartan 150 MG Oral Tablet, through Oral route, started on 2009-09-21, presumably until 2009-12-22, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime. PLEASE DISPENSE GENERIC FORMULATION.  PATIENT WAS TOLD BY PHARMACY THAT THERE IS A GENERIC BRAND FOR AVAPRO. FAX: 999-999-9999 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-29 14:11:01, ended at 2009-09-29 14:32:30\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-09-29, presumably until 2009-12-22, with intended 0 refill(s). Instructions: 1-2 Puffs by Inhalation route every 6 hours as needed \n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2009-09-29, presumably until 2009-12-22, with intended 0 refill(s). Instructions: take 5 mL by mouth every bedtime as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-22 10:54:12, ended at 2009-12-22 11:54:43\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- Body height: 5' 8.75\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2010-12-23, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. FAX: 999-999-9999 \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2010-12-23, with quantity of 180.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Please note that this replaces Toprol XL 50 mg. FAX: 999-999-9999 \n- valsartan 80 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2010-12-23, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-22 12:03:00, ended at 2009-12-22 23:59:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 135 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 246 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.3 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.51 (micro-international unit per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.4 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.9 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 10:49:00, ended at 2009-12-30 14:55:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 14:56:00, ended at 2009-12-30 23:59:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Heart murmur\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-12 09:54:00, ended at 2010-05-12 23:59:00\nThe patient in this visit was 66 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Mammography; bilateral\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; diagnostic mammography (List separately in addition to code\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-23 12:50:06, ended at 2010-12-23 13:45:27\nThe patient in this visit was 67 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Primary malignant neoplasm of female breast\n- Insomnia\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2010-12-23, presumably until 2011-12-29, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. FAX: 999-999-9999 \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2010-12-23, presumably until 2011-12-29, with quantity of 180.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Please note that this replaces Toprol XL 50 mg. FAX: 999-999-9999 \n- valsartan 80 MG Oral Tablet, through Oral route, started on 2010-12-23, presumably until 2011-12-29, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2010-12-23, presumably until 2011-06-21, with quantity of 20.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every bedtime as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-23 13:49:00, ended at 2010-12-23 23:59:00\nThe patient in this visit was 67 years old, unknown race, unknown ethnicity, FEMALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 6.98 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.5 (femtoliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 130 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Insomnia\n- Primary malignant neoplasm of female breast\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma value in the current visit is 130.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol in Low Density Lipoprotein [Mass/volume] in Serum or Plasma, normal values are 130 mg/dL or below, while abnormal values are above 130 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "781bb17cd4bac8baec7f2a5671e9145d070fa6d7eacaa4f0019fa88933af7056", "prompt_hash": "7eda1b3dc2341d9ffb346cc6dec155308cd0644338a22131f054a31e0c119b7b", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
